研究者基本情報

研究者

• 氏名

  樋口　徹也, ヒグチ　テツヤ

所属

• 放射線診断核医学分野, 准教授

基本情報

• 研究者氏名（日本語）

  樋口, 徹也

• 研究者氏名（カナ）

  ヒグチ, テツヤ

使用外国語

• 発表に使用する外国語

  英語

• 執筆に使用する外国語

  英語

所属

• 群馬大学, 准教授

所属部局等

• 所属情報

  大学院医学系研究科, 病態腫瘍制御学講座

• 職名情報

  准教授

学歴

• 1998年, 群馬大学, 医学研究科
• 1992年, 群馬大学, 医学部, 医学科
• 1998年, 群馬大学
• 1992年, 群馬大学

学位

• 博士（医学）

所属学協会

• 日本内科学会
• European Association of Nuclear Medicine
• 日本癌学会
• 日本医学放射線学会
• 日本核医学会
• The Society of Nuclear Medicine

経歴

• 2001年, 2007年
• 群馬大学
• 2007年, 2011年
• 群馬大学
• 2011年, 9999年
• 群馬大学
• 2001年, 2007年, 群馬大学医学部 助手
• 2007年, 2011年, 群馬大学大学院 助教
• 2011年, 9999年, 群馬大学大学院医学系研究科 准教授

研究活動情報

研究分野

• ライフサイエンス, 放射線科学

研究キーワード

• 腫瘍核医学 画像診断

研究テーマ

• RIを用いた腫瘍の診断と治療, RI、腫瘍、核医学, 機関内共同研究, 2001, 2002, 科学研究費補助金

論文

• An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma., Inaki A, Shiga T, Tsushima Y, Jinguji M, Wakabayashi H, Kayano D, Akatani N, Yamase T, Kunita Y, Watanabe S, Hiromasa T, Mori H, Hirata K, Watanabe S, Higuchi T, Tomonaga H, Kinuya S., 2022年03月, Ann Nucl Med, 36, 3, 267, 278

  DOI
• Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma., Wakabayashi H, Inaki A, Yoshimura K, Murayama T, Imai Y, Higuchi T, Jinguji M, Shiga T, Kinuya S., 2022年01月, Sci Rep, 19, 12(1), 1347

  DOI
• Most Important Prognostic Values to Predict Major Adverse Cardiovascular, Cerebrovascular, and Renal Events in Patients with Chronic Kidney Disease Including Hemodialysis for 2 Years., Toyama T, Kasama S, Sato M, Sano H, Ueda T, Sasaki T, Nakahara T, Higuchi T, Tsushima Y, Kurabayashi M., 2019年, Cardiology, 142, 1, 14, 23

  DOI
• Clinical value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis., Motegi SI, Fujiwara C, Sekiguchi A, Hara K, Yamaguchi K, Maeno T, Higuchi T, Hirasawa H, Kodaira S, Tomonaga H, Tsushima Y, Ishikawa O., 2019年03月, J Dermatol, 46, 3, 213, 218

  DOI
• Impact of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma., Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Tomonaga H, Higuchi T, Tsushima Y, Shirabe K., 2019年02月, Anticancer Res, 39, 2, 971, 977

  DOI
• Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer's Disease., Kasahara H, Ikeda M, Nagashima K, Fujita Y, Makioka K, Tsukagoshi S, Yamazaki T, Takai E, Sanada E, Kobayashi A, Kishi K, Suto T, Higuchi T, Tsushima Y, Ikeda Y., 2019年, J Alzheimers Dis, 68, 2, 797, 808

  DOI
• 18F-FDG and 18F-FAMT PET-derived metabolic parameters predict outcome of oral squamous cell carcinoma., Kim M, Higuchi T, Nakajima T, Andriana P, Hirasawa H, Tokue A, Kurihara J, Yokoo S, Tsushima Y., Oral Radiol, 35, 3, 308, 314

  DOI
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy., Tsukamoto N, Yokohama A, Higuchi T, Mitsui T, Koiso H, Takizawa M, Shimizu H, Ishizaki T, Matsumoto M, Toyama K, Sakura T, Ogura H, Saitoh T, Ishida F, Murakami H, Tsushima Y, Handa H., 2019年01月, Int J Hematol, 109, 1, 91, 97

  DOI
• Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer., Kasahara N, Kaira K, Yamaguchi K, Masubuchi H, Tsurumaki H, Hara K, Koga Y, Sakurai R, Higuchi T, Handa T, Oyama T, Yokobori T, Shimizu K, Asao T, Hisada T., 2019年08月, Lung Cancer, 134, 180, 186

  DOI
• Recurrent Lobar Hemorrhages and Multiple Cortical Superficial Siderosis in a Patient of Alzheimer's Disease With Homozygous APOE ε2 Allele Presenting Hypobetalipoproteinemia and Pathological Findings, Ikeda M, Okamoto K, Suzuki K, Takai E, Kasahara H, Furuta N, Furuta M, Tashiro Y, Shimizu C, Takatama S, Naito I, Sato M, Sakai Y, Takahashi M, Amari M, Takatama M, Higuchi T, Tsushima Y, Yokoo H, Kur, 2021年07月, Front Neurol, 7, 12, 645625

  DOI
• Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer., Kasahara N, Kaira K, Yamaguchi K, Masubuchi H, Tsurumaki H, Hara K, Koga Y, Sakurai R, Higuchi T, Handa T, Oyama T, Yokobori T, Shimizu K, Asao T, Hisada T., 2019年08月, Lung Cancer, 134, 180, 186

  DOI
• Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid., Kanai A, Hanaoka H, Yamaguchi A, Mahendra I, Palangka C, Ohshima Y, Higuchi T, Tsushima Y., 2022年01月, Nucl Med Biol, 104, 105, 47, 52

  DOI
• Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma., Takahashi H, Sakakura K, Arisaka Y, Tokue A, Kaira K, Tada H, Higuchi T, Okamoto A, Tsushima Y, Chikamatsu K., 2019年06月, Anticancer Res, 39, 6, 3039, 3046

  DOI
• Improvement of diagnostic accuracy of Parkinson's disease on I-123-ioflupane single photon emission computed tomography (123I FP-CIT SPECT) using new Japanese normal database., Kanzaki T, Higuchi T, Takahashi Y, Suto T, Tsushima Y., 2020年, Asia Ocean J Nucl Med Biol, 8, 2, 95, 101

  DOI
• Novel 18F-Labeled α-Methyl-Phenylalanine Derivative with High Tumor Accumulation and Ideal Pharmacokinetics for Tumor-Specific Imaging., Hanaoka H, Ohshima Y, Yamaguchi A, Suzuki H, Ishioka NS, Higuchi T, Arano Y, Tsushima Y., 2019年08月, Mol Pharm, 5, 16(8), 3609, 3616

  DOI
• A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma., Wakabayashi H, Inaki A, Yoshimura K, Murayama T, Imai Y, Higuchi T, Jinguji M, Shiga T, Kinuya S., 2019年05月, 20, 9(1)
• Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy., Sakashita T, Matsumoto S, Watanabe S, Hanaoka H, Ohshima Y, Ikoma Y, Ukon N, Sasaki I, Higashi T, Higuchi T, Tsushima Y, Ishioka NS., 2021年12月, EJNMMI Phys, 11, 8(1), 80

  DOI
• Evaluation of a Correction Method for 111In-Pentetreotide SPECT Imaging of Gastroenteropancreatic Neuroendocrine Tumors., Kanzaki T, Takahashi Y, Higuchi T, Zhang X, Mogi N, Suto T, Tsushima Y., 2020年12月, J Nucl Med Technol, 48, 4, 326, 330

  DOI
• Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study., Mukada N, Tosaka M, Matsumura N, Yamaguchi R, Aihara M, Isoda K, Higuchi T, Tsushima Y, Yokoo H, Yoshimoto Y., 2021年01月, Sci Rep, 8, 11(1), 126

  DOI
• Texture analysis of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinom, Kim M, Gu W, Nakajima T, Higuchi T, Ogawa M, Shimizu T, Yamaguchi T, Takahashi A, Tsushima Y, Yokoo S., 2021年08月, Ann Nucl Med, 35, 8, 871, 880

  DOI
• Rapid-Onset Dystonia-Parkinsonism Phenotype Consistency for a Novel Variant of ATP1A3 in Patients Across 3 Global Populations., Hoshino K, Sweadner KJ, Kawarai T, Saute JA, Freitas J, Damasio J, Donis KC, Kimura K, Fukuda H, Hayashi M, Higuchi T, Ikeda Y, Ozelius LJ, Kaji R., 2021年03月, Neurol Genet, 15, 7(2), e562

  DOI
• Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease., Ikeda M, Kodaira S, Kasahara H, Takai E, Nagashima K, Fujita Y, Makioka K, Hirayanagi K, Furuta N, Furuta M, Sanada E, Kobayashi A, Harigaya Y, Nagamine S, Hattori N, Tashiro Y, Kishi K, Shimada H, Su, 2021年04月, Front Neurol., 6, 12, 543866

  DOI
• FDG-PET for preoperative evaluation of tumor invasion in ampullary cancer: A retrospective analysis., Watanabe A, Harimoto N, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Hirai K, Tanaka H, Mochida Y, Kogure N, Higuchi T, Shirabe K., 2021年09月, J Surg Oncol, 124, 3, 317, 323

  DOI
• Absorbed dose simulation of meta-211At-astato-benzylguanidine using pharmacokinetics of 131I-MIBG and a novel dose conversion method, RAP., Sakashita T, Watanabe S, Hanaoka H, Ohshima Y, Ikoma Y, Ukon N, Sasaki I, Higashi T, Higuchi T, Tsushima Y, Ishioka NS., 2021年01月, Ann Nucl Med, 35, 1, 121, 131

  DOI
• Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET., Zhang H. / Tian M. / ORIUCHI NOBORU / HIGUCHI TETSUYA / Tanada S. / ENDO KEIGO, 2002年05月, The British Journal of Radiology
• A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer., Khan N. / ORIUCHI NOBORU / Zhang H. / HIGUCHI TETSUYA / Tian M. / Inoue T. / SATO NORIKO / ENDO KEIGO, 2003年04月, Nuclear Mediicne Communications
• PET in the follow-up of differentiated thyroid cancer., Khan N. / ORIUCHI NOBORU / HIGUCHI TETSUYA / Zhang H. / ENDO KEIGO, 2003年10月, The British Journal of Radiology
• Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor., Takasu, S., Takahashi, T., Okamoto, S., Oriuchi, N., Nakayashiki, N., Okamoto, K., Muramatsu, H., Hayashi, T., Nakahara, N., Mizuno, M., Wakabayashi, T., Higuchi, T., Endo, K., Kozaki, K., Miyaishi, O., Saga, S., Ueda, R., Yoshida, J., Yoshikawa, K., 2003年03月, Journal Neuro-Oncology
• 11C-choline PET for the detection of bone and soft tissue tumorurs in comparison with FDG PET, WATANABE HIDEOMI / ORIUCHI NOBORU / HIGUCHI TETSUYA / ENDO KEIGO / Aoki Jun, 2003年06月, Nucl. Med. Commun.
• Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET., Tian, M / Koyama, K. / Zhang, H. / ORIUCHI NOBORU / HIGUCHI TETSUYA / ENDO KEIGO, 2003年04月, Nuclear Medicine Communications
• 11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET., Zhang H. / Tian M. / ORIUCHI NOBORU / HIGUCHI TETSUYA / WATANABE HIDEOMI / AOKI JUN / Tanada S. / ENDO KEIGO, 2003年03月, Nuclear Medicine Communications
• Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET., Zhang Hong / Tian Mei / ORIUCHI NOBORU / HIGUCHI TETSUYA / Tanada Syuji / ENDO KEIGO, 2003年, EJR
• FDG-PET検査のがん診療への臨床応用（悪性リンパ腫）, 樋口 徹也, 2002年05月, 日本医学放射線学会雑誌, 62, 6, 278-283
• 悪性リンパ腫患者の診療におけるPETの有用性., 樋口 徹也 / 井上登美夫, 2001年, 血液・腫瘍科, 43(4):272-278
• PETの放射線治療への応用, 樋口 徹也 / 織内 昇 / 遠藤 啓吾, 2002年11月, 映像情報Medical, 34, 1316-1320
• Oncological diagnosis using 11C-choline-positron emission tomography in comparison with 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography., Mei Tian / Hong Zhang / HIGUCHI TETSUYA / ORIUCHI NOBORU / ENDO KEIGO, 2004年, Mol Imag Biol
• Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging., Mei Tian / Zhang Hong / HIGUCHI TETSUYA / ORIUCHI NOBORU / NAKASONE YOSHIKI / TAKATA KUNIAKI / Nakajima N. / MOGI KENJI / ENDO KEIGO, 2005年06月, Ann Nucl Med
• Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas., KHAN NASIM MOHAMMAD / ORIUCHI NOBORU / HIGUCHI TETSUYA / ENDO KEIGO, 2005年10月, Cancer Control
• Pulmonary thromboembolism -Evaluating the indication and effect of a vena caval filter with indium-111-platelet scintigraphy-., YAGI AKIKO / ORIUCHI NOBORU / SATO NORIKO / AOKI JUN / HIGUCHI TETSUYA / ENDO KEIGO, 2004年06月, Circ J
• Usefulness of FDG-PET in the evaluation of diffuse pulmonary involvement of malignant lymphoma., HIGUCHI TETSUYA / ORIUCHI NOBORU / MIYAKUBO MITSUYUKI / OOTAKE HIDENORI / MATSUBARA KUNIO / KHAN NASIM MOHAMMAD / 田　梅 / ENDO KEIGO, 2004年, International Congress Series
• Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET., KHAN NASIM MOHAMMAD / ORIUCHI NOBORU / NINOMIYA HIROSHI / HIGUCHI TETSUYA / KAMADA HIDEO / ENDO KEIGO, 2004年07月, Ann Nucl Med
• Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice., Mei Tian / Hong Zhang / HIGUCHI TETSUYA / ORIUCHI NOBORU / Tomio Inoue / ENDO KEIGO, 2004年05月, Cancer Biother Radiopharm
• Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: Comparative study with 2-[18F]fluoro-2-dexy-D-glucose (FDG) PET, NINOMIYA HIROSHI / ORIUCHI NOBORU / Nasim Kahn / HIGUCHI TETSUYA / ENDO KEIGO / TAKAHASHI KATSUMASA / CHIKAMATSU KAZUAKI / KAMADA HIDEO / FURUYA NOBUHIKO, 2004年02月, Ann Nucl Med
• Diagnositic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer., KHAN NASIM MOHAMMAD / ORIUCHI NOBORU / Yoshizaki, A. / Kanuma, T. / HIGUCHI TETSUYA / ENDO KEIGO, 2005年04月, Ann Nucl Med
• Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors., Mei Tian / Hong Zhang / ORIUCHI NOBORU / HIGUCHI TETSUYA / ENDO KEIGO, 2004年03月, Eur J Nucl Med Mol Imaging
• FDG-PETによる頭頚部腫瘍診断．, 織内 昇 / 宮久保 満之 / 樋口 徹也 / 二宮 洋 / 近松 一朗 / 鎌田 英男 / 遠藤 啓吾, 2004年, 頭頚部癌, 30, 3, 439-444
• Current status of cancer therapy with radiolabeled monoclonal antibody., ORIUCHI NOBORU / HIGUCHI TETSUYA / HANAOKA HIROFUMI / IIDA YASUHIKO / ENDO KEIGO, 2005年07月, Ann Nucl Med
• がんの分子画像診断の動向．, 樋口 徹也 / 織内 昇 / 宮久保 満之 / 新井 清和 / 遠藤 啓吾, 2004年, がん分子標的治療, 2, 2, 170-173
• FDG-PETが診断の契機となったPancoast腫瘍の1例．, 2002., 濱口真吾 / 織内 昇 / 樋口 徹也 / 市川聡裕 / 小山 恵子 / 青木 純 / 井上登美夫 / 福里利夫 / 遠藤 啓吾, 2002年, 画像診断, 22, 58-62
• ポジトロンCTが特徴的な所見を示した全身サルコイドーシスの2例., 濱口真吾 / 織内 昇 / 樋口 徹也 / 市川聡裕 / 小山 恵子 / 冨吉勝美 / 青木 純 / 井上登美夫 / 遠藤 啓吾, 2001年, 画像診断, 21(11):1232-1237
• カドミウム亜鉛テルライド半導体検出器を使用した小型ガンマカメラの性能評価., 大竹英則、樋口徹也、竹内康直、流王英樹、神保昌夫、松原國夫、小山一郎、織内　昇、井上登美夫、遠藤啓吾．, 2002年11月, 核医学, 39, 549-553
• Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer. , Khan N., Oriuchi, N., Yoshizaki, A., Kanuma, T., Higuchi, T., Endo, K, 2005年04月, Annals of Nuclear Medicine
• Clinicopathological presentation of varying (18)F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma, Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Higuchi T, Miyakubo M, Ishikita T, Nakajima T, Endo K., 2008年01月, Ann Nucl Med
• Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging (DWI): Comparison with 18F-FDG positron emission tomography (PET) and 123I-MIBG scintigraphy. , Takano A, Oriuchi N, Tsushima Y, Taketomi-Takahashi A, Higuchi H, Nakajima T, Ishikita T, Arisaka Y, Amanuma M, Endo K. , 2008年, Ann Nuc Med
• Biodistribution and scintigraphy of [111ln]DTPA-adriamycin in mammaary tumor-bearing rats., HIGUCHI TETSUYA / Yang DJ. / IIgan S. / Tansey LW. / Zareneyrizi F. / Inoue T. / ENDO KEIGO / Kim EE. / Podoloff DA., 1999年, Anticancer Drugs
• Biodistribution studies on L-3-[Fluorine-18]fluoro-a-methyl tyrosine : A potential tumor-detecting agent, Inoue T. / Tomiyoshi K. / HIGUCHI TETSUYA / Ahmed K. / Sarwar M. / koyama keiko / Amano S. / Aflyafei S. / Zhan H. / ENDO KEIGO, 1998年04月, J Nucl Med
• Evaluation of thoracic tumors with 18F-FMT and 18F-FDG PET-CT: A clinicopathological study., Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M., 2009年, Int J Cancer
• Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy. , Hamamoto K, Oriuchi N, Kanazawa T, Higuchi T, Endo K., 2009年, PEDIATRIC NEUROLOGY
• Dual functional molecular imaging probe targeting CD20 with PET and optical imaging., Paudyal P, Paudyal B, Iida Y, Oriuchi N, Hanaoka H, Tominaga H, Ishikita T, Yoshioka H, Higuchi T, Endo K. , 2009年, ONCOLOGY REPORTS
• Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. , Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M. , 2009年04月, Cancer Sci.
• L-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. , Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. , 2009年12月, Cancer Sci.
• Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity., Hanaoka H, Katagiri T, Fukukawa C, Yoshioka H, Yamamoto S, Iida Y, Higuchi T, Oriuchi N, Paudyal B, Paudyal P, Nakamura Y, Endo K., 2009年, Ann Nucl Med
• Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography., Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T, Endo K., 2008年02月, Cancer Sci.
• In vitro effect of contrast agents during immunoradimetric assay for tumour-associated antigens, Watanabe N, Oriuchi N, Higuchi T, Yukihiro M, Fukushima Y, Tomiyoshi K, Hirano T, Inoue T, Endo K., 1998年, Nucl Med Commun
• Technetium-99m-labeled chimeric human/mouse antigranulocyte antibody bone marrow scintigraphy: A Preliminary clinical study, Higuchi T, Inoue T, Sarwar M, Oriuchi N, Karasawa M, Naruse T, Yamanaka H, Watanabe T, Chung JK, Endo K., 1998年, Nucl Med Commun
• Preparation of yttrium-90-labeled human macroaggregated albumin for regional radiotherapy, Watnabe N, Oriuchi N, Igarashi H, Higuchi T, Yukihiro M, Fukushima Y, Tomiyoshi K, Hirano T, Inoue T, Endo K., 1997年, Nucl Med Biol
• Grade II astrocytoma visualized by technetium-99m-ECD SPECT, Hirano T, Suzuki H, Higuchi T, Watnabe N, Oriuchi N, Shibazaki , 1996年, Clin Nudl Med
• Different biodistribution of 99mTc-labeled chimeric mouse-human monoclonal antibody between athymic mice model and human, Oriuchi N, Watanabe N, Sugiyama S, Higuchi T, Imai K, Yamanaka H, Hashimoto M, Kanda H, Endo K, 1996年, Br J Cancer
• Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy, Ishikita T, Oriuchi N, Higuchi T, Miyashita G, Arisaka Y, Paudyal B, Paudyal P, Hanaoka H, Miyakubo M, Nakasone Y, Negishi A, Yokoo S, Endo K., 2010年, Ann Nucl Med
• 99mTc-labeled chimeric antij-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging, Sarwar M, Higuchi T, Tomiyoshi K, Inoue T, Oriuchi N, Khalil A, Alyafei S, Sakahara H, Chung JK, Endo K., 1998年, Radiat Med
• Noninvasive measurement of renal function with 99mTc-MAG3 gamma-camera renograohy based on the one-compartment model, Oriuchi N, Onishi Y, Kitamura H, Inoue T, Tomaru Y, Higuchi T, Inoue T, Endo K., 1998年, Clin Nephrol
• Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors. , Hanaoka H, Tominaga H, Yamada K, Paudyal P, Iida Y, Watanabe S, Paudyal B, Higuchi T, Oriuchi N, Endo K., 2009年08月, Ann Nucl Med.
• 癌診断および癌スクリーニング検査としてのFDG-PETと拡散強調MRIの有用性, 遠藤啓吾,織内昇,樋口徹也,堀越浩幸,渡辺祐司,落合礼次,那須克宏, 2008年, 核医学, 45, 2, 130-131
• Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment, Kurosaki H, Oriuchi N, Okazaki A, Tamaki T, Uki A, Izuta M, Kojima R, Kato Y, Higuchi T, Maruno H, 2006年, Ann Nucl Med
• Evaluation of In-111-paclitaxel scintigraphy to predict response on musine tumors to paclitaxel, Inoue T, Li C, Yang DJ, Higuchi T, Oriuchi N, Yu DF, Milas L, Hunter NR, Wallace S, Kim EE, Podoloff DA, 1999年, Ann Nucl Med
• 透析医療におけるアイソトープ診断と治療, 樋口徹也、織内　昇、有坂有紀子、宮下　剛、石北朋宏、対馬義人、遠藤啓吾, 2008年, 日本透析医学会雑誌, 23, 3, 415-419
• Direct labeling of macroaggregated albumin with indium-111-chloride using acetate buffer, Watnabe N, Shirakami Y, Tomiyoshi K, Oriuchi N, Hirano T, Higuchi T, Inoue T, Endo K., 1997年, J Nucl Med
• Fill-in after reinjection of Tc-99m MAA, Watanabe N, Oriuchi N, Higuchi T, Yukihiro M, Fukushima Y, Hirano T, Inoue T, Endo K., 1998年, Clin Nuc Med
• 甲状腺分化癌のRI内照射療法, 樋口徹也、織内　昇, 2009年, 臨床画像, 25 , 585-591
• PET/CT診断特集肺癌-診断・治療の実際, 樋口徹也、織内　昇、宮下　剛、有坂有紀子、遠藤啓吾, 2010年, 臨床画像, 26, 2, 162-169
• 18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with 18F-FDG PET and immunohistochemistry., Miyashita G, Higuchi T, Oriuchi N, Arisaka Y, Hanaoka H, Tominaga H, Morita S, Miyakubo M, Ishikita T, Nakasone Y, Negishi A, Yokoo S, Endo K., 2010年10月, Ann Nucl Med.
• Pulmonary artery intimal sarcoma: the role of 18F-fluorodeoxyglucose positron emission tomography in monitoring response to treatment. , Ote EL, Oriuchi N, Miyashita G, Paudyal B, Ishikita T, Arisaka Y, Higuchi T, Hirato J, Endo K., 2011年04月, Jpn J Radiol.
• Clinical significance of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma., Nakazawa A, Higuchi T, Oriuchi N, Arisaka Y, Endo K., 2011年10月, Eur J Nucl Med Mol Imaging.
• Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma., Nakano S, Tsushima Y, Taketomi-Takahashi A, Higuchi T, Amanuma M, Oriuchi N, Endo K., 2011年07月, Jpn J Radiol.
• In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy., Yoshioka H, Yamamoto S, Hanaoka H, Iida Y, Paudyal P, Higuchi T, Tominaga H, Oriuchi N, Nakagawa H, Shiba Y, Yoshida K, Osawa R, Katagiri T, Tsunoda T, Nakamura Y, Endo K., 2012年08月, Cancer Immunol Immunother.
• Contrast-and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma., Nakano S, Tsushima Y, Higuchi T, Taketomi-Takahashi A, Amanuma M., 2012年05月, Jpn J Radiol.
• 18F-FAMT in patients with multiple myeloma: clinical utility compared to 18F-FDG., Isoda A, Higuchi T, Nakano S, Arisaka Y, Kaira K, Kamio T, Mawatari M, Matsumoto M, Sawamura M, Tsushima Y., 2012年08月, Ann Nucl Med.
• 特集 最近の核医学検査・PETと核医学治療 核医学治療（アイソトープ治療）., 樋口徹也, 岡内研三, 織内　昇, 遠藤啓吾, 2010年, 画像診断, 30, 1198-1206
• 肺癌のPET診断, 樋口徹也, 有坂有紀子, 中澤梓, 対馬義人, 織内昇, 遠藤啓吾, 2012年, 肺癌, 52, 161-167
• 核医学におけるチームワーク医療の試み－骨シンチ診断支援ソフトBONENAVIの積極的活用－, 樋口徹也, 2012年, みちのく核医学の会会誌, 19, 43-47
• シンチグラフィ　　 , 2011年04月, 内分泌画像検査・診断マニュアル　診断と治療社
• 123I-IMP脳血流SPECTノーマルデータベース（NDB）作成時の散乱および減弱補正が統計学的画像解析結果に与える影響., 2012年11月, 日本核医学会機関誌, 49, 341-349
• 核医学におけるチームワーク医療の試み－骨シンチ診断支援ソフトBONENAVIの積極的活用－. , 2012年01月, みちのく核医学の会会誌, 19, 43-47
• Differentiation of malignant tumours from granulomas by using dynamic [F-18]-fluoro-L-alpha-methyltyrosine positron emission tomography, Yamaguchi, Aiko; Hanaoka, Hirofumi; Fujisawa, Yutaka; Zhao, Songji; Suzue, Kazutomo; Morita, Akihiro; Tominaga, Hideyuki; Higuchi, Tetsuya; Hisaeda, Hajime; Tsushima, Yoshito; Kuge, Yuji; Iida, Yasuhiko, 2015年, EJNMMI RESEARCH

  DOI
• Superficial Siderosis of the Central Nervous System Caused by Hemorrhagic Intraventricular Craniopharyngioma: Case Report and Literature Review, Tosaka, Masahiko; Sato, Koji; Amanuma, Makoto; Higuchi, Tetsuya; Arai, Motohiro; Aishima, Kaoru; Shimizu, Tatsuya; Horiguchi, Keishi; Sugawara, Kenichi; Yoshimoto, Yuhei, 2015年, NEUROLOGIA MEDICO-CHIRURGICA

  DOI
• Effects of Intratumoral Inflammatory Process on F-18-FDG Uptake: Pathologic and Comparative Study with F-18-Fluoro-alpha-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma, Kim, Mai; Achmad, Arifudin; Higuchi, Tetsuya; Arisaka, Yukiko; Yokoo, Hideaki; Yokoo, Satoshi; Tsushima, Yoshito, 2015年, JOURNAL OF NUCLEAR MEDICINE

  DOI
• Effects and safety of I-131-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results, from a multicenter observational registry, Yoshinaga, Keiichiro; Oriuchi, Noboru; Wakabayashi, Hiroshi; Tomiyama, Yuuki; Jinguji, Megumi; Higuchi, Tetsuya; Kayano, Daiki; Fukuoka, Makoto; Inaki, Anri; Toratani, Ayane; Okamoto, Shozo; Shiga, Tohru; Ito, Yoichi M.; Nakajo, Masatoyo; Nakajo, Masayuki; Kinuya, Seigo, 2015年12月, ENDOCRINE JOURNAL
• L-[3-F-18]-alpha-Methyltyrosine Uptake by Lymph Node Metastasis Is a Predictor of Complete Response to CRT in Esophageal Cancer, Sohda, Makoto; Miyazaki, Tatsuya; Honjyo, Hiroaki; Hara, Keigo; Ozawa, Daigo; Suzuki, Shigemasa; Tanaka, Naritaka; Sano, Akihiko; Sakai, Makoto; Yokobori, Takehiko; Nakajima, Masanobu; Fukuchi, Minoru; Kato, Hiroyuki; Higuchi, Tetsuya; Tsushima, Yoshito; Kuwano, Hiroyuki, 2014年12月, ANTICANCER RESEARCH
• Case of radioactive iodine exposure during pregnancy, Sadakata, Hisanobu; Shinozaki, Hiromitsu; Higuchi, Tetsuya; Minegishi, Takashi, 2015年12月, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

  DOI
• CSF levels of A beta 1-38/A beta 1-40/A beta 1-42 and C-11 PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease, Ikeda, Masaki; Tashiro, Yuichi; Takai, Eriko; Kurose, Sachiko; Fugami, Naoko; Tsuda, Kazuhisa; Arisaka, Yukiko; Kodaira, Sayaka; Fujita, Yukio; Makioka, Kouki; Mizuno, Yuji; Shimada, Hirotaka; Harigaya, Yasuo; Takatama, Masamitsu; Amari, Masakuni; Yamazaki, Tsuneo; Yamaguchi, Haruyasu; Higuchi, Tetsuya; Okamoto, Koichi; Tsushima, Yoshito; Ikeda, Yoshio, 2014年12月, AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

  DOI
• Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT, Okamura, Koichi; Yonemoto, Yukio; Okura, Chisa; Higuchi, Tetsuya; Tsushima, Yoshito; Takagishi, Kenji, 2014年11月, BMC MUSCULOSKELETAL DISORDERS

  DOI
• Use of Pre-treatment F-18-FAMT PET to Predict Patient Survival in Squamous Cell Carcinoma of the Esophagus Treated by Curative Surgery, Sohda, Makoto; Sakai, Makoto; Honjyo, Hiroaki; Hara, Keigo; Ozawa, Daigo; Suzuki, Shigemasa; Tanaka, Naritaka; Yokobori, Takehiko; Miyazaki, Tatsuya; Fukuchi, Minoru; Higuchi, Tetsuya; Tsushima, Yoshito; Kuwano, Hiroyuki, 2014年, ANTICANCER RESEARCH
• A case of multiple hepatic angiomyolipomas with high F-18-fluorodeoxyglucose uptake, Kumasaka, Soma; Arisaka, Yukiko; Tokue, Azusa; Higuchi, Tetsuya; Nakajima, Takahito; Tsushima, Yoshito, 2014年, BMC MEDICAL IMAGING

  DOI
• Fractionated Radioimmunotherapy with Y-90-Labeled Fully Human Anti-CEA Antibody, Hanaoka, Hirofumi; Kuroki, Masahide; Yamaguchi, Aiko; Achmad, Arifudin; Iida, Yasuhiko; Higuchi, Tetsuya; Oriuchi, Noboru; Tsushima, Yoshito; Endo, Keigo, 2014年, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

  DOI
• L[3-F-18]-alpha-Methyltyrosine Accumulation as a Definitive Chemoradiotherapy Response Predictor in Patients with Esophageal Cancer, Sohda, Makoto; Honjyo, Hiroaki; Hara, Keigo; Ozawa, Daigo; Suzuki, Shigemasa; Tanaka, Naritaka; Sano, Akihiko; Sakai, Makoto; Yokobori, Takehiko; Inose, Takanori; Miyazaki, Tatsuya; Ojima, Hitoshi; Higuchi, Tetsuya; Tsushima, Yoshito; Kuwano, Hiroyuki, 2014年, ANTICANCER RESEARCH
• Effectiveness of FDG-PET in Screening of Synchronous Cancer of Other Organs in Patients with Esophageal Cancer, Miyazaki, Tatsuya; Sohda, Makoto; Higuchi, Tetsuya; Tanaka, Naritaka; Suzuki, Shigemasa; Sakai, Makoto; Yokobori, Takehiko; Nakajima, Masanobu; Fukuchi, Minoru; Tsushima, Yoshito; Kato, Hiroyuki; Kuwano, Hiroyuki, 2014年, ANTICANCER RESEARCH
• Complementary roles of tumour specific PET tracer F-18-FAMT to F-18-FDG PET/CT for the assessment of bone metastasis, Morita, Motoho; Higuchi, Tetsuya; Achmad, Arifudin; Tokue, Azusa; Arisaka, Yukiko; Tsushima, Yoshito, 2013年10月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

  DOI
• Diagnostic usefulness of F-18-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma, Nobusawa, Aiko; Kim, Mai; Kaira, Kyoichi; Miyashita, Go; Negishi, Akihide; Oriuchi, Noboru; Higuchi, Tetsuya; Tsushima, Yoshito; Kanai, Yoshikatsu; Yokoo, Satoshi; Oyama, Tetsunari, 2017年10月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

  DOI
• Clinical significance of F-18-alpha-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with F-18-FDG PET/CT and MRI, Kim, Mai; Higuchi, Tetsuya; Arisaka, Yukiko; Achmad, Arifudin; Tokue, Azusa; Tominaga, Hideyuki; Miyashita, Go; Miyazaki, Hidetaka; Negishi, Akihide; Yokoo, Satoshi; Tsushima, Yoshito, 2013年, ANNALS OF NUCLEAR MEDICINE

  DOI
• Metabolic activity by F-18-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC, Kaira, Kyoichi; Higuchi, Tetsuya; Naruse, Ichiro; Arisaka, Yukiko; Tokue, Azusa; Altan, Bolag; Suda, Satoshi; Mogi, Akira; Shimizu, Kimihiro; Sunaga, Noriaki; Hisada, Takeshi; Kitano, Shigehisa; Obinata, Hideru; Yokobori, Takehiko; Mori, Keita; Nishiyama, Masahiko; Tsushima, Yoshihito; Asao, Takayuki, 2018年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

  DOI
• Evaluation of muscle activity just after straight leg raising exercise by using (18)FDG-PET, Shiozawa, Hiroyuki; Ohsawa, Takashi; Tsushima, Yoshito; Higuchi, Tetsuya; Takagishi, Kenji; Chikuda, Hirotaka, 2018年, JOURNAL OF ORTHOPAEDIC SCIENCE

  DOI
• Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors., Yamaguchi A, Hanaoka H, Higuchi T, Tsushima Y., 2018年, JOURNAL OF NUCLEAR MEDICINE

  DOI
• 18F-FAMT PET Is Useful to Distinguish between Specific Uptake and Nonspecific Uptake Compared to 18F-Flourodeoxyglucose Position Emission Tomography in Esophageal Cancer Patients., Sohda M, Miyazaki T, Honjyo H, Hara K, Ozawa D, Sakai M, Yokobori T, Higuchi T, Tsushima Y, Kuwano H, 2017年11月, DIGESTIVE SURGERY

  DOI
• Quantitative Analysis of Iodine Image of Dual-energy Computed Tomography at Rest: Comparison With 99mTc-Tetrofosmin Stress-rest Single-photon Emission Computed Tomography Myocardial Perfusion Imaging as the Reference Standard, Nakahara T, Toyama T, Jinzaki M, Seki R, Saito Y, Higuchi T, Yamada M, Arai M, Tsushima Y, Kuribayashi S, Kurabayashi M, 2018年, JOURNAL OF THORACIC IMAGING

  DOI
• A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma: a study protocol., Inaki A, Yoshimura K, Murayama T, Imai Y, Kuribayashi Y, Higuchi T, Jinguji M, Shiga T, Kinuya S, 2017年, The Journal of Medical Investigation

  DOI
• 最近の核医学診療その進歩とこれから., 樋口徹也, 2017年, 臨床画像, 33, 4, 391
• Computer-assisted Diagnosis of Metastases Based on Bone Scintigraphy:Lesion Detection Compared Using BONENAVI 1 and 2., Tomonaga H, Nakajima T, Arisaka Y, Azusa T, Higuchi T, Tsushima Y, 2017年11月, The Kitakanto Medical Journal

  DOI
• Biological significance of fluorine-18-alpha-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer, Suzuki, S.; Kaira, K.; Ohshima, Y.; Ishioka, N. S.; Sohda, M.; Yokobori, T.; Miyazaki, T.; Oriuchi, N.; Tominaga, H.; Kanai, Y.; Tsukamoto, N.; Asao, T.; Tsushima, Y.; Higuchi, T.; Oyama, T.; Kuwano, H., 2014年, BRITISH JOURNAL OF CANCER

  DOI
• 「IgG4関連疾患の画像所見を整理する」核医学所見‐特にFDG-PETの有用性‐, 徳江 梓, 樋口 徹也, 有坂 有紀子, 徳江 浩之, 対馬 義人, 2014年, 臨床画像, 30, 1
• Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective., Higuchi T, Achmad A, Binh DD, Bhattarai A, Tsushima Y., 2018年, ENDOCRINE JOURNAL

  DOI
• Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma, Kasahara, Norimitsu; Kaira, Kyoichi; Bao, Pinjie; Higuchi, Tetsuya; Arisaka, Yukiko; Erichem-Ochir, Bilguun; Sunaga, Noriaki; Ohtaki, Yoichi; Yajima, Toshiki; Kosaka, Takayuki; Oyama, Tetsunari; Yokobori, Takehiko; Asao, Takayuki; Nishiyama, Masahiko; Tsushima, Yoshito; Kuwano, Hiroyuki; Shimizu, Kimihiro; Mogi, Akira, 2018年, LUNG CANCER

  DOI
• Normal database (NDB) of 123I-IMP brain perfusion SPECT examination is affected by statistical image analysis in the presence or absence of scatter correction and attenuation correction., Shimada H, Otake H, Higuchi T, Arisaka Y, Oriuchi N, Endo K, 2012年11月, Kaku Igaku.
• The diagnostic performance of F-18-FAMT PET and F-18-FDG PET for malignancy detection: a meta-analysis, Achmad, Arifudin; Bhattarai, Anu; Yudistiro, Ryan; Heryanto, Yusri Dwi; Higuchi, Tetsuya; Tsushima, Yoshito, 2017年12月, BMC MEDICAL IMAGING

  DOI
• Iodine concentration calculated by dual-energy computed tomography (DECT) as a functional parameter to evaluate thyroid metabolism in patients with hyperthyroidism, Duong Duc Binh; Nakajima, Takahito; Otake, Hidenori; Higuchi, Tetsuya; Tsushima, Yoshito, 2017年, BMC MEDICAL IMAGING

  DOI
• Preoperative Evaluation of Sellar and Parasellar Macrolesions by [F-18] Fluorodeoxyglucose Positron Emission Tomography, Tosaka, Masahiko; Higuchi, Tetsuya; Horiguchi, Keishi; Osawa, Tadashi; Arisaka, Yukiko; Fujita, Haruyasu; Tsushima, Yoshito; Yoshimoto, Yuhei, 2017年, WORLD NEUROSURGERY

  DOI
• Clinical value of fluorine-18a-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET, Horiguchi, Keishi; Tosaka, Masahiko; Higuchi, Tetsuya; Arisaka, Yukiko; Sugawara, Kenichi; Hirato, Junko; Yokoo, Hideaki; Tsushima, Yoshito; Yoshimoto, Yuhei, 2017年12月, EJNMMI RESEARCH

  DOI
• Usefulness of F-18-alpha-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer, Kaira, Kyoichi; Higuchi, Tetsuya; Sunaga, Noriaki; Arisaka, Yukiko; Hisada, Takeshi; Tominaga, Hideyuki; Oriuchi, Noboru; Asao, Takayuki; Tsushima, Yoshihito; Yamada, Masanobu, 2016年12月, ANTICANCER RESEARCH

  DOI
• Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma, Okano, Yudai; Satoh, Tetsurou; Horiguchi, Kazuhiko; Toyoda, Minoru; Osaki, Aya; Matsumoto, Shunichi; Tomaru, Takuya; Nakajima, Yasuyo; Ishii, Sumiyasu; Ozawa, Atsushi; Shibusawa, Nobuyuki; Shimada, Takehiro; Higuchi, Tetsuya; Chikamatsu, Kazuaki; Yamada, Masanobu, 2014年10月, ENDOCRINE JOURNAL

  DOI
• Advantages of L-3-[F-18] fluoro-alpha-methyl tyrosine over 2-[F-18]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan, Kodaira, Sayaka; Nakajima, Takahito; Arisaka, Yukiko; Tokue, Azusa; Higuchi, Tetsuya; Tsushima, Yoshito, 2016年, SPRINGERPLUS

  DOI
• Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study, Kasama, Shu; Toyama, Takuji; Sato, Makito; Sano, Hirokazu; Ueda, Tetsuya; Sasaki, Toyoshi; Nakahara, Takehiro; Higuchi, Tetsuya; Tsushima, Yoshito; Kurabayashi, Masahiko, 2016年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

  DOI
• A new approach for simple radioisotope cisternography examination in cerebrospinal fluid leakage detection, Hoshino, Hiromitsu; Higuchi, Tetsuya; Achmad, Arifudin; Taketomi-Takahashi, Ayako; Fujimaki, Hiroya; Tsushima, Yoshito, 2016年, ANNALS OF NUCLEAR MEDICINE

  DOI
• Evaluation of bone scan index change over time on automated calculation in bone scintigraphy, Shintawati, Rini; Achmad, Arifudin; Higuchi, Tetsuya; Shimada, Hirotaka; Hirasawa, Hiromi; Arisaka, Yukiko; Takahashi, Ayako; Nakajima, Takahito; Tsushima, Yoshito, 2015年12月, ANNALS OF NUCLEAR MEDICINE

  DOI
• Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands, Tokue, Azusa; Higuchi, Tetsuya; Arisaka, Yukiko; Nakajima, Takahito; Tokue, Hiroyuki; Tsushima, Yoshito, 2015年, ANNALS OF NUCLEAR MEDICINE

  DOI
• Draft guidelines regarding appropriate use of I-131-MIBG radiotherapy for neuroendocrine tumors, Kinuya, Seigo; Yoshinaga, Keiichiro; Higuchi, Tetsuya; Jinguji, Megumi; Kurihara, Hiroaki; Kawamoto, Hiroshi, 2014年, ANNALS OF NUCLEAR MEDICINE

  DOI
• Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma, Okamura, Takashi; Nakajima, Yasuyo; Satoh, Tetsurou; Hashimoto, Koshi; Sapkota, Santosh; Yamada, Eijiro; Okada, Shuichi; Fukuda, Junya; Higuchi, Tetsuya; Tsushima, Yoshito; Yamada, Masanobu, 2015年, METABOLISM-CLINICAL AND EXPERIMENTAL

  DOI
• 難治性褐色細胞腫における131I-MIBG内照射療法の現状と展望－先進医療から企業治験へ. , 朝永博康, 樋口徹也, 対馬義人, 2018年11月, インナービジョン, 33, 11, 49-51
• Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT-2 pancreatic cancer mouse model. , Higuchi T, Yokobori T, Naito T, Kakinuma C, Hagiwara S, Nishiyama M, Asao T. , 2018年03月, Oncol Lett.
• Dedifferentiated retroperitoneal liposarcoma spontaneously occurring in an aged SD rat. , Naito T, Saito T, Higuchi T, Inomata A, Hayashi T, Shimada Y, Yamauchi-Ohguchi A, Kenmochi S, Kakinuma C, Yao T. , 2018年04月, J Toxicol Pathol.
• Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer. , Kumasaka S, Nakajima T, Arisaka Y, Tokue A, Achmad A, Fukushima Y, Shimizu K, Kaira K, Higuchi T, Tsushima Y. , 2018年11月, BMC Med Imaging. 2018 Nov 26;18(1):46.
• Clinical value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis. , Motegi SI, Fujiwara C, Sekiguchi A, Hara K, Yamaguchi K, Maeno T, Higuchi T, Hirasawa H, Kodaira S, Tomonaga H, Tsushima Y, Ishikawa O. , 2019年01月, J Dermatol.
• Impact of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma. , Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Tomonaga H, Higuchi T, Tsushima Y, Shirabe K., 2019年02月, Anticancer Res.
• 18F-FDG and 18F-FAMT PET-derived metabolic parameters predict outcome of oral squamous cell carcinoma. , Kim M, Higuchi T, Nakajima T, Andriana P, Hirasawa H, Tokue A, Kurihara J, Yokoo S, Tsushima Y. , 2019年02月, Oral Radiol.
• 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma. , Kaira K, Shimizu K, Kitahara S, Yajima T, Atsumi J, Kosaka T, Ohtaki Y, Higuchi T, Oyama T, Asao T, Mogi A. , 2018年09月, Eur J Cancer. 2018 Sep;101:181-190.
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy. , Tsukamoto N, Yokohama A, Higuchi T, Mitsui T, Koiso H, Takizawa M, Shimizu H, Ishizaki T, Matsumoto M, Toyama K, Sakura T, Ogura H, Saitoh T, Ishida F, Murakami H, Tsushima Y, Handa H. , 2019年01月, Int J Hematol. 2019 Jan;109(1):91-97.
• Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer's Disease. , Kasahara H, Ikeda M, Nagashima K, Fujita Y, Makioka K, Tsukagoshi S, Yamazaki T, Takai E, Sanada E, Kobayashi A, Kishi K, Suto T, Higuchi T, Tsushima Y, Ikeda Y. , 2019年02月, J Alzheimers Dis.
• Dual functional molecular imaging probe targeting CD20 with PET and optical imaging, Paudyal, Pramila;Paudyal, Bishnuhari;Iida, Yasuhiko;Oriuchi, Noboru;Hanaoka, Hirofumi;Tominaga, Hideyuki;Ishikita, Tomohiro;Yoshioka, Hiroki;Higuchi, Tetsuya;Endo, Keigo, 2009年, ONCOLOGY REPORTS, ONCOLOGY REPORTS, 22, 1, 115, 119

  DOI
• Correlation of angiogenesis with F-18-FMT and F-18-FDG uptake in non-small cell lung cancer, Kaira, Kyoichi;Oriuchi, Noboru;Shimizu, Kimihiro;Ishikita, Tomohiro;Higuchi, Tetsuya;Imai, Hisao;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Endo, Keigo;Mori, Masatomo, 2009年, CANCER SCIENCE, CANCER SCIENCE, 100, 4, 753, 758

  DOI
• Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with F-18-FDG positron emission tomography and I-123-MIBG scintigraphy, Takano, Akie;Oriuchi, Noboru;Tsushima, Yoshito;Taketomi-Takahashi, Ayako;Nakajima, Takahito;Arisaka, Yukiko;Higuchi, Tetsuya;Amanuma, Makoto;Endo, Keigo, 2008年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 22, 5, 395, 401

  DOI
• Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [F-18]-2-fluro-2-deoxy-D-glucose positron emission tomography, Paudyal, Bishnuhari;Oriuchi, Noboru;Paudyal, Pramila;Higuchi, Tetsuya;Nakajima, Takashi;Endo, Keigo, 2008年, CANCER SCIENCE, CANCER SCIENCE, 99, 2, 260, 266

  DOI
• Clinicopathological presentation of varying F-18-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma, Paudyal, Bishnuhari;Oriuchi, Noboru;Paudyal, Pramila;Tsushima, Yoshito;Higuchi, Tetsuya;Miyakubo, Mitsuyuki;Ishikita, Tomohiro;Nakajima, Takashi;Endo, Keigo, 2008年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 22, 1, 83, 86

  DOI
• Early diagnosis of recurrent hepatocellular carcinoma with F-18-FDG PET after radiofrequency ablation therapy, Paudyal, Bishnuhari;Oriuchi, Noboru;Paudyal, Pramila;Tsushima, Yoshito;Iida, Yasuhiko;Higuchi, Tetsuya;Hanaoka, Hirofumi;Miyakubo, Mitsuyuki;Takano, Akie;Ishikita, Tomohiro;Endo, Keigo, 2007年, ONCOLOGY REPORTS, ONCOLOGY REPORTS, 18, 6, 1469, 1473
• Diagnosis of maxillofacial tumor with L-3-[F-18]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET, Miyakubo, Mitsuyuki;Oriuchi, Noboru;Tsushima, Yoshito;Higuchi, Tetsuya;Koyama, Keiko;Arai, Kiyokazu;Paudyal, Bishnuhari;Iida, Yasuhiko;Hanaoka, Hirofumi;Ishikita, Tomohiro;Nakasone, Yoshiki;Negishi, Akihide;Mogi, Kenji;Endo, Keigo, 2007年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 21, 2, 129, 135
• Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity, Hanaoka, Hirofumi;Katagiri, Toyomasa;Fukukawa, Chikako;Yoshioka, Hiroki;Yamamoto, Shinji;Iida, Yasuhiko;Higuchi, Tetsuya;Oriuchi, Noboru;Paudyal, Bishnuhari;Paudyal, Pramila;Nakamura, Yusuke;Endo, Keigo, 2009年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 23, 5, 479, 485

  DOI
• Evaluation of Cu-64-labeled DOTA-d-Phe(1)-Tyr(3)-octreotide (Cu-64-DOTA-TOC) for imaging somatostatin receptor-expressing tumors, Hanaoka, Hirofumi;Tominaga, Hideyuki;Yamada, Keiich;Paudyal, Pramila;Iida, Yasuhiko;Watanabe, Shigeki;Paudyal, Bishnuhari;Higuchi, Tetsuya;Oriuchi, Noboru;Endo, Keigo, 2009年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 23, 6, 559, 567

  DOI
• Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy, Ishikita, Tomohiro;Oriuchi, Noboru;Higuchi, Tetsuya;Miyashita, Go;Arisaka, Yukiko;Paudyal, Bishnuhari;Paudyal, Pramila;Hanaoka, Hirofumi;Miyakubo, Mitsuyuki;Nakasone, Yoshiki;Negishi, Akihide;Yokoo, Satoshi;Endo, Keigo, 2010年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 24, 2, 77, 82

  DOI
• F-18-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with F-18-FDG PET and immunohistochemistry, Miyashita, Go;Higuchi, Tetsuya;Oriuchi, Noboru;Arisaka, Yukiko;Hanaoka, Hirofumi;Tominaga, Hideyuki;Morita, Satoshi;Miyakubo, Mitsuyuki;Ishikita, Tomohiro;Nakasone, Yoshiki;Negishi, Akihide;Yokoo, Satoshi;Endo, Keigo, 2010年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 24, 8, 579, 584

  DOI
• Pulmonary artery intimal sarcoma: the role of F-18-fluorodeoxyglucose positron emission tomography in monitoring response to treatment, Ote, Enrique Leonardo P.;Oriuchi, Noboru;Miyashita, Go;Paudyal, Bishnuhari;Ishikita, Tomohiro;Arisaka, Yukiko;Higuchi, Tetsuya;Hirato, Junko;Endo, Keigo, 2011年, JAPANESE JOURNAL OF RADIOLOGY, JAPANESE JOURNAL OF RADIOLOGY, 29, 4, 279, 282

  DOI
• Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma, Nakano, Sachiko;Tsushima, Yoshito;Higuchi, Tetsuya;Taketomi-Takahashi, Ayako;Amanuma, Makoto, 2012年, JAPANESE JOURNAL OF RADIOLOGY, JAPANESE JOURNAL OF RADIOLOGY, 30, 4, 310, 316

  DOI
• Preliminary analysis of the difference of amyloid beta detectability by C-11-pittsburgh compound-B PET (PIB PET) in different image display conditions, Tsuda, Kazuhisa;Higuchi, Tetsuya;Kodaira, Sayaka;Arisaka, Yukiko;Tokue, Azusa;Shimazaki, Ayako;Tan, Syougo;Shimada, Hirotaka;Otake, Hidenori;Tsushima, Yoshito, 2012年, JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 32, S86, S86
• F-18-FAMT in patients with multiple myeloma: clinical utility compared to F-18-FDG, Isoda, Atsushi;Higuchi, Tetsuya;Nakano, Sachiko;Arisaka, Yukiko;Kaira, Kyoichi;Kamio, Tadashi;Mawatari, Momoko;Matsumoto, Morio;Sawamura, Morio;Tsushima, Yoshito, 2012年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 26, 10, 811, 816

  DOI
• Clinical significance of F-18-alpha-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with F-18-FDG PET/CT and MRI, Kim, Mai;Higuchi, Tetsuya;Arisaka, Yukiko;Achmad, Arifudin;Tokue, Azusa;Tominaga, Hideyuki;Miyashita, Go;Miyazaki, Hidetaka;Negishi, Akihide;Yokoo, Satoshi;Tsushima, Yoshito, 2013年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 27, 5, 423, 430

  DOI
• Effectiveness of FDG-PET in Screening of Synchronous Cancer of Other Organs in Patients with Esophageal Cancer, Miyazaki, Tatsuya;Sohda, Makoto;Higuchi, Tetsuya;Tanaka, Naritaka;Suzuki, Shigemasa;Sakai, Makoto;Yokobori, Takehiko;Nakajima, Masanobu;Fukuchi, Minoru;Tsushima, Yoshito;Kato, Hiroyuki;Kuwano, Hiroyuki, 2014年, ANTICANCER RESEARCH, ANTICANCER RESEARCH, 34, 1A, 283, 287
• Fractionated Radioimmunotherapy with Y-90-Labeled Fully Human Anti-CEA Antibody, Hanaoka, Hirofumi;Kuroki, Masahide;Yamaguchi, Aiko;Achmad, Arifudin;Iida, Yasuhiko;Higuchi, Tetsuya;Oriuchi, Noboru;Tsushima, Yoshito;Endo, Keigo, 2014年, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 29, 2, 70, 76

  DOI
• L[3-F-18]-alpha-Methyltyrosine Accumulation as a Definitive Chemoradiotherapy Response Predictor in Patients with Esophageal Cancer, Sohda, Makoto;Honjyo, Hiroaki;Hara, Keigo;Ozawa, Daigo;Suzuki, Shigemasa;Tanaka, Naritaka;Sano, Akihiko;Sakai, Makoto;Yokobori, Takehiko;Inose, Takanori;Miyazaki, Tatsuya;Ojima, Hitoshi;Higuchi, Tetsuya;Tsushima, Yoshito;Kuwano, Hiroyuki, 2014年, ANTICANCER RESEARCH, ANTICANCER RESEARCH, 34, 2, 909, 913
• Objective Analysis Of Myocardial Ischemia Using Iodine Image Of Dual-energy Computed Tomography: Comparison With (99)mTc-stress Perfusion Spect, Nakahara, Takehiro;Toyama, Takuji;Jinzaki, Masahiro;Seki, Ryotarou;Saito, Yuichirou;Higuchi, Tetsuya;Yamada, Minoru;Arai, Masashi;Tsushima, Yoshito;Kuribayashi, Sachio;Kurabayashi, Masahiko, 2013年, CIRCULATION, CIRCULATION, 128, 22
• Use of Pre-treatment F-18-FAMT PET to Predict Patient Survival in Squamous Cell Carcinoma of the Esophagus Treated by Curative Surgery, Sohda, Makoto;Sakai, Makoto;Honjyo, Hiroaki;Hara, Keigo;Ozawa, Daigo;Suzuki, Shigemasa;Tanaka, Naritaka;Yokobori, Takehiko;Miyazaki, Tatsuya;Fukuchi, Minoru;Higuchi, Tetsuya;Tsushima, Yoshito;Kuwano, Hiroyuki, 2014年, ANTICANCER RESEARCH, ANTICANCER RESEARCH, 34, 7, 3623, 3628
• Usefulness of l-[3-(18)f]-alpha-methyl tyrosine (F-18-FAMT) PET as therapeutic monitoring for patients with advanced lung cancer, Kaira, Kyoichi;Higuchi, Tetsuya;Oriuchi, Noboru;Sunaga, Noriaki;Hisada, Takeshi;Asao, Takayuki;Tsushima, Yoshihito;Yamada, Masanobu, 2014年, JOURNAL OF CLINICAL ONCOLOGY, JOURNAL OF CLINICAL ONCOLOGY, 32, 15
• FDG uptake in pineal body tumor: Significant correlation with proliferative activity measured by Ki-67 labeling index, Kodaira, Sayaka;Higuchi, Tetsuya;Arisaka, Yukiko;Nakazawa, Azusa;Oriuchi, Noboru;Endo, Keigo, 2011年, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 52
• Expression of L-type amino acid transporter 1 determined by [F-18] alpha-methyl tyrosine PET correlates with the prognosis of patients with resectable stage I-III non-small cell lung cancer, Oriuchi, Noboru;Kaira, Kyoichi;Tominaga, Hideyuki;Arisaka, Yukiko;Higuchi, Tetsuya;Miyashita, Go;Ishikita, Tomohiro;Hanaoka, Hirofumi;Iida, Yasuhiko;Endo, Keio, 2009年, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 50
• Initial evaluation of [F-18] alpha-methyl tyrosine PET for differential diagnosis of pancreatic lesions, Nakano, Sachiko;Oriuchi, Noboru;Higuchi, Tetsuya;Arisaka, Yukiko;Endo, Keigo, 2009年, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 50
• Preliminary evaluation of L-[F-18]-alpha-methyl tyrosine PET/CT in the differential diagnosis of maxillofacial tumor., Miyashita, Go;Higuchi, Tetsuya;Oriuchi, Noboru;Arisaka, Yukiko;Endo, Keigo;Yokoo, Satoshi, 2009年, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 50
• 2-Deoxy-2-[fluorine-18] fluoro-D-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma, Kaira, Kyoichi;Shimizu, Kimihiro;Kitahara, Shinsuke;Yajima, Toshiki;Atsumi, Jun;Kosaka, Takayuki;Ohtaki, Yoichi;Higuchi, Tetsuya;Oyama, Tetsunari;Asao, Takayuki;Mogi, Akira, 2018年, EUROPEAN JOURNAL OF CANCER, EUROPEAN JOURNAL OF CANCER, 101, 181, 190

  DOI
• Association of F-18-FDG uptake on PET with PD-L1 expression in patients with non-small cell lung cancer., Kaira, Kyoichi;Shimizu, Kimihiro;Higuchi, Tetsuya;Kasahara, Norimitsu;Kitahara, Shinsuke;Oyama, Tetsunari;Asao, Takayuki;Mogi, Akira, 2018年, JOURNAL OF CLINICAL ONCOLOGY, JOURNAL OF CLINICAL ONCOLOGY, 36, 15
• Prognostic value of metabolic tumor volume of pretreatment F-18-FAMT PET/CT in non-small cell lung Cancer, Kumasaka, Soma;Nakajima, Takahito;Arisaka, Yukiko;Tokue, Azusa;Achmad, Arifudin;Fukushima, Yasuhiro;Shimizu, Kimihiro;Kaira, Kyoichi;Higuchi, Tetsuya;Tsushima, Yoshito, 2018年, BMC MEDICAL IMAGING, BMC MEDICAL IMAGING, 18

  DOI
• Radiolabeled (4-Fluoro-3-Iodobenzyl) Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors, Yamaguchi, Aiko;Hanaoka, Hirofumi;Higuchi, Tetsuya;Tsushima, Yoshito, 2018年, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 59, 5, 815, 821

  DOI
• Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma, Kasahara, Norimitsu;Kaira, Kyoichi;Bao, Pinjie;Higuchi, Tetsuya;Arisaka, Yukiko;Erkhem-Ochir, Bilguun;Sunaga, Noriaki;Ohtaki, Yoichi;Yajima, Toshiki;Kosaka, Takayuki;Oyama, Tetsunari;Yokobori, Takehiko;Asao, Takayuki;Nishiyama, Masahiko;Tsushima, Yoshito;Kuwano, Hiroyuki;Shimizu, Kimihiro;Mogi, Akira, 2018年, LUNG CANCER, LUNG CANCER, 119, 71, 77

  DOI
• Evaluation of muscle activity just after straight leg raising exercise by using (18)FDG-PET, Shiozawa, Hiroyuki;Ohsawa, Takashi;Tsushima, Yoshito;Higuchi, Tetsuya;Takagishi, Kenji;Chikuda, Hirotaka, 2018年, JOURNAL OF ORTHOPAEDIC SCIENCE, JOURNAL OF ORTHOPAEDIC SCIENCE, 23, 2, 328, 333

  DOI
• Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective, Higuchi, Tetsuya;Achmad, Arifudin;Duong Duc Binh;Bhattarai, Anu;Tsushima, Yoshito, 2018年, ENDOCRINE JOURNAL, ENDOCRINE JOURNAL, 65, 3, 345, 357

  DOI
• Metabolic activity by F-18-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC, Kaira, Kyoichi;Higuchi, Tetsuya;Naruse, Ichiro;Arisaka, Yukiko;Tokue, Azusa;Altan, Bolag;Suda, Satoshi;Mogi, Akira;Shimizu, Kimihiro;Sunaga, Noriaki;Hisada, Takeshi;Kitano, Shigehisa;Obinata, Hideru;Yokobori, Takehiko;Mori, Keita;Nishiyama, Masahiko;Tsushima, Yoshihito;Asao, Takayuki, 2018年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, 1, 56, 66

  DOI
• The diagnostic performance of F-18-FAMT PET and F-18-FDG PET for malignancy detection: a meta-analysis, Achmad, Arifudin;Bhattarai, Anu;Yudistiro, Ryan;Heryanto, Yusri Dwi;Higuchi, Tetsuya;Tsushima, Yoshito, 2017年, BMC MEDICAL IMAGING, BMC MEDICAL IMAGING, 17

  DOI
• Iodine concentration calculated by dual-energy computed tomography (DECT) as a functional parameter to evaluate thyroid metabolism in patients with hyperthyroidism, Duong Duc Binh;Nakajima, Takahito;Otake, Hidenori;Higuchi, Tetsuya;Tsushima, Yoshito, 2017年, BMC MEDICAL IMAGING, BMC MEDICAL IMAGING, 17

  DOI
• Usefulness of F-18-alpha-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer, Kaira, Kyoichi;Higuchi, Tetsuya;Sunaga, Noriaki;Arisaka, Yukiko;Hisada, Takeshi;Tominaga, Hideyuki;Oriuchi, Noboru;Asao, Takayuki;Tsushima, Yoshihito;Yamada, Masanobu, 2016年, ANTICANCER RESEARCH, ANTICANCER RESEARCH, 36, 12, 6481, 6490

  DOI
• Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma, Okano, Yudai;Satoh, Tetsurou;Horiguchi, Kazuhiko;Toyoda, Minoru;Osaki, Aya;Matsumoto, Shunichi;Tomaru, Takuya;Nakajima, Yasuyo;Ishii, Sumiyasu;Ozawa, Atsushi;Shibusawa, Nobuyuki;Shimada, Takehiro;Higuchi, Tetsuya;Chikamatsu, Kazuaki;Yamada, Masanobu, 2016年, ENDOCRINE JOURNAL, ENDOCRINE JOURNAL, 63, 10, 905, 912
• Advantages of L-3-[F-18] fluoro-alpha-methyl tyrosine over 2-[F-18]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan, Kodaira, Sayaka;Nakajima, Takahito;Arisaka, Yukiko;Tokue, Azusa;Higuchi, Tetsuya;Tsushima, Yoshito, 2016年, SPRINGERPLUS, SPRINGERPLUS, 5

  DOI
• Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study, Kasama, Shu;Toyama, Takuji;Sato, Makito;Sano, Hirokazu;Ueda, Tetsuya;Sasaki, Toyoshi;Nakahara, Takehiro;Higuchi, Tetsuya;Tsushima, Yoshito;Kurabayashi, Masahiko, 2016年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 43, 2, 302, 311

  DOI
• A new approach for simple radioisotope cisternography examination in cerebrospinal fluid leakage detection, Hoshino, Hiromitsu;Higuchi, Tetsuya;Achmad, Arifudin;Taketomi-Takahashi, Ayako;Fujimaki, Hiroya;Tsushima, Yoshito, 2016年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 30, 1, 40, 48

  DOI
• Evaluation of bone scan index change over time on automated calculation in bone scintigraphy, Shintawati, Rini;Achmad, Arifudin;Higuchi, Tetsuya;Shimada, Hirotaka;Hirasawa, Hiromi;Arisaka, Yukiko;Takahashi, Ayako;Nakajima, Takahito;Tsushima, Yoshito, 2015年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 29, 10, 911, 920

  DOI
• Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands, Tokue, Azusa;Higuchi, Tetsuya;Arisaka, Yukiko;Nakajima, Takahito;Tokue, Hiroyuki;Tsushima, Yoshito, 2015年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 29, 6, 499, 505

  DOI
• Draft guidelines regarding appropriate use of I-131-MIBG radiotherapy for neuroendocrine tumors, Kinuya, Seigo;Yoshinaga, Keiichiro;Higuchi, Tetsuya;Jinguji, Megumi;Kurihara, Hiroaki;Kawamoto, Hiroshi, 2015年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 29, 6, 543, 552

  DOI
• Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma, Okamura, Takashi;Nakajima, Yasuyo;Satoh, Tetsurou;Hashimoto, Koshi;Sapkota, Santosh;Yamada, Eijiro;Okada, Shuichi;Fukuda, Junya;Higuchi, Tetsuya;Tsushima, Yoshito;Yamada, Masanobu, 2015年, METABOLISM-CLINICAL AND EXPERIMENTAL, METABOLISM-CLINICAL AND EXPERIMENTAL, 64, 6, 706, 712

  DOI
• Differentiation of malignant tumours from granulomas by using dynamic [F-18]-fluoro-L-alpha-methyltyrosine positron emission tomography, Yamaguchi, Aiko;Hanaoka, Hirofumi;Fujisawa, Yutaka;Zhao, Songji;Suzue, Kazutomo;Morita, Akihiro;Tominaga, Hideyuki;Higuchi, Tetsuya;Hisaeda, Hajime;Tsushima, Yoshito;Kuge, Yuji;Iida, Yasuhiko, 2015年, EJNMMI RESEARCH, EJNMMI RESEARCH, 5

  DOI
• Superficial Siderosis of the Central Nervous System Caused by Hemorrhagic Intraventricular Craniopharyngioma: Case Report and Literature Review, Tosaka, Masahiko;Sato, Koji;Amanuma, Makoto;Higuchi, Tetsuya;Arai, Motohiro;Aishima, Kaoru;Shimizu, Tatsuya;Horiguchi, Keishi;Sugawara, Kenichi;Yoshimoto, Yuhei, 2015年, NEUROLOGIA MEDICO-CHIRURGICA, NEUROLOGIA MEDICO-CHIRURGICA, 55, 1, 89, 94

  DOI
• Effects of Intratumoral Inflammatory Process on F-18-FDG Uptake: Pathologic and Comparative Study with F-18-Fluoro-alpha-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma, Kim, Mai;Achmad, Arifudin;Higuchi, Tetsuya;Arisaka, Yukiko;Yokoo, Hideaki;Yokoo, Satoshi;Tsushima, Yoshito, 2015年, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 56, 1, 16, 21

  DOI
• Effects and safety of I-131-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results, from a multicenter observational registry, Yoshinaga, Keiichiro;Oriuchi, Noboru;Wakabayashi, Hiroshi;Tomiyama, Yuuki;Jinguji, Megumi;Higuchi, Tetsuya;Kayano, Daiki;Fukuoka, Makoto;Inaki, Anri;Toratani, Ayane;Okamoto, Shozo;Shiga, Tohru;Ito, Yoichi M.;Nakajo, Masatoyo;Nakajo, Masayuki;Kinuya, Seigo;Drafting Comm Guidelines Internal;Japanese Soc Nucl Med Oncology Imm;Japanese Soc Nucl Med, 2014年, ENDOCRINE JOURNAL, ENDOCRINE JOURNAL, 61, 12, 1171, 1180
• L-[3-F-18]-alpha-Methyltyrosine Uptake by Lymph Node Metastasis Is a Predictor of Complete Response to CRT in Esophageal Cancer, Sohda, Makoto;Miyazaki, Tatsuya;Honjyo, Hiroaki;Hara, Keigo;Ozawa, Daigo;Suzuki, Shigemasa;Tanaka, Naritaka;Sano, Akihiko;Sakai, Makoto;Yokobori, Takehiko;Nakajima, Masanobu;Fukuchi, Minoru;Kato, Hiroyuki;Higuchi, Tetsuya;Tsushima, Yoshito;Kuwano, Hiroyuki, 2014年, ANTICANCER RESEARCH, ANTICANCER RESEARCH, 34, 12, 7473, 7477
• Case of radioactive iodine exposure during pregnancy, Sadakata, Hisanobu;Shinozaki, Hiromitsu;Higuchi, Tetsuya;Minegishi, Takashi, 2014年, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 40, 12, 2201, 2203

  DOI
• CSF levels of A beta 1-38/A beta 1-40/A beta 1-42 and C-11 PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease, Ikeda, Masaki;Tashiro, Yuichi;Takai, Eriko;Kurose, Sachiko;Fugami, Naoko;Tsuda, Kazuhisa;Arisaka, Yukiko;Kodaira, Sayaka;Fujita, Yukio;Makioka, Kouki;Mizuno, Yuji;Shimada, Hirotaka;Harigaya, Yasuo;Takatama, Masamitsu;Amari, Masakuni;Yamazaki, Tsuneo;Yamaguchi, Haruyasu;Higuchi, Tetsuya;Okamoto, Koichi;Tsushima, Yoshito;Ikeda, Yoshio, 2014年, AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 21, 4, 238, 245

  DOI
• Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT, Okamura, Koichi;Yonemoto, Yukio;Okura, Chisa;Higuchi, Tetsuya;Tsushima, Yoshito;Takagishi, Kenji, 2014年, BMC MUSCULOSKELETAL DISORDERS, BMC MUSCULOSKELETAL DISORDERS, 15

  DOI
• Prognostic value of volumetric FDG-PET/CT parameters in patients with Stage I non-small cell lung cancer (NSCLC) treated with carbon-ion therapy, Shrestha, Suman;Higuchi, Tetsuya;Shirai, Katsuyuki;Tokue, Azusa;Saitoh, Jun-ichi;Hirasawa, Hiromi;Ohno, Tatsuya;Nakano, Takashi;Tsushima, Yoshito, 2018年, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 59
• FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis, Watanabe, Akira;Harimoto, Norifumi;Yokobori, Takehiko;Araki, Kenichiro;Kubo, Norio;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Yamanaka, Takahiro;Handa, Tadashi;Oyama, Tetsunari;Higuchi, Tetsuya;Shirabe, Ken, 2020年02月, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25, 2, 322, 329

  DOI
• Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy, Shrestha, Suman;Higuchi, Tetsuya;Shirai, Katsuyuki;Tokue, Azusa;Shrestha, Shreya;Saitoh, Jun-ichi;Hirasawa, Hiromi;Ohno, Tatsuya;Nakano, Takashi;Tsushima, Yoshito, 2020年05月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47, 5, 1220, 1227

  DOI
• Relationship Between Tumor Immune Markers and Fluorine-18-alpha-Methyltyrosine ([F-18]FAMT) Uptake in Patients with Lung Cancer, Shimizu, Kimihiro;Kaira, Kyoichi;Higuchi, Tetsuya;Hisada, Takeshi;Yokobori, Takehiko;Oyama, Tetsunari;Asao, Takayuki;Tsushima, Yoshito;Shirabe, Ken, 2020年08月, MOLECULAR IMAGING AND BIOLOGY, 22, 4, 1078, 1086

  DOI
• F-18-FAMT-PET Is Useful for Judging Clinical Complete Response in Advanced Esophageal Cancer Patients Who Have Received Definitive Chemoradiotherapy, Sohda, Makoto;Honjyo, Hiroaki;Hara, Keigo;Ozawa, Daigo;Suzuki, Shigemasa;Tanaka, Naritaka;Sano, Akihiko;Sakai, Makoto;Inose, Takanori;Miyazaki, Tatsuya;Higuchi, Tetsuya;Tsushima, Yoshito;Kuwano, Hiroyuki, 2018年, INTERNATIONAL SURGERY, INTERNATIONAL SURGERY, 103, 11-12, 561, 566

  DOI
• 臨床外科に役立つ診断と治療のイノベーション　食道癌治療前診断におけるFAMT-PETの有用性, 斉藤 秀幸;宗田 真;吉田 知典;熊倉 裕二;本城 裕章;横堀 武彦;酒井 真;宮崎 達也;樋口 徹也;対馬 義人;桑野 博行, 2015年10月, 日本臨床外科学会雑誌, 76, 増刊, 379
• PET/CTの起源　世界初の群馬大学・日立の並列型PET/CT装置, 対馬 義人;樋口 徹也;須藤 高行;永井 輝夫;石原 十三夫;柴崎 尚;松原 國夫;佐々木 康人;熊本 三矢戒;井上 愼一;田口 正俊, 2016年04月, メディックス, 64, 8
• 【Nuclear Medicine Today 2015　実臨床におけるPET/CT、SPECT/CTの意義と今後の展開】非腫瘍性疾患における最新動向　神経内分泌腫瘍に対するPET/CTの有用性　18F-FDG-PET/CTを中心に, 徳江 梓;樋口 徹也;有坂 有紀子;中嶌 崇仁;徳江 浩之;対馬 義人, 2015年11月, INNERVISION, 30, 12, 36
• 大腸癌肝転移におけるFDG-PETに基づく集学的治療戦略構築の試み, 渡辺 亮;新木 健一郎;播本 憲史;久保 憲生;五十嵐 隆通;塚越 真梨子;石井 範洋;山中 崇弘;萩原 慶;沖 英次;前原 喜彦;山下 洋市;馬場 秀夫;樋口 徹也;小川 博臣;桑野 博行;調 憲, 2018年04月, 日本外科学会定期学術集会抄録集, 118回, 1080
• 既治療進行非小細胞肺癌におけるニボルマブ療法の早期治療効果判定としてのFDG-PETの役割, 解良 恭一;樋口 徹也;成 清一郎;砂長 則明;久田 剛志, 2018年03月, 日本呼吸器学会誌, 7, 増刊, 172
• 皮膚筋炎患者の筋炎と間質性肺炎の評価におけるFDG-PETの有用性について, 藤原 千紗子;茂木 精一郎;原 健一郎;樋口 徹也;平澤 裕美;小平 明果;朝永 博康;対馬 義人;石渕 裕久;石川 治, 2018年05月, 日本皮膚科学会雑誌, 128, 5, 1176
• 甲状腺癌の内照射、外照射併用治療後の治療方針決定にSUV値補正が有用であった症例, 朝永 博康;樋口 徹也;小平 明果;徳江 梓;有坂 有紀子;対馬 義人, 2017年02月, 核医学, 54, 1, 645
• Marine-Lenhart症候群に対し、放射性ヨード内用療法が有効であった1症例, 熊坂 百香;朝永 博康;樋口 徹也;有坂 有紀子;小平 明果;徳江 梓;対馬 義人, 2017年02月, 核医学, 54, 1, 537
• 新規F-18標識αメチル-フェニルアラニンの開発, 花岡 宏史;大島 康宏;山口 藍子;鈴木 博元;樋口 徹也;石岡 典子;荒野 泰;対馬 義人, 2017年09月, 核医学, 54, Suppl., S199
• FDG-PETによるトルコ鞍部、傍鞍部腫瘍の術前診断, 登坂 雅彦;樋口 徹也;堀口 桂志;有坂 有紀子;柴崎 尚;好本 裕平;対馬 義人, 2017年09月, 核医学, 54, Suppl., S194
• IgG4関連疾患における18F-FAMT PET/CTの検討　18F-FDG PET/CTとの比較, 徳江 梓;樋口 徹也;有坂 有紀子;中嶌 崇仁;小平 明果;朝永 博康;対馬 義人, 2017年09月, 核医学, 54, Suppl., S185
• 肝転移巣に対するFAMT-PETとFDG-PETの検出能比較, 小平 明果;中島 崇仁;有坂 有紀子;徳江 梓;樋口 徹也;対馬 義人, 2016年10月, 核医学, 53, Suppl., S316
• 心電図同期心筋SPECTと心臓MRIの心機能解析結果の比較　心臓MRI解析時、左室肉柱有無の影響, 富田 優衣;小山 恵子;持木 瑞規;狩野 めぐみ;小椋 太地;星崎 洋;大島 茂;樋口 徹也;対馬 義人, 2016年10月, 核医学, 53, Suppl., S290
• 減弱マップ補正(SSPAC)法による心筋下壁・中隔領域のSPECT画像の診断評価　Prone撮影と比較して, 嶋田 博孝;笠間 周;樋口 徹也;高橋 康幸;勘崎 貴雄;須藤 高行;佐藤 万基人;有坂 有紀子;徳江 梓;対馬 義人, 2016年10月, 核医学, 53, Suppl., S289
• 放射性ヨード抵抗性分化型甲状腺癌におけるTKI治療適応判断でのサイログロブリン倍加時間の有用性の検討, 樋口 徹也;朝永 博康;有坂 有紀子;徳江 梓;小平 明果;嶋田 博孝;小山 恵子;対馬 義人, 2016年10月, 核医学, 53, Suppl., S274
• 骨シンチグラフィーのBONENAVI解析におけるバージョン別、領域別の特徴と評価, 朝永 博康;中島 崇仁;有坂 有紀子;樋口 徹也;対馬 義人, 2016年10月, 核医学, 53, Suppl., S273
• 褐色細胞腫のPET診断薬剤としての18F標識MIBGアナログの開発, 山口 藍子;花岡 宏史;樋口 徹也;対馬 義人, 2016年10月, 核医学, 53, Suppl., S264
• AIMAHに対する片側副腎摘出術により血糖コントロールの改善が見られた二次性糖尿病の1例, 高見澤 哲也;佐藤 哲郎;堤 荘一;新井 秀雄;岡村 孝志;渡邉 琢也;吉野 聡;松本 俊一;堀口 和彦;登丸 琢也;石井 角保;中島 康代;小澤 厚志;渋沢 信行;樋口 徹也;対馬 義人;桑野 博行;山田 正信, 2017年04月, 糖尿病, 60, Suppl.1, S
• 大腸癌肝転移に対するConversion surgery　大腸癌肝転移切除に対するconversion therapyの適応決定におけるFDG-PETの意義, 渡辺 亮;新木 健一郎;久保 憲生;五十嵐 隆通;塚越 真梨子;石井 範洋;山中 崇弘;萩原 慶;播本 憲史;沖 英次;前原 喜彦;樋口 徹也;桑野 博行;調 憲, 2017年10月, 日本臨床外科学会雑誌, 78, 増刊, 391
• 褐色細胞腫のPET診断薬剤としての18F標識MIBGアナログの有用性評価, 山口 藍子;花岡 宏史;樋口 徹也;対馬 義人, 2017年05月, JSMI Report, 10, 2, 160
• 副腎collision tumorとの鑑別に苦慮した副腎皮質腺腫内出血の1例, 高見澤 哲也;佐藤 哲郎;石井 角保;朝永 博康;茂木 陽子;越 浩美;岡村 孝志;吉野 聡;松本 俊一;堀口 和彦;登丸 琢也;中島 康代;小澤 厚志;渋沢 信行;樋口 徹也;堤 荘一;佐野 孝昭;小山 徹也;桑野 博行;山田 正信, 2017年04月, 日本内分泌学会雑誌, 93, 1, 340
• 腫瘍集積性および滞留性に優れたMIBG誘導体「FIBG」に関する基礎的検討, 山口 藍子;花岡 宏史;樋口 徹也;対馬 義人, 2016年11月, 群馬県核医学研究会会誌, 31, 1, 14
• PCAを呈するAD、早期発症型AD、DLBの臨床、髄液および画像的検討, 池田 将樹;田代 裕一;甘利 雅邦;高玉 真光;岡本 幸市;針谷 康夫;山崎 恒夫;山口 晴保;樋口 徹也;対馬 義人;池田 佳生, 2015年12月, 臨床神経学, 55, Suppl., S426
• 【顎口腔・歯科領域の画像診断と放射線治療】口腔癌画像診断に役立つ知識　PET, 金 舞;徳江 梓;樋口 徹也;清水 崇寛;横尾 聡;対馬 義人, 2018年11月, 臨床画像, 34, 11, 1289
• 【Nuclear Medicine Today 2018　最新トピックスから探る核医学の現在と未来】Theranosticsに向けた研究開発の最新トピックス　難治性褐色細胞腫における131I-MIBG内照射療法の現状と展望　先進医療から企業治験へ, 朝永 博康;樋口 徹也;対馬 義人, 2018年10月, INNERVISION, 33, 11, 49
• 【肝】大腸癌多発肝転移に対する手術の工夫　大腸癌肝転移におけるFDG-PETに基づく新たな治療戦略, 渡辺 亮;新木 健一郎;播本 憲史;吉住 朋晴;有馬 浩太;山下 洋市;馬場 秀夫;樋口 徹也;イトウ 雅昭;調 憲, 2018年07月, 日本消化器外科学会総会, 73回, 71
• 神経芽腫診断薬剤としての18F-FIBGの有用性評価, 山口 藍子;花岡 宏史;樋口 徹也;対馬 義人, 2018年11月, 核医学, 55, Suppl., S160
• 左室心筋領域ごとのFDG集積評価による心臓サルコイドーシス診断, 小平 明果;笠間 周;小山 恵子;樋口 徹也;倉林 正彦;対馬 義人, 2018年11月, 核医学, 55, Suppl., S192
• 【甲状腺をめぐる最近の問題】甲状腺がん　甲状腺がんに対する放射性ヨウ素内用療法の現状と展望, 徳江 梓;樋口 徹也;朝永 博康;徳江 浩之;中嶌 崇仁;対馬 義人, 2019年01月, 内分泌・糖尿病・代謝内科, 48, 1, 36
• IgG4関連疾患における18F-FAMT PET/CTの検討　18F-FDG PET/CTとの比較, 徳江 梓;徳江 浩之;樋口 徹也;中嶌 崇仁;対馬 義人, 2019年03月, 臨床放射線, 64, 3, 273
• 医学・医療のトピックス　頭頸部がんに対する放射線治療の現状と展望　アイソトープ内用療法, 朝永 博康;樋口 徹也;対馬 義人, 2019年03月, 日本耳鼻咽喉科学会会報, 122, 3, 179
• 大腸癌多発肝転移におけるFDG-PETのimaging biomarkerとしての有用性, 渡辺 亮;播本 憲史;新木 健一郎;久保 憲生;田中 寛;五十嵐 隆通;塚越 真梨子;石井 範洋;樋口 徹也;調 憲, 2019年04月, 日本外科学会定期学術集会抄録集, 119回, PS
• 口腔扁平上皮癌の予後予測における18F-FDGおよび18F-FAMTPETの有用性, 金 舞;樋口 徹也;中島 崇人;プトゥリ・アンドリアナ ;平澤 裕美;徳江 梓;栗原 淳;対馬 義人;横尾 聡, 2018年08月, The Kitakanto Medical Journal, 68, 3, 203
• 皮膚筋炎患者の筋炎と間質性肺炎の評価におけるFDG-PETの有用性について, 藤原 千紗子;茂木 精一郎;関口 明子;原 健一郎;樋口 徹也;平澤 裕美;小平 明果;朝永 博康;対馬 義人;石川 治, 2018年08月, The Kitakanto Medical Journal, 68, 3, 203
• 【注意したいFDG-PET/CTでの見逃しと読み過ぎ】頭頸部領域, 徳江 梓;樋口 徹也;徳江 浩之;中嶌 崇仁;対馬 義人, 2019年08月, 臨床放射線, 64, 9, 1119
• 大腸癌肝転移におけるFDG-PETのimaging biomarkerとしての有用性　免疫組織化学的評価における検討, 渡辺 亮;播本 憲史;新木 健一郎;久保 憲生;五十嵐 隆通;塚越 真梨子;石井 範洋;横堀 武彦;樋口 徹也;調 憲, 2019年07月, 日本消化器外科学会総会, 74回, RS36
• 肝内胆管癌切除症例における18F-FDG PET/CTのSUVmaxが予後に与える影響と炎症関連スコアとの比較に関する検討, 播本 憲史;星野 弘毅;村主 遼;萩原 慶;山中 崇弘;石井 範洋;塚越 真梨子;五十嵐 隆通;渡辺 亮;久保 憲生;新木 健一郎;調 憲;樋口 徹也;対馬 義人, 2019年10月, 胆道, 33, 3, 532
• 口腔扁平上皮癌におけるPD-L1発現と18F-FDG集積の関連について, 東郷 真理亜;横堀 武彦;半田 正;佐野 孝昭;片山 彩香;下田 雄輝;清水 公裕;樋口 徹也;横尾 聡;小山 徹也, 2019年04月, 日本病理学会会誌, 108, 1, 324
• サルコイドーシス患者における左室FDG集積のばらつきと他臨床データとの関連について, 小平 明果;笠間 周;樋口 徹也;小山 恵子;対馬 義人, 2019年10月, 核医学, 56, Suppl., S181
• 大腸癌肝転移におけるFDG-PETに基づく治療戦略, 渡辺 亮;播本 憲史;新木 健一郎;久保 憲生;五十嵐 隆通;塚越 真梨子;石井 範洋;樋口 徹也;調 憲, 2019年10月, 日本臨床外科学会雑誌, 80, 増刊, 519
• 大腸癌肝転移conversion surgeryにおけるSUV変化率に基づいた治療戦略, 渡辺 亮;播本 憲史;新木 健一郎;久保 憲生;五十嵐 隆通;塚越 真梨子;石井 範洋;吉住 朋晴;有馬 浩太;山下 洋市;馬場 秀夫;樋口 徹也;調 憲, 2019年10月, 日本癌治療学会学術集会抄録集, 57回, RT21
• 新たな評価法による食道癌治療前FAMT-PETの有用性, 宗田 真;斉藤 秀幸;原 圭吾;酒井 真;横堀 武彦;緒方 杏一;朝永 博康;樋口 徹也;対馬 義人;佐伯 浩司, 2020年01月, 日本消化管学会雑誌, 4, Suppl., 301
• Impact of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma., Harimoto Norifumi;Hoshino Kouki;Muranushi Ryo;Hagiwara Kei;Yamanaka Takahiro;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Tanaka Hiroshi;Watanabe Akira;Kubo Norio;Araki Kenichirou;Tomonaga Hiroyasu;Higuchi Tetsuya;Tsushima Yoshito;Shirabe Ken, Anticancer research, Anticancer research, 39, 2

  DOI
• Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer., Kumasaka Soma;Nakajima Takahito;Arisaka Yukiko;Tokue Azusa;Achmad Arifudin;Fukushima Yasuhiro;Shimizu Kimihiro;Kaira Kyoichi;Higuchi Tetsuya;Tsushima Yoshito, 2018年11月26日, BMC medical imaging, BMC medical imaging, 18, 1

  DOI
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy., Tsukamoto Norifumi;Yokohama Akihiko;Higuchi Tetsuya;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Shimizu Hiroaki;Ishizaki Takuma;Matsumoto Morio;Toyama Kohtaro;Sakura Tohru;Ogura Hidemi;Saitoh Takayuki;Ishida Fumihiro;Murakami Hirokazu;Tsushima Yoshito;Handa Hiroshi, 2018年09月10日, International journal of hematology, International journal of hematology, 109, 1

  DOI
• 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma., Kaira Kyoichi;Shimizu Kimihiro;Kitahara Shinsuke;Yajima Toshiki;Atsumi Jun;Kosaka Takayuki;Ohtaki Yoichi;Higuchi Tetsuya;Oyama Tetsunari;Asao Takayuki;Mogi Akira, 2018年08月01日, European journal of cancer (Oxford, England : 1990), European journal of cancer (Oxford, England : 1990), 101

  DOI
• Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma., Kasahara Norimitsu;Kaira Kyoichi;Bao Pinjie;Higuchi Tetsuya;Arisaka Yukiko;Erkhem-Ochir Bilguun;Sunaga Noriaki;Ohtaki Yoichi;Yajima Toshiki;Kosaka Takayuki;Oyama Tetsunari;Yokobori Takehiko;Asao Takayuki;Nishiyama Masahiko;Tsushima Yoshito;Kuwano Hiroyuki;Shimizu Kimihiro;Mogi Akira, 2018年03月16日, Lung cancer (Amsterdam, Netherlands), Lung cancer (Amsterdam, Netherlands), 119

  DOI
• Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective., Higuchi Tetsuya;Achmad Arifudin;Binh Duong Duc;Bhattarai Anu;Tsushima Yoshito, 2018年01月16日, Endocrine journal, Endocrine journal, 65, 3

  DOI
• The diagnostic performance of 18F-FAMT PET and 18F-FDG PET for malignancy detection: a meta-analysis., Achmad Arifudin;Bhattarai Anu;Yudistiro Ryan;Heryanto Yusri Dwi;Higuchi Tetsuya;Tsushima Yoshito, 2017年12月28日, BMC medical imaging, BMC medical imaging, 17, 1

  DOI
• Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors., Yamaguchi Aiko;Hanaoka Hirofumi;Higuchi Tetsuya;Tsushima Yoshito, 2017年12月07日, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 59, 5

  DOI
• 18F-FAMT PET Is Useful to Distinguish between Specific Uptake and Nonspecific Uptake Compared to 18F-Flourodeoxyglucose Position Emission Tomography in Esophageal Cancer Patients., Sohda Makoto;Miyazaki Tatsuya;Honjyo Hiroaki;Hara Keigo;Ozawa Daigo;Sakai Makoto;Yokobori Takehiko;Higuchi Tetsuya;Tsushima Yoshito;Kuwano Hiroyuki, 2017年11月02日, Digestive surgery, Digestive surgery, 35, 5

  DOI
• A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma: a study protocol., Inaki Anri;Yoshimura Kenichi;Murayama Toshinori;Imai Yasuhito;Kuribayashi Yoshikazu;Higuchi Tetsuya;Jinguji Megumi;Shiga Tohru;Kinuya Seigo, The journal of medical investigation : JMI, The journal of medical investigation : JMI, 64, 3.4

  DOI
• Metabolic activity by 18F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC., Kaira Kyoichi;Higuchi Tetsuya;Naruse Ichiro;Arisaka Yukiko;Tokue Azusa;Altan Bolag;Suda Satoshi;Mogi Akira;Shimizu Kimihiro;Sunaga Noriaki;Hisada Takeshi;Kitano Shigehisa;Obinata Hideru;Yokobori Takehiko;Mori Keita;Nishiyama Masahiko;Tsushima Yoshihito;Asao Takayuki, 2017年08月21日, European journal of nuclear medicine and molecular imaging, European journal of nuclear medicine and molecular imaging, 45, 1

  DOI
• Iodine concentration calculated by dual-energy computed tomography (DECT) as a functional parameter to evaluate thyroid metabolism in patients with hyperthyroidism., Binh Duong Duc;Nakajima Takahito;Otake Hidenori;Higuchi Tetsuya;Tsushima Yoshito, 2017年07月19日, BMC medical imaging, BMC medical imaging, 17, 1

  DOI
• Quantitative Analysis of Iodine Image of Dual-energy Computed Tomography at Rest: Comparison With 99mTc-Tetrofosmin Stress-rest Single-photon Emission Computed Tomography Myocardial Perfusion Imaging as the Reference Standard., Nakahara Takehiro;Toyama Takuji;Jinzaki Masahiro;Seki Ryotaro;Saito Yuichiro;Higuchi Tetsuya;Yamada Minoru;Arai Masashi;Tsushima Yoshito;Kuribayashi Sachio;Kurabayashi Masahiko, Journal of thoracic imaging, Journal of thoracic imaging, 33, 2

  DOI
• Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET., Horiguchi Keishi;Tosaka Masahiko;Higuchi Tetsuya;Arisaka Yukiko;Sugawara Kenichi;Hirato Junko;Yokoo Hideaki;Tsushima Yoshito;Yoshimoto Yuhei, 2017年05月31日, EJNMMI research, EJNMMI research, 7, 1

  DOI
• Preoperative Evaluation of Sellar and Parasellar Macrolesions by [18F]Fluorodeoxyglucose Positron Emission Tomography., Tosaka Masahiko;Higuchi Tetsuya;Horiguchi Keishi;Osawa Tadashi;Arisaka Yukiko;Fujita Haruyasu;Tsushima Yoshito;Yoshimoto Yuhei, 2017年04月17日, World neurosurgery, World neurosurgery, 103

  DOI
• Usefulness of 18F-α-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer., Kaira Kyoichi;Higuchi Tetsuya;Sunaga Noriaki;Arisaka Yukiko;Hisada Takeshi;Tominaga Hideyuki;Oriuchi Noboru;Asao Takayuki;Tsushima Yoshihito;Yamada Masanobu, Anticancer research, Anticancer research, 36, 12

  DOI
• Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma., Okano Yudai;Satoh Tetsurou;Horiguchi Kazuhiko;Toyoda Minoru;Osaki Aya;Matsumoto Shunichi;Tomaru Takuya;Nakajima Yasuyo;Ishii Sumiyasu;Ozawa Atsushi;Shibusawa Nobuyuki;Shimada Takehiro;Higuchi Tetsuya;Chikamatsu Kazuaki;Yamada Masanobu, 2016年07月20日, Endocrine journal, Endocrine journal, 63, 10

  DOI
• Advantages of L-3-[(18)F] fluoro-alpha-methyl tyrosine over 2-[(18)F]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan., Kodaira Sayaka;Nakajima Takahito;Arisaka Yukiko;Tokue Azusa;Higuchi Tetsuya;Tsushima Yoshito, 2016年05月13日, SpringerPlus, SpringerPlus, 5

  DOI
• Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study., Kasama Shu;Toyama Takuji;Sato Makito;Sano Hirokazu;Ueda Tetsuya;Sasaki Toyoshi;Nakahara Takehiro;Higuchi Tetsuya;Tsushima Yoshito;Kurabayashi Masahiko, 2015年09月25日, European journal of nuclear medicine and molecular imaging, European journal of nuclear medicine and molecular imaging, 43, 2

  DOI
• Evaluation of bone scan index change over time on automated calculation in bone scintigraphy., Shintawati Rini;Achmad Arifudin;Higuchi Tetsuya;Shimada Hirotaka;Hirasawa Hiromi;Arisaka Yukiko;Takahashi Ayako;Nakajima Takahito;Tsushima Yoshito, 2015年09月15日, Annals of nuclear medicine, Annals of nuclear medicine, 29, 10

  DOI
• Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography., Yamaguchi Aiko;Hanaoka Hirofumi;Fujisawa Yutaka;Zhao Songji;Suzue Kazutomo;Morita Akihiro;Tominaga Hideyuki;Higuchi Tetsuya;Hisaeda Hajime;Tsushima Yoshito;Kuge Yuji;Iida Yasuhiko, 2015年04月30日, EJNMMI research, EJNMMI research, 5

  DOI
• Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands., Tokue Azusa;Higuchi Tetsuya;Arisaka Yukiko;Nakajima Takahito;Tokue Hiroyuki;Tsushima Yoshito, 2015年04月16日, Annals of nuclear medicine, Annals of nuclear medicine, 29, 6

  DOI
• Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma., Okamura Takashi;Nakajima Yasuyo;Satoh Tetsurou;Hashimoto Koshi;Sapkota Santosh;Yamada Eijiro;Okada Shuichi;Fukuda Junya;Higuchi Tetsuya;Tsushima Yoshito;Yamada Masanobu, 2015年03月14日, Metabolism: clinical and experimental, Metabolism: clinical and experimental, 64, 6

  DOI
• L-[3-¹⁸F]-α-methyltyrosine uptake by lymph node metastasis is a predictor of complete response to CRT in esophageal cancer., Sohda Makoto;Miyazaki Tatsuya;Honjyo Hiroaki;Hara Keigo;Ozawa Daigo;Suzuki Shigemasa;Tanaka Naritaka;Sano Akihiko;Sakai Makoto;Yokobori Takehiko;Nakajima Masanobu;Fukuchi Minoru;Kato Hiroyuki;Higuchi Tetsuya;Tsushima Yoshito;Kuwano Hiroyuki, Anticancer research, Anticancer research, 34, 12
• Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma., Kim Mai;Achmad Arifudin;Higuchi Tetsuya;Arisaka Yukiko;Yokoo Hideaki;Yokoo Satoshi;Tsushima Yoshito, 2014年12月04日, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 56, 1

  DOI
• Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT., Okamura Koichi;Yonemoto Yukio;Okura Chisa;Higuchi Tetsuya;Tsushima Yoshito;Takagishi Kenji, 2014年11月22日, BMC musculoskeletal disorders, BMC musculoskeletal disorders, 15

  DOI
• CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease., Ikeda Masaki;Tashiro Yuichi;Takai Eriko;Kurose Sachiko;Fugami Naoko;Tsuda Kazuhisa;Arisaka Yukiko;Kodaira Sayaka;Fujita Yukio;Makioka Kouki;Mizuno Yuji;Shimada Hirotaka;Harigaya Yasuo;Takatama Masamitsu;Amari Masakuni;Yamazaki Tsuneo;Yamaguchi Haruyasu;Higuchi Tetsuya;Okamoto Koichi;Tsushima Yoshito;Ikeda Yoshio, 2014年08月20日, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 21, 4

  DOI
• Case of radioactive iodine exposure during pregnancy., Sadakata Hisanobu;Shinozaki Hiromitsu;Higuchi Tetsuya;Minegishi Takashi, 2014年08月11日, The journal of obstetrics and gynaecology research, The journal of obstetrics and gynaecology research, 40, 12

  DOI
• Use of pre-treatment 18F-FAMT PET to predict patient survival in squamous cell carcinoma of the esophagus treated by curative surgery., Sohda Makoto;Sakai Makoto;Honjyo Hiroaki;Hara Keigo;Ozawa Daigo;Suzuki Shigemasa;Tanaka Naritaka;Yokobori Takehiko;Miyazaki Tatsuya;Fukuchi Minoru;Higuchi Tetsuya;Tsushima Yoshito;Kuwano Hiroyuki, Anticancer research, Anticancer research, 34, 7
• A case of multiple hepatic angiomyolipomas with high (18) F-fluorodeoxyglucose uptake., Kumasaka Soma;Arisaka Yukiko;Tokue Azusa;Higuchi Tetsuya;Nakajima Takahito;Tsushima Yoshito, 2014年05月20日, BMC medical imaging, BMC medical imaging, 14

  DOI
• Superficial siderosis of the central nervous system caused by hemorrhagic intraventricular craniopharyngioma: case report and literature review., Tosaka Masahiko;Sato Koji;Amanuma Makoto;Higuchi Tetsuya;Arai Motohiro;Aishima Kaoru;Shimizu Tatsuya;Horiguchi Keishi;Sugawara Kenichi;Yoshimoto Yuhei, 2014年03月27日, Neurologia medico-chirurgica, Neurologia medico-chirurgica, 55, 1

  DOI
• L-[3-18F]-α-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancer., Sohda Makoto;Honjyo Hiroaki;Hara Keigo;Ozawa Daigo;Suzuki Shigemasa;Tanaka Naritaka;Sano Akihiko;Sakai Makoto;Yokobori Takehiko;Inose Takanori;Miyazaki Tatsuya;Ojima Hitoshi;Higuchi Tetsuya;Tsushima Yoshito;Kuwano Hiroyuki, Anticancer research, Anticancer research, 34, 2
• Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer., Miyazaki Tatsuya;Sohda Makoto;Higuchi Tetsuya;Tanaka Naritaka;Suzuki Shigemasa;Sakai Makoto;Yokobori Takehiko;Nakajima Masanobu;Fukuchi Minoru;Tsushima Yoshito;Kato Hiroyuki;Kuwano Hiroyuki, Anticancer research, Anticancer research, 34, 1
• Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibody., Hanaoka Hirofumi;Kuroki Masahide;Yamaguchi Aiko;Achmad Arifudin;Iida Yasuhiko;Higuchi Tetsuya;Oriuchi Noboru;Tsushima Yoshito;Endo Keigo, 2013年12月03日, Cancer biotherapy & radiopharmaceuticals, Cancer biotherapy & radiopharmaceuticals, 29, 2

  DOI
• Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis., Morita Motoho;Higuchi Tetsuya;Achmad Arifudin;Tokue Azusa;Arisaka Yukiko;Tsushima Yoshito, 2013年09月05日, European journal of nuclear medicine and molecular imaging, European journal of nuclear medicine and molecular imaging, 40, 11

  DOI
• Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma., Nobusawa Aiko;Kim Mai;Kaira Kyoichi;Miyashita Go;Negishi Akihide;Oriuchi Noboru;Higuchi Tetsuya;Tsushima Yoshito;Kanai Yoshikatsu;Yokoo Satoshi;Oyama Tetsunari, 2013年06月26日, European journal of nuclear medicine and molecular imaging, European journal of nuclear medicine and molecular imaging, 40, 11

  DOI
• Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI., Kim Mai;Higuchi Tetsuya;Arisaka Yukiko;Achmad Arifudin;Tokue Azusa;Tominaga Hideyuki;Miyashita Go;Miyazaki Hidetaka;Negishi Akihide;Yokoo Satoshi;Tsushima Yoshito, 2013年02月24日, Annals of nuclear medicine, Annals of nuclear medicine, 27, 5

  DOI
• [Normal database (NDB) of 123I-IMP brain perfusion SPECT examination is affected by statistical image analysis in the presence or absence of scatter correction and attenuation correction]., Shimada Hirotaka;Otake Hidenori;Higuchi Tetsuya;Arisaka Yukiko;Oriuchi Noboru;Endo Keigo, Kaku igaku. The Japanese journal of nuclear medicine, Kaku igaku. The Japanese journal of nuclear medicine, 49, 4
• Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma., Nakano Sachiko;Tsushima Yoshito;Higuchi Tetsuya;Taketomi-Takahashi Ayako;Amanuma Makoto, 2012年01月24日, Japanese journal of radiology, Japanese journal of radiology, 30, 4

  DOI
• In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy., Yoshioka Hiroki;Yamamoto Shinji;Hanaoka Hirofumi;Iida Yasuhiko;Paudyal Pramila;Higuchi Tetsuya;Tominaga Hideyuki;Oriuchi Noboru;Nakagawa Hidewaki;Shiba Yasuhiro;Yoshida Koji;Osawa Ryuji;Katagiri Toyomasa;Tsunoda Takuya;Nakamura Yusuke;Endo Keigo, 2012年01月06日, Cancer immunology, immunotherapy : CII, Cancer immunology, immunotherapy : CII, 61, 8

  DOI
• Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma., Nakano Sachiko;Tsushima Yoshito;Taketomi-Takahashi Ayako;Higuchi Tetsuya;Amanuma Makoto;Oriuchi Noboru;Endo Keigo, 2011年07月24日, Japanese journal of radiology, Japanese journal of radiology, 29, 6

  DOI
• Clinical significance of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma., Nakazawa Azusa;Higuchi Tetsuya;Oriuchi Noboru;Arisaka Yukiko;Endo Keigo, 2011年07月06日, European journal of nuclear medicine and molecular imaging, European journal of nuclear medicine and molecular imaging, 38, 10

  DOI
• ¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry., Miyashita Go;Higuchi Tetsuya;Oriuchi Noboru;Arisaka Yukiko;Hanaoka Hirofumi;Tominaga Hideyuki;Morita Satoshi;Miyakubo Mitsuyuki;Ishikita Tomohiro;Nakasone Yoshiki;Negishi Akihide;Yokoo Satoshi;Endo Keigo, 2010年07月21日, Annals of nuclear medicine, Annals of nuclear medicine, 24, 8

  DOI
• Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy., Ishikita Tomohiro;Oriuchi Noboru;Higuchi Tetsuya;Miyashita Go;Arisaka Yukiko;Paudyal Bishnuhari;Paudyal Pramila;Hanaoka Hirofumi;Miyakubo Mitsuyuki;Nakasone Yoshiki;Negishi Akihide;Yokoo Satoshi;Endo Keigo, Annals of nuclear medicine, Annals of nuclear medicine, 24, 2

  DOI
• [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients]., Oriuchi Noboru;Higuchi Tetsuya;Endo Keigo;Tsukamoto Norifuni;Matsuda Hiroshi;Kuji Ichiei;Murakami Koji;Nakajima Kotaro, Kaku igaku. The Japanese journal of nuclear medicine, Kaku igaku. The Japanese journal of nuclear medicine, 46, 2
• Dual functional molecular imaging probe targeting CD20 with PET and optical imaging., Paudyal Pramila;Paudyal Bishnuhari;Iida Yasuhiko;Oriuchi Noboru;Hanaoka Hirofumi;Tominaga Hideyuki;Ishikita Tomohiro;Yoshioka Hiroki;Higuchi Tetsuya;Endo Keigo, Oncology reports, Oncology reports, 22, 1

  DOI
• Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors., Hanaoka Hirofumi;Tominaga Hideyuki;Yamada Keiich;Paudyal Pramila;Iida Yasuhiko;Watanabe Shigeki;Paudyal Bishnuhari;Higuchi Tetsuya;Oriuchi Noboru;Endo Keigo, 2009年06月06日, Annals of nuclear medicine, Annals of nuclear medicine, 23, 6

  DOI
• Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity., Hanaoka Hirofumi;Katagiri Toyomasa;Fukukawa Chikako;Yoshioka Hiroki;Yamamoto Shinji;Iida Yasuhiko;Higuchi Tetsuya;Oriuchi Noboru;Paudyal Bishnuhari;Paudyal Pramila;Nakamura Yusuke;Endo Keigo, 2009年05月02日, Annals of nuclear medicine, Annals of nuclear medicine, 23, 5

  DOI
• Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy., Hamamoto Kouhei;Oriuchi Noboru;Kanazawa Takashi;Higuchi Tetsuya;Endo Keigo, Pediatric neurology, Pediatric neurology, 40, 4

  DOI
• Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer., Kaira Kyoichi;Oriuchi Noboru;Shimizu Kimihiro;Ishikita Tomohiro;Higuchi Tetsuya;Imai Hisao;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Endo Keigo;Mori Masatomo, 2009年01月12日, Cancer science, Cancer science, 100, 4

  DOI
• Evaluation of thoracic tumors with (18)F-FMT and (18)F-FDG PET-CT: a clinicopathological study., Kaira Kyoichi;Oriuchi Noboru;Shimizu Kimihiro;Ishikita Tomohiro;Higuchi Tetsuya;Imai Hisao;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Endo Keigo;Mori Masatomo, International journal of cancer, International journal of cancer, 124, 5

  DOI
• Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy., Takano Akie;Oriuchi Noboru;Tsushima Yoshito;Taketomi-Takahashi Ayako;Nakajima Takahito;Arisaka Yukiko;Higuchi Tetsuya;Amanuma Makoto;Endo Keigo, 2008年07月04日, Annals of nuclear medicine, Annals of nuclear medicine, 22, 5

  DOI
• Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography., Paudyal Bishnuhari;Oriuchi Noboru;Paudyal Pramila;Higuchi Tetsuya;Nakajima Takashi;Endo Keigo, Cancer science, Cancer science, 99, 2

  DOI
• Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma., Paudyal Bishnuhari;Oriuchi Noboru;Paudyal Pramila;Tsushima Yoshito;Higuchi Tetsuya;Miyakubo Mitsuyuki;Ishikita Tomohiro;Nakajima Takashi;Endo Keigo, Annals of nuclear medicine, Annals of nuclear medicine, 22, 1

  DOI
• Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy., Paudyal Bishnuhari;Oriuchi Noboru;Paudyal Pramila;Tsushima Yoshito;Iida Yasuhiko;Higuchi Tetsuya;Hanaoka Hirofumi;Miyakubo Mitsuyuki;Takano Akie;Ishikita Tomohiro;Endo Keigo, Oncology reports, Oncology reports, 18, 6
• Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET., Miyakubo Mitsuyuki;Oriuchi Noboru;Tsushima Yoshito;Higuchi Tetsuya;Koyama Keiko;Arai Kiyokazu;Paudyal Bishnuhari;Iida Yasuhiko;Hanaoka Hirofumi;Ishikita Tomohiro;Nakasone Yoshiki;Negishi Akihide;Mogi Kenji;Endo Keigo, Annals of nuclear medicine, Annals of nuclear medicine, 21, 2

  DOI
• Present role and future prospects of positron emission tomography in clinical oncology., Oriuchi Noboru;Higuchi Tetsuya;Ishikita Tomohiro;Miyakubo Mitsuyuki;Hanaoka Hirofumi;Iida Yasuhiko;Endo Keigo, Cancer science, Cancer science, 97, 12

  DOI
• PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients., Endo Keigo;Oriuchi Noboru;Higuchi Tetsuya;Iida Yasuhiko;Hanaoka Hirofumi;Miyakubo Mitsuyuki;Ishikita Tomohiro;Koyama Keiko, International journal of clinical oncology, International journal of clinical oncology, 11, 4

  DOI
• Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas., Khan Nasim;Oriuchi Noboru;Higuchi Tetsuya;Endo Keigo, Cancer control : journal of the Moffitt Cancer Center, Cancer control : journal of the Moffitt Cancer Center, 12, 4

  DOI
• Current status of cancer therapy with radiolabeled monoclonal antibody., Oriuchi Noboru;Higuchi Tetsuya;Hanaoka Hirofumi;Iida Yasuhiko;Endo Keigo, Annals of nuclear medicine, Annals of nuclear medicine, 19, 5

  DOI
• Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer., Khan Nasim;Oriuchi Noboru;Yoshizaki Akira;Kanuma Tatsuya;Higuchi Tetsuya;Endo Keigo, Annals of nuclear medicine, Annals of nuclear medicine, 19, 2

  DOI
• Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice., Tian Mei;Zhang Hong;Higuchi Tetsuya;Oriuchi Noboru;Inoue Tomio;Endo Keigo, Cancer biotherapy & radiopharmaceuticals, Cancer biotherapy & radiopharmaceuticals, 19, 5

  DOI
• Cerebral metabolic reduction in severe malaria: fluorodeoxyglucose-positron emission tomography imaging in a primate model of severe human malaria with cerebral involvement., Sugiyama Munehiro;Ikeda Eiji;Kawai Satoru;Higuchi Tetsuya;Zhang Hong;Khan Nasim;Tomiyoshi Katsumi;Inoue Tomio;Yamaguchi Haruyasu;Katakura Ken;Endo Keigo;Suzuki Mamoru, The American journal of tropical medicine and hygiene, The American journal of tropical medicine and hygiene, 71, 5
• Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET., Khan Nasim;Oriuchi Noboru;Ninomiya Hiroshi;Higuchi Tetsuya;Kamada Hideo;Endo Keigo, Annals of nuclear medicine, Annals of nuclear medicine, 18, 5

  DOI
• Oncological diagnosis using (11)C-choline-positron emission tomography in comparison with 2-deoxy-2-[(18)F] fluoro-D-glucose-positron emission tomography., Tian Mei;Zhang Hong;Higuchi Tetsuya;Oriuchi Noboru;Endo Keigo, Molecular imaging and biology, Molecular imaging and biology, 6, 3

  DOI
• Pulmonary thromboembolism. Evaluating the indication and effect of a vena caval filter with indium-111-platelet scintigraphy., Yagi Akiko;Oriuchi Noboru;Sato Noriko;Aoki Jun;Higuchi Tetsuya;Endo Keigo, Circulation journal : official journal of the Japanese Circulation Society, Circulation journal : official journal of the Japanese Circulation Society, 68, 6

  DOI
• Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PET., Ninomiya Hiroshi;Oriuchi Noboru;Kahn Nasim;Higuchi Tetsuya;Endo Keigo;Takahashi Katsumasa;Chikamatsu Kazuaki;Kamada Hideo;Furuya Nobuhiko, Annals of nuclear medicine, Annals of nuclear medicine, 18, 1

  DOI
• Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors., Tian Mei;Zhang Hong;Oriuchi Noboru;Higuchi Tetsuya;Endo Keigo, 2004年03月11日, European journal of nuclear medicine and molecular imaging, European journal of nuclear medicine and molecular imaging, 31, 8

  DOI
• High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome., Shimizu Akiko;Oriuchi Noboru;Tsushima Yoshito;Higuchi Tetsuya;Aoki Jun;Endo Keigo, Annals of nuclear medicine, Annals of nuclear medicine, 17, 5

  DOI
• Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET., Zhang Hong;Tian Mei;Oriuchi Noboru;Higuchi Tetsuya;Tanada Shuji;Endo Keigo, European journal of radiology, European journal of radiology, 47, 3

  DOI
• [Evaluation of efficiency of a semiconductor gamma camera]., Otake Hidenori;Higuchi Tetsuya;Takeuchi Yasunao;Ryuo Hideki;Jimbo Masao;Matsubara Kunio;Koyama Ichiro;Oriuchi Noboru;Inoue Tomio;Endo Keigo, Kaku igaku. The Japanese journal of nuclear medicine, Kaku igaku. The Japanese journal of nuclear medicine, 39, 4
• [Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Malignant lymphoma]., Higuchi Tetsuya, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 62, 6
• Positron Emission Tomography/Computed Tomography before Treatment as a Predictor of ⁹⁰Y-Ibritumomab Tiuxetan Response, Yudistiro Ryan;Handa Hiroshi;Koiso Hiromi;Ishizaki Takuma;Tsushima Yoshito;Dwi Heryanto Yusri;Kodaira Sayaka;Higuchi Tetsuya;Arisaka Yukiko;Tokue Azusa;Taketomi-Takahashi Ayako;Tsukamoto Norifumi;Yokohama Akihiko, 2020年, 北関東医学, The Kitakanto Medical Journal, 70, 1, 79, 80
• The Influence of Attenuation and Scatter Corrections on Quantitative Analysis of ¹²³I-FP-CIT SPECT Brain Imaging, Kanzaki Takao;Quynh Vy Tran Vu;Higuchi Tetsuya;Nakajima Takahito;Achmad Arifudin;Takahashi Yasuyuki;Taketomi-Takahashi Ayako;Suto Takayuki;Tsushima Yoshito, 2019年, 北関東医学, The Kitakanto Medical Journal, 69, 2, 121, 127
• アイソトープ内用療法, 朝永 博康;樋口 徹也;対馬 義人, 2019年, 日本耳鼻咽喉科学会会報, Nippon Jibiinkoka Gakkai Kaiho, 122, 3, 179, 186
• Positron Emission Tomography/Computed Tomography before Treatment as a Predictor of ⁹⁰Y-Ibritumomab Tiuxetan Response, Yudistiro Ryan;Heryanto Yusri Dwi;Kodaira Sayaka;Higuchi Tetsuya;Arisaka Yukiko;Tokue Azusa;Taketomi-Takahashi Ayako;Tsukamoto Norifumi;Yokohama Akihiko;Handa Hiroshi;Koiso Hiromi;Ishizaki Takuma;Tsushima Yoshito, 2018年, Ｔｈｅ　ＫＩＴＡＫＡＮＴＯ　Ｍｅｄｉｃａｌ　Ｊｏｕｒｎａｌ, The Kitakanto Medical Journal, 68, 3, 151, 156
• Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective, Higuchi Tetsuya;Achmad Arifudin;Binh Duong Duc;Bhattarai Anu;Tsushima Yoshito, 2018年, Endocrine Journal, Endocrine Journal, 65, 3, 345, 357
• Current Status of Respiratory Nuclear Medicine in Asian Countries:- A Questionnaire Survey Study -, Yudistiro Ryan;Kosuda Shigeru;Higuchi Tetsuya;Taketomi-Takahashi Ayako;Tsushima Yoshito, 2017年, Ｔｈｅ　ＫＩＴＡＫＡＮＴＯ　Ｍｅｄｉｃａｌ　Ｊｏｕｒｎａｌ, The Kitakanto Medical Journal, 67, 3, 229, 232
• Computer-assisted Diagnosis of Metastases Based on Bone Scintigraphy::Lesion Detection Compared Using BONENAVI 1 and 2, Tomonaga Hiroyasu;Nakajima Takahito;Arisaka Yukiko;Tokue Azusa;Higuchi Tetsuya;Tsushima Yoshito, 2017年, Ｔｈｅ　ＫＩＴＡＫＡＮＴＯ　Ｍｅｄｉｃａｌ　Ｊｏｕｒｎａｌ, The Kitakanto Medical Journal, 67, 4, 299, 305
• A phase I clinical trial for [¹³¹I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma: a study protocol, Inaki Anri;Yoshimura Kenichi;Murayama Toshinori;Imai Yasuhito;Kuribayashi Yoshikazu;Higuchi Tetsuya;Jinguji Megumi;Shiga Tohru;Kinuya Seigo, 2017年, The Journal of Medical Investigation, The Journal of Medical Investigation, 64, 3, 205, 209
• Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma, Okano Yudai;Ozawa Atsushi;Shibusawa Nobuyuki;Shimada Takehiro;Higuchi Tetsuya;Chikamatsu Kazuaki;Yamada Masanobu;Satoh Tetsurou;Horiguchi Kazuhiko;Toyoda Minoru;Osaki Aya;Matsumoto Shunichi;Tomaru Takuya;Nakajima Yasuyo;Ishii Sumiyasu, 2016年, Endocrine Journal, Endocrine Journal, 63, 10, 905, 912
• 核医学を通してつながる群馬とアジアの絆の構築を目指して, 樋口 徹也, 2015年, Ｔｈｅ　ＫＩＴＡＫＡＮＴＯ　Ｍｅｄｉｃａｌ　Ｊｏｕｒｎａｌ, The Kitakanto Medical Journal, 65, 4, 307, 308
• Superficial Siderosis of the Central Nervous System Caused by Hemorrhagic Intraventricular Craniopharyngioma: Case Report and Literature Review, TOSAKA Masahiko;YOSHIMOTO Yuhei;SATO Koji;AMANUMA Makoto;HIGUCHI Tetsuya;ARAI Motohiro;AISHIMA Kaoru;SHIMIZU Tatsuya;HORIGUCHI Keishi;SUGAWARA Kenichi, 2015年, Neurologia medico-chirurgica, Neurologia medico-chirurgica, 55, 1, 89, 94
• PLS-6-2 食道扁平上皮癌におけるFAMT-PETとLAT1発現の意義及びその阻害薬による新規治療法の可能性(PLS-6 プレナリーセッション(6)「食道」,第114回日本外科学会定期学術集会), 鈴木 茂正;解良 恭一;横堀 武彦;田中 成岳;酒井 真;宗田 真;宮崎 達也;樋口 徹也;対馬 義人;桑野 博行, 2014年03月, 日本外科学会雑誌, Journal of Japan Surgical Society, 115, 2
• Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results from a multicenter observational registry, Yoshinaga Keiichiro;Toratani Ayane;Okamoto Shozo;Shiga Tohru;Ito Yoichi M.;Nakajo Masatoyo;Nakajo Masayuki;Kinuya Seigo;Oriuchi Noboru;Wakabayashi Hiroshi;Tomiyama Yuuki;Jinguji Megumi;Higuchi Tetsuya;Kayano Daiki;Fukuoka Makoto;Inaki Anri, 2014年, Endocrine Journal, Endocrine Journal, 61, 12, 1171, 1180
• Clinical significance of ^<18>F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma : comparison with ^<18>F-FDG PET/CT and MRI, KIM Mai;HIGUCHI Tetsuya;ARISAKA Yukiko;ACHMAD Arifudin;TOKUE Azusa;TOMINAGA Hideyuki;MIYASHITA Go;MIYAZAKI Hidetaka;NEGISHI Akihide;YOKOO Satoshi;TSUSHIMA Yoshito, 2013年06月, Annals of nuclear medicine, 27, 5, 423, 430
• ^<18>F-FAMT in patients with multiple myeloma : clinical utility compared to ^<18>F-FDG, ISODA Atsushi;HIGUCHI Tetsuya;NAKANO Sachiko;ARISAKA Yukiko;KAIRA Kyoichi;KAMIO Tadashi;MAWATARI Momoko;MATSUMOTO Morio;SAWAMURA Morio;TSUSHIMA Yoshito, 2012年12月, Annals of nuclear medicine, Ann Nucl Med, 26, 10, 811, 816
• ^<123>I-IMP脳血流SPECTノーマルデータベース(NDB)作成時の散乱および減弱補正が統計学的画像解析結果に与える影響, 嶋田 博孝;大竹 英則;樋口 徹也;有坂 有紀子;織内 昇;遠藤 啓吾, 2012年11月, 核医学 : 日本核医学会機関誌 : the Japanese journal of nuclear medicine, 49, 4, 341, 349
• Whole body SPECTを用いたMIP像の有用性と事前評価 : 従来の骨シンチグラフィとの比較, 齋藤 享子;高橋 康幸;嶋田 博孝;有坂 有紀子;樋口 徹也;織内 昇, 2012年03月, 群馬県立県民健康科学大学紀要, Bulletin of Gunma Prefectural College of Health Sciences, 7, 75, 82
• 肺癌のPET診断, 樋口 徹也;有坂 有紀子;中澤 梓;対馬 義人;織内 昇;遠藤 啓吾, 2012年, 肺癌, Haigan, 52, 2, 161, 167
• ^<18>F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma : comparative study with ^<18>F-FDG PET and immunohistochemistry, MIYASHITA Go;HIGUCHI Tetsuya;ORIUCHI Noboru;ARISAKA Yukiko;HANAOKA Hirofumi;TOMINAGA Hideyuki;MORITA Satoshi;MIYAKUBO Mitsuyuki;ISHIKITA Tomohiro;NAKASONE Yoshiki;NEGISHI Akihide;YOKOO Satoshi;ENDO Keigo, 2010年10月, Annals of nuclear medicine, Ann Nucl Med, 24, 8, 579, 584
• SF-048-1 転移性甲状腺髄葉癌および再発悪性褐色細胞腫に対する131I-MIBG内照射の有用性(内分泌-2,サージカルフォーラム,第110回日本外科学会定期学術集会), 鯉淵 幸生;堀口 淳;菊地 麻美;長岡 りん;六反田 奈和;佐藤 亜矢子;小田原 宏樹;時庭 英彰;戸塚 勝理;黒住 献;樋口 徹也;織内 昇;遠藤 啓吾;竹吉 泉, 2010年03月, 日本外科学会雑誌, Journal of Japan Surgical Society, 111, 2
• Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy, ISHIKITA Tomohiro;ORIUCHI Noboru;HIGUCHI Tetsuya;MIYASHITA Go;ARISAKA Yukiko;PAUDYAL Bishnuhari;PAUDYAL Pramila;HANAOKA Hirofumi;MIYAKUBO Mitsuyuki;NAKASONE Yoshiki;NEGISHI Akihide;YOKOO Satoshi;ENDO Keigo, 2010年02月, Annals of nuclear medicine, Ann Nucl Med, 24, 2, 77, 82
• Evaluation of ^<64>Cu-labeled DOTA-D-Phe^1-Tyr^3-octreotide (^<64>Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors, HANAOKA Hirofumi;TOMINAGA Hideyuki;YAMADA Keiich;PAUDYAL Pramila;IIDA Yasuhiko;WATANABE Shigeki;PAUDYAL Bishnuhari;HIGUCHI Tetsuya;ORIUCHI Noboru;ENDO Keigo, 2009年08月, Annals of nuclear medicine, Ann Nucl Med, 23, 6, 559, 567
• Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10 : therapeutic efficacy largely depends on radiosensitivity, HANAOKA Hirofumi;KATAGIRI Toyomasa;FUKUKAWA Chikako;YOSHIOKA Hiroki;YAMAMOTO Shinji;IIDA Yasuhiko;HIGUCHI Tetsuya;ORIUCHI Noboru;PAUDYAL Bishnuhari;PAUDYAL Pramila;NAKAMURA Yusuke;ENDO Keigo, 2009年07月, Annals of nuclear medicine, 23, 5, 479, 485
• 悪性リンパ腫の早期の治療効果と予後予測における^<18>F-FDG PETの有用性の研究, 織内 昇;樋口 徹也;遠藤 啓吾;塚本 憲史;松田 博史;久慈 一英;村上 康二;中島 光太郎, 2009年06月, 核医学 : 日本核医学会機関誌 : the Japanese journal of nuclear medicine, 46, 2, 96, 99
• Correlation of angiogenesis with ^<18>F-FMT and ^<18>F-FDG uptake in non-small cell lung cancer, KAIRA Kyoichi;ORIUCHI Noboru;SHIMIZU Kimihiro;ISHIKITA Tomohiro;HIGUCHI Tetsuya;IMAI Hisao;YANAGITANI Noriko;SUNAGA Noriaki;HISADA Takeshi;ISHIZUKA Tamotsu;KANAI Yoshikatsu;ENDOU Hitoshi;NAKAJIMA Takashi;ENDO Keigo;MORI Masatomo, 2009年04月, Cancer science, Cancer Sci., 100, 4, 753, 758
• 悪性リンパ腫の早期の治療効果と予後予測における^<18>F-FDG PETの有用性の研究, 織内 昇;松田 博史;村上 康二;樋口 徹也;塚本 憲史;久慈 一英;中島 光太郎;遠藤 啓吾, 2008年09月, 核医学 : 日本核医学会機関誌 : the Japanese journal of nuclear medicine, 45, 3
• PETの臨床と分子イメージング, 富永 英之;石北 朋宏;有坂 有紀子;樋口 徹也;織内 昇;遠藤 啓吾, 2008年07月, 電子情報通信学会論文誌. D, 情報・システム = The IEICE transactions on information and systems (Japanese edition), The IEICE transactions on information and systems, 91, 7, 1708, 1714
• Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging : comparison with ^<18>F-FDG positron emission tomography and ^<123>I-MIBG scintigraphy, TAKANO Akie;ORIUCHI Noboru;TSUSHIMA Yoshito;TAKETOMI TAKAHASHI Ayako;NAKAJIMA Takahito;ARISAKA Yukiko;HIGUCHI Tetsuya;AMANUMA Makoto;ENDO Keigo, 2008年06月, Annals of nuclear medicine, Ann. Nucl. Med., 22, 5, 395, 401
• 癌診断および癌スクリーニング検査としてのFDG-PETと拡散強調MRIの有用性, 遠藤 啓吾;織内 昇;樋口 徹也;堀越 浩幸;渡辺 祐司;落合 礼次;那須 克宏, 2008年05月, 核医学, 45, 2, 130, 131
• Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [^<18>F]-2-fluro-2-deoxy-D-glucose positron emission tomography, PAUDYAL Bishnuhari;ORIUCHI Noboru;PAUDYAL Pramila;HIGUCHI Tetsuya;NAKAJIMA Takashi;ENDO Keigo, 2008年02月, Cancer science, 99, 2, 260, 266
• Clinicopathological presentation of varying ^<18>F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma, PAUDYAL Bishnuhari;ORIUCHI Noboru;PAUDYAL Pramila;TSUSHIMA Yoshito;HIGUCHI Tetsuya;MIYAKUBO Mitsuyuki;ISHIKITA Tomohiro;NAKAJIMA Takashi;ENDO Keigo, 2008年01月, Annals of nuclear medicine, Ann Nucl Med, 22, 1, 83, 86
• MIBG治療の現状 : 群馬大学における悪性褐色細胞腫の画像診断と治療, 織内 昇;樋口 徹也;遠藤 啓吾, 2007年11月, ホルモンと臨牀, 55, 11, 1105, 1111
• 最終報告 : 2. 癌診断および癌スクリーニング検査としてのFDG-PETと拡散強調MRIの有用性, 遠藤 啓吾;樋口 徹也;堀越 浩幸;渡辺 祐司;落合 礼次;那須 克宏, 2007年10月, 核医学, 44, 3
• 非密封アイソトープによる治療 : II. ^<90>Y標識抗体による悪性リンパ腫の治療, 織内 昇;樋口 徹也;遠藤 啓吾, 2007年04月, Radioisotopes, Radioisotopes, 56, 4, 197, 202
• Diagnosis of maxillofacial tumor with L-3-[^<18>F]-fluoro-α-methyltyrosine (FMT) PET : a comparative study with FDG-PET, MIYAKUBO Mitsuyuki;ORIUCHI Noboru;TSUSHIMA Yoshito;HIGUCHI Tetsuya;KOYAMA Keiko;ARAI Kiyokazu;PAUDYAL Bishnuhari;IIDA Yasuhiko;HANAOKA Hirofumi;ISHIKITA Tomohiro;NAKASONE Yoshiki;NEGISHI Akihide;MOGI Kenji;ENDO Keigo, 2007年02月, Annals of nuclear medicine, Ann Nucl Med, 21, 2, 129, 135
• 非密封アイソトープによる治療　　ＩＩ．｀９０´Ｙ標識抗体による悪性リンパ腫の治療, 織内 昇;樋口 徹也;遠藤 啓吾, 2007年, ＲＡＤＩＯＩＳＯＴＯＰＥＳ, RADIOISOTOPES, 56, 4, 197, 202
• Present role and future prospects of positron emission tomography in clinical oncology, ORIUCHI Noboru;HIGUCHI Tetsuya;ISHIKITA Tomohiro;MIYAKUBO Mitsuyuki;HANAOKA Hirofumi;IIDA Yasuhiko;ENDO Keigo, 2006年12月, Cancer science, Cancer Sci., 97, 12, 1291, 1297
• 癌診断および癌スクリーニング検査としてのFDG-PETと拡散強調MRIの有用性, 遠藤 啓吾;織内 昇;樋口 徹也;堀越 浩幸;渡邊 祐司;落合 礼次;那須 克宏, 2006年10月, 核医学 : 日本核医学会機関誌 : the Japanese journal of nuclear medicine, 43, 3
• PET and PET/CT using ^<18>F-FDG in the diagnosis and management of cancer patients, ENDO Keigo;ORIUCHI Noboru;HIGUCHI Tetsuya;IIDA Yasuhiko;HANAOKA Hirofumi;MIYAKUBO Mitsuyuki;ISHIKITA Tomohiro;KOYAMA Keiko, 2006年08月, International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology, Int J Clin Oncol, 11, 4, 286, 296
• Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment, KUROSAKI Hiromasa;ORIUCHI Noboru;OKAZAKI Atsushi;TAMAKI Tomoaki;UKI Akiyoshi;IZUTA Masato;KOJIMA Rieko;KATO Yoshio;HIGUCHI Tetsuya;MARUNO Hirotaka, 2006年04月, Annals of nuclear medicine, Ann Nucl Med., 20, 3, 171, 174
• Current status of cancer therapy with radiolabeled monoclonal antibody, ORIUCHI Noboru;HIGUCHI Tetsuya;HANAOKA Hirofumi;IIDA Yasuhiko;ENDO Keigo, 2005年07月, Annals of nuclear medicine, Ann Nucl Med, 19, 5, 355, 365
• Hexokinase-II expression in untreated oral squamous cell carcinoma : comparison with FDG PET imaging, TIAN Mei;ZHANG Hong;HIGUCHI Tetsuya;ORIUCHI Noboru;NAKASONE Yoshiki;TAKATA Kuniaki;NAKAJIMA Nobuaki;MOGI Kenji;ENDO Keigo, 2005年06月, Annals of nuclear medicine, Ann Nucl Med, 19, 4, 335, 338
• Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer, KHAN Nasim;ORIUCHI Noboru;YOSHIZAKI Akira;KANUMA Tatsuya;HIGUCHI Tetsuya;ENDO Keigo, 2005年04月, Annals of nuclear medicine, Annals of Nuclear Medicine, 19, 2, 137, 145
• FDG-PETによる頭頸部腫瘍診断, 織内 昇;宮久保 満之;樋口 徹也;二宮 洋;近松 一朗;鎌田 英男;遠藤 啓吾, 2004年10月, 頭頸部癌/ 日本頭頸部癌学会, Toukeibu Gan, 30, 3, 439, 444
• Positron emission tomographic imaging with ^<11>C-choline in differential diagnosis of head and neck tumors : comparison with ^<18>F-FDG PET, KHAN Nasim;ORIUCHI Noboru;NINOMIYA Hiroshi;HIGUCHI Tetsuya;KAMADA Hideo;ENDO Keigo, 2004年07月, Annals of nuclear medicine, Ann Nucl Med., 18, 5, 409, 417
• Pulmonary Thromboembolism : Evaluating the Indication and Effect of a Vena Caval Filter With Indium-111-Platelet Scintigraphy, YAGI Akiko;ORIUCHI Noboru;SATO Noriko;AOKI Jun;HIGUCHI Tetsuya;ENDO Keigo, 2004年05月, Circulation journal : official journal of the Japanese Circulation Society, Circulation Journal, 68, 6, 599, 601
• Diagnosis of tumor in the nasal cavity and paranasal sinuses with [^<11>C]choline PET : Comparative study with 2-[^<18>F]fluoro-2-deoxy-D-glucose (FDG) PET, NINOMIYA Hiroshi;ORIUCHI Noboru;KAHN Nasim;HIGUCHI Tetsuya;ENDO Keigo;TAKAHASHI Katsumasa;CHIKAMATSU Kazuaki;KAMADA Hideo;FURUYA Nobuhiko, 2004年02月, Annals of nuclear medicine, Ann Nucl Med., 18, 1, 29, 34
• High [^<18>F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome, SHIMIZU Akiko;ORIUCHI Noboru;TSUSHIMA Yoshito;HIGUCHI Tetsuya;AOKI Jun;ENDO Keigo, 2003年07月, Annals of nuclear medicine, Ann Nucl Med, 17, 5, 403, 406
• カドミウム亜鉛テルライド半導体検出器を使用した小型ガンマカメラの性能評価, 大竹 英則;樋口 徹也;竹内 康直;流王 英樹;神保 昌夫;松原 國夫;小山 一郎;織内 昇;井上 登美夫;遠藤 啓吾, 2002年11月, 核医学, 39, 4, 549, 553
• 悪性リンパ腫, 樋口 徹也, 2002年05月, 日本醫學放射線學會雜誌, 62, 6, 278, 283
• Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel, INOUE Tomio;LI Chun;YANG David J.;HIGUCHI Tetsuya;ORIUCHI Noboru;YU Dongfang;MILAS Luka;HUNTER Nancy;WALLACE Sidney;KIM E. Edmund;PODOLOFF Donald A., 1999年06月, Annals of nuclear medicine, 13, 3, 169, 174
• Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer's Disease., Kasahara Hiroo;Ikeda Masaki;Nagashima Kazuaki;Fujita Yukio;Makioka Kouki;Tsukagoshi Setsuki;Yamazaki Tsuneo;Takai Eriko;Sanada Etsuko;Kobayashi Ayumi;Kishi Kazuhiro;Suto Takayuki;Higuchi Tetsuya;Tsushima Yoshito;Ikeda Yoshio, Journal of Alzheimer's disease : JAD, Journal of Alzheimer's disease : JAD, 68, 2

  DOI
• Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma., Takahashi Hideyuki;Sakakura Koichi;Arisaka Yukiko;Tokue Azusa;Kaira Kyoichi;Tada Hiroe;Higuchi Tetsuya;Okamoto Ayako;Tsushima Yoshito;Chikamatsu Kazuaki, Anticancer research, Anticancer research, 39, 6

  DOI
• Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer., Yamaguchi Aiko;Achmad Arifudin;Hanaoka Hirofumi;Heryanto Yusri Dwi;Bhattarai Anu;Ratianto ;Khongorzul Erdene;Shintawati Rini;Kartamihardja A Adhipatria P;Kanai Ayaka;Sugo Yumi;S Ishioka Noriko;Higuchi Tetsuya;Tsushima Yoshito, 2019年10月24日, BMC cancer, 19, 1, 1000

  DOI
• Relationship Between Tumor Immune Markers and Fluorine-18-α-Methyltyrosine ([18F]FAMT) Uptake in Patients with Lung Cancer., Shimizu Kimihiro;Kaira Kyoichi;Higuchi Tetsuya;Hisada Takeshi;Yokobori Takehiko;Oyama Tetsunari;Asao Takayuki;Tsushima Yoshito;Shirabe Ken, Molecular imaging and biology, Molecular imaging and biology, 22, 4

  DOI
• Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodine., Zhang Xieyi;Higuchi Tetsuya;Tomonaga Hiroyasu;Lamid-Ochir Oyunbold;Bhattarai Anu;Nguyen-Thu Huong;Taketomi-Takahashi Ayako;Hirasawa Hiromi;Tsushima Yoshito, Nuclear medicine communications, Nuclear medicine communications, 41, 4

  DOI
• Selective synthesis of L-2-[18 F]fluoro-alpha-methylphenylalanine via copper-mediated 18 F-fluorination of (mesityl)(aryl)iodonium salt., Yamaguchi Aiko;Hanaoka Hirofumi;Higuchi Tetsuya;Tsushima Yoshito, 2020年06月30日, Journal of labelled compounds & radiopharmaceuticals, 63, 8, 368, 375

  DOI
• Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma., Togo Maria;Yokobori Takehiko;Shimizu Kimihiro;Handa Tadashi;Kaira Kyoichi;Sano Takaaki;Tsukagoshi Mariko;Higuchi Tetsuya;Yokoo Satoshi;Shirabe Ken;Oyama Tetsunari, 2020年05月, British journal of cancer, 122, 11, 1686, 1694

  DOI
• Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma., Kuriyama Kengo;Higuchi Tamami;Yokobori Takehiko;Saito Hideyuki;Yoshida Tomonori;Hara Keigo;Suzuki Shigemasa;Sakai Makoto;Sohda Makoto;Higuchi Tetsuya;Tsushima Yoshito;Asao Takayuki;Kaira Kyoichi;Kuwano Hiroyuki;Shirabe Ken;Saeki Hiroshi, 2020年06月, Cancer science, 111, 6, 1969, 1978

  DOI
• Improvement of diagnostic accuracy of Parkinson's disease on I-123-ioflupane single photon emission computed tomography (123I FP-CIT SPECT) using new Japanese normal database., Kanzaki Takao;Higuchi Tetsuya;Takahashi Yasuyuki;Suto Takayuki;Tsushima Yoshito, Asia Oceania journal of nuclear medicine & biology, Asia Oceania journal of nuclear medicine & biology, 8, 2

  DOI
• Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors., Harimoto Norifumi;Araki Kenichiro;Hoshino Kouki;Muranushi Ryo;Hagiwara Kei;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Watanabe Akira;Kubo Norio;Tomonaga Hiroyasu;Higuchi Tetsuya;Tsushima Yoshito;Ikota Hayato;Shirabe Ken, 2020年12月, World journal of surgery, 44, 12, 4136, 4141

  DOI
• Increased Neurofilament Light Chain and YKL-40 CSF Levels in One Japanese IBMPFD Patient With VCP R155C Mutation: A Clinical Case Report With CSF Biomarker Analyses., Ikeda Masaki;Kuwabara Takeo;Takai Eriko;Kasahara Hiroo;Furuta Minori;Sekine Akiko;Makioka Kouki;Yamazaki Tsuneo;Fujita Yukio;Nagashima Kazuaki;Higuchi Tetsuya;Tsushima Yoshito;Ikeda Yoshio, 2020年08月11日, Frontiers in neurology, Frontiers in neurology, 11, 757

  DOI
• Evaluation of 111In-Pentetreotide SPECT imaging correction for GEP-NET., Kanzaki Takao;Takahashi Yasuyuki;Higuchi Tetsuya;Zhang Xieyi;Mogi Nao;Suto Takayuki;Tsushima Yoshito, 2020年09月04日, Journal of nuclear medicine technology

  DOI
• Present role and future prospects of positron emission tomography in clinical oncology, Oriuchi, Noboru;Higuchi, Tetsuya;Ishikita, Tomohiro;Miyakubo, Mitsuyuki;Hanaoka, Hirofumi;Iida, Yasuhiko;Endo, Keigo, 2006年, CANCER SCIENCE, CANCER SCIENCE, 97, 12, 1291, 1297

  DOI
• Evaluation of thoracic tumors with ¹⁸F-FMT and ¹⁸F-FDG PET-CT: A clinicopathological study, Kaira, Kyoichi;Oriuchi, Noboru;Shimizu, Kimihiro;Ishikita, Tomohiro;Higuchi, Tetsuya;Imai, Hisao;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Endo, Keigo;Mori, Masatomo, 2009年, INTERNATIONAL JOURNAL OF CANCER, INTERNATIONAL JOURNAL OF CANCER, 124, 5, 1152, 1160

  DOI
• Mesial Temporal Sclerosis Associated With Methotrexate-Induced Leukoencephalopathy, Hamamoto, Kouhei;Oriuchi, Noboru;Kanazawa, Takashi;Higuchi, Tetsuya;Endo, Keigo, 2009年, PEDIATRIC NEUROLOGY, PEDIATRIC NEUROLOGY, 40, 4, 306, 309

  DOI
• Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma, Nakano, Sachiko;Tsushima, Yoshito;Taketomi-Takahashi, Ayako;Higuchi, Tetsuya;Amanuma, Makoto;Oriuchi, Noboru;Endo, Keigo, 2011年, JAPANESE JOURNAL OF RADIOLOGY, JAPANESE JOURNAL OF RADIOLOGY, 29, 6, 449, 451

  DOI
• Clinical significance of 2-[F-18]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of I-131-metaiodobenzylguanidine therapy in malignant phaeochromocytoma, Nakazawa, Azusa;Higuchi, Tetsuya;Oriuchi, Noboru;Arisaka, Yukiko;Endo, Keigo, 2011年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 38, 10, 1869, 1875

  DOI
• In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy, Yoshioka, Hiroki;Yamamoto, Shinji;Hanaoka, Hirofumi;Iida, Yasuhiko;Paudyal, Pramila;Higuchi, Tetsuya;Tominaga, Hideyuki;Oriuchi, Noboru;Nakagawa, Hidewaki;Shiba, Yasuhiro;Yoshida, Koji;Osawa, Ryuji;Katagiri, Toyomasa;Tsunoda, Takuya;Nakamura, Yusuke;Endo, Keigo, 2012年, CANCER IMMUNOLOGY IMMUNOTHERAPY, CANCER IMMUNOLOGY IMMUNOTHERAPY, 61, 8, 1211, 1220

  DOI
• Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis, Morita, Motoho;Higuchi, Tetsuya;Achmad, Arifudin;Tokue, Azusa;Arisaka, Yukiko;Tsushima, Yoshito, 2013年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 40, 11, 1672, 1681

  DOI
• Diagnostic usefulness of F-18-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma, Nobusawa, Aiko;Kim, Mai;Kaira, Kyoichi;Miyashita, Go;Negishi, Akihide;Oriuchi, Noboru;Higuchi, Tetsuya;Tsushima, Yoshito;Kanai, Yoshikatsu;Yokoo, Satoshi;Oyama, Tetsunari, 2013年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 40, 11, 1692, 1700

  DOI
• A case of multiple hepatic angiomyolipomas with high ¹⁸F-fluorodeoxyglucose uptake, Kumasaka, Soma;Arisaka, Yukiko;Tokue, Azusa;Higuchi, Tetsuya;Nakajima, Takahito;Tsushima, Yoshito, 2014年, BMC MEDICAL IMAGING, BMC MEDICAL IMAGING, 14

  DOI
• Clinical value of fluorine-18a-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET, Horiguchi, Keishi;Tosaka, Masahiko;Higuchi, Tetsuya;Arisaka, Yukiko;Sugawara, Kenichi;Hirato, Junko;Yokoo, Hideaki;Tsushima, Yoshito;Yoshimoto, Yuhei, 2017年, EJNMMI RESEARCH, EJNMMI RESEARCH, 7

  DOI
• Preoperative Evaluation of Sellar and Parasellar Macrolesions by [¹⁸F] Fluorodeoxyglucose Positron Emission Tomography, Tosaka, Masahiko;Higuchi, Tetsuya;Horiguchi, Keishi;Osawa, Tadashi;Arisaka, Yukiko;Fujita, Haruyasu;Tsushima, Yoshito;Yoshimoto, Yuhei, 2017年, WORLD NEUROSURGERY, WORLD NEUROSURGERY, 103, 591, 599

  DOI
• Quantitative Analysis of Iodine Image of Dual-energy Computed Tomography at Rest Comparison With ^99mTc-Tetrofosmin Stress-rest Single-photon Emission Computed Tomography Myocardial Perfusion Imaging as the Reference Standard, Nakahara, Takehiro;Toyama, Takuji;Jinzaki, Masahiro;Seki, Ryotaro;Saito, Yuichiro;Higuchi, Tetsuya;Yamada, Minoru;Arai, Masashi;Tsushima, Yoshito;Kuribayashi, Sachio;Kurabayashi, Masahiko, 2018年, JOURNAL OF THORACIC IMAGING, JOURNAL OF THORACIC IMAGING, 33, 2, 97, 104

  DOI
• ¹⁸F-FAMT PET Is Useful to Distinguish between Specific Uptake and Nonspecific Uptake Compared to ¹⁸F-Flourodeoxyglucose Position Emission Tomography in Esophageal Cancer Patients, Sohda, Makoto;Miyazaki, Tatsuya;Honjyo, Hiroaki;Hara, Keigo;Ozawa, Daigo;Sakai, Makoto;Yokobori, Takehiko;Higuchi, Tetsuya;Tsushima, Yoshito;Kuwano, Hiroyuki, 2018年, DIGESTIVE SURGERY, DIGESTIVE SURGERY, 35, 5, 383, 388

  DOI
• Most Important Prognostic Values to Predict Major Adverse Cardiovascular, Cerebrovascular, and Renal Events in Patients with Chronic Kidney Disease Including Hemodialysis for 2 Years, Toyama, Takuji;Kasama, Shu;Sato, Makito;Sano, Hirokazu;Ueda, Tetsuya;Sasaki, Toyoshi;Nakahara, Takehiro;Higuchi, Tetsuya;Tsushima, Yoshito;Kurabayashi, Masahiko, 2019年, CARDIOLOGY, CARDIOLOGY, 142, 1, 14, 23

  DOI
• ¹⁸F-FDG and ¹⁸F-FAMT PET-derived metabolic parameters predict outcome of oral squamous cell carcinoma, Kim, Mai;Higuchi, Tetsuya;Nakajima, Takahito;Andriana, Putri;Hirasawa, Hiromi;Tokue, Azusa;Kurihara, Jun;Yokoo, Satoshi;Tsushima, Yoshito, 2019年, ORAL RADIOLOGY, ORAL RADIOLOGY, 35, 3, 308, 314

  DOI
• Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodine, Zhang, Xieyi;Higuchi, Tetsuya;Tomonaga, Hiroyasu;Lamid-Ochir, Oyunbold;Bhattarai, Anu;Nguyen-Thu, Huong;Taketomi-Takahashi, Ayako;Hirasawa, Hiromi;Tsushima, Yoshito, 2020年, NUCLEAR MEDICINE COMMUNICATIONS, NUCLEAR MEDICINE COMMUNICATIONS, 41, 4, 350, 355

  DOI
• Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma, Kuriyama, Kengo;Higuchi, Tamami;Yokobori, Takehiko;Saito, Hideyuki;Yoshida, Tomonori;Hara, Keigo;Suzuki, Shigemasa;Sakai, Makoto;Sohda, Makoto;Higuchi, Tetsuya;Tsushima, Yoshito;Asao, Takayuki;Kaira, Kyoichi;Kuwano, Hiroyuki;Shirabe, Ken;Saeki, Hiroshi, 2020年, CANCER SCIENCE, CANCER SCIENCE, 111, 6, 1969, 1978

  DOI
• Radioimmunotherapy of triple negative breast cancer using ⁹⁰Y-DTPA-bevacizumab, Hanaoka, Hirofumi;Yudistiro, Ryan;Yamaguchi, Aiko;Higuchi, Tetsuya;Tsushima, Yoshito, 2017年, JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 60, S202, S202
• Absorbed dose simulation of meta-²¹¹At-astato-benzylguanidine using pharmacokinetics of ¹³¹I-MIBG and a novel dose conversion method, RAP, Sakashita, Tetsuya;Watanabe, Shigeki;Hanaoka, Hirofumi;Ohshima, Yasuhiro;Ikoma, Yoko;Ukon, Naoyuki;Sasaki, Ichiro;Higashi, Tatsuya;Higuchi, Tetsuya;Tsushima, Yoshito;Ishioka, Noriko S., 2021年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 35, 1, 121, 131

  DOI
• Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study, Mukada, Naoto;Tosaka, Masahiko;Matsumura, Nozomi;Yamaguchi, Rei;Aihara, Masanori;Isoda, Koji;Higuchi, Tetsuya;Tsushima, Yoshito;Yokoo, Hideaki;Yoshimoto, Yuhei, 2021年, SCIENTIFIC REPORTS, SCIENTIFIC REPORTS, 11, 1

  DOI
• Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease, Ikeda, Masaki;Kodaira, Sayaka;Kasahara, Hiroo;Takai, Eriko;Nagashima, Kazuaki;Fujita, Yukio;Makioka, Kouki;Hirayanagi, Kimitoshi;Furuta, Natsumi;Furuta, Minori;Sanada, Etsuko;Kobayashi, Ayumi;Harigaya, Yasuo;Nagamine, Shun;Hattori, Noriaki;Tashiro, Yuichi;Kishi, Kazuhiro;Shimada, Hirotaka;Suto, Takayuki;Tanaka, Hisashi;Sakai, Yasujiro;Yamazaki, Tsuneo;Tanaka, Yukiko;Aihara, Yuko;Amari, Masakuni;Yamaguchi, Haruyasu;Okamoto, Koichi;Takatama, Masamitsu;Ishii, Kenji;Higuchi, Tetsuya;Tsushima, Yoshito;Ikeda, Yoshio, 2021年, FRONTIERS IN NEUROLOGY, FRONTIERS IN NEUROLOGY, 12

  DOI
• FDG-PET for preoperative evaluation of tumor invasion in ampullary cancer: A retrospective analysis, Watanabe, Akira;Harimoto, Norifumi;Araki, Kenichiro;Kubo, Norio;Igarashi, Takamichi;Tsukagoshi, Mariko;Ishii, Norihiro;Hirai, Keitaro;Tanaka, Hiroshi;Mochida, Yasushi;Kogure, Norimichi;Higuchi, Tetsuya;Shirabe, Ken, 2021年, JOURNAL OF SURGICAL ONCOLOGY, JOURNAL OF SURGICAL ONCOLOGY, 124, 3, 317, 323

  DOI
• Texture analysis of [¹⁸F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinoma treated with cetuximab, Kim, Mai;Gu, Wenchao;Nakajima, Takahito;Higuchi, Tetsuya;Ogawa, Masaru;Shimizu, Takahiro;Yamaguchi, Takahiro;Takahashi, Ayako;Tsushima, Yoshito;Yokoo, Satoshi, 2021年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 35, 8, 871, 880

  DOI
• Rapid-Onset Dystonia-Parkinsonism Phenotype Consistency for a Novel Variant of ATP1A3 in Patients Across 3 Global Populations, Hoshino, Kyoko;Sweadner, Kathleen J.;Kawarai, Toshitaka;Saute, Jonas Alex;Freitas, Joel;Damasio, Joana;Donis, Karina C.;Kimura, Kazue;Fukuda, Hideki;Hayashi, Masaharu;Higuchi, Tetsuya;Ikeda, Yoshio;Ozelius, Laurie J.;Kaji, Ryuji, 2021年, NEUROLOGY-GENETICS, NEUROLOGY-GENETICS, 7, 2

  DOI
• Recurrent Lobar Hemorrhages and Multiple Cortical Superficial Siderosis in a Patient of Alzheimer's Disease With Homozygous APOE ε2 Allele Presenting Hypobetalipoproteinemia and Pathological Findings of ¹⁸F-THK5351 Positron Emission Tomography: A Case Report, Ikeda, Masaki;Okamoto, Koichi;Suzuki, Keiji;Takai, Eriko;Kasahara, Hiroo;Furuta, Natsumi;Furuta, Minori;Tashiro, Yuichi;Shimizu, Chisato;Takatama, Shin;Naito, Isao;Sato, Mie;Sakai, Yasujiro;Takahashi, Manabu;Amari, Masakuni;Takatama, Masamitsu;Higuchi, Tetsuya;Tsushima, Yoshito;Yokoo, Hideaki;Kurabayashi, Masahiko;Ishibashi, Shun;Ishii, Kenji;Ikeda, Yoshio, 2021年, FRONTIERS IN NEUROLOGY, FRONTIERS IN NEUROLOGY, 12

  DOI
• An open-label, single-arm, multi-center, phase II clinical trial of single-dose [¹³¹I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma, Inaki, Anri;Shiga, Tohru;Tsushima, Yoshito;Jinguji, Megumi;Wakabayashi, Hiroshi;Kayano, Daiki;Akatani, Norihito;Yamase, Takafumi;Kunita, Yuji;Watanabe, Satoru;Hiromasa, Tomo;Mori, Hiroshi;Hirata, Kenji;Watanabe, Shiro;Higuchi, Tetsuya;Tomonaga, Hiroyasu;Kinuya, Seigo, 2022年, ANNALS OF NUCLEAR MEDICINE, ANNALS OF NUCLEAR MEDICINE, 36, 3, 267, 278

  DOI
• Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy, Sakashita, Tetsuya;Matsumoto, Shojiro;Watanabe, Shigeki;Hanaoka, Hirofumi;Ohshima, Yasuhiro;Ikoma, Yoko;Ukon, Naoyuki;Sasaki, Ichiro;Higashi, Tatsuya;Higuchi, Tetsuya;Tsushima, Yoshito;Ishioka, Noriko S., 2021年, EJNMMI PHYSICS, EJNMMI PHYSICS, 8, 1

  DOI
• Enhancing the accumulation level of 3-[¹⁸F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid, Kanai, Ayaka;Hanaoka, Hirofumi;Yamaguchi, Aiko;Mahendra, Isa;Palangka, Citra;Ohshima, Yasuhiro;Higuchi, Tetsuya;Tsushima, Yoshito, 2022年, NUCLEAR MEDICINE AND BIOLOGY, NUCLEAR MEDICINE AND BIOLOGY, 104, 47, 52

  DOI
• Usefulness of dual isotope ¹²³I-IMP and ²⁰¹Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma, Osawa, Sho;Tosaka, Masahiko;Horiguchi, Keishi;Tokue, Azusa;Higuchi, Tetsuya;Tsushima, Yoshito;Yoshimoto, Yuhei, 2022年, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 27, 8, 1264, 1272

  DOI
• Prospective assessment using ¹⁸F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer, Yamaguchi, Ou;Kaira, Kyoichi;Naruse, Ichiro;Umeda, Yukihiro;Honda, Takeshi;Watanabe, Satoshi;Ichikawa, Kosuke;Tateishi, Kazunari;Kasahara, Norimitsu;Higuchi, Tetsuya;Hashimoto, Kosuke;Shinomiya, Shun;Miura, Yu;Shiono, Ayako;Mouri, Atsuto;Imai, Hisao;Iizuka, Kunihiko;Ishizuka, Tamotsu;Minato, Koichi;Suda, Satoshi;Kagamu, Hiroshi;Mori, Keita;Kuji, Ichiei;Seki, Nobuhiko, 2022年, SCIENTIFIC REPORTS, SCIENTIFIC REPORTS, 12, 1

  DOI
• Usefulness of simulation in optimizing imaging settings for pediatric technetium-99m-dimercaptosuccinic acid single-photon emission computed tomography, Kurosawa, Yuji;Kanzaki, Takao;Higuchi, Tetsuya;Suto, Takayuki;Tsushima, Yoshito, 2022年, NUCLEAR MEDICINE COMMUNICATIONS, NUCLEAR MEDICINE COMMUNICATIONS, 43, 9, 987, 994

  DOI
• Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer, Kaira, Kyoichi;Yamaguchi, Ou;Naruse, Ichiro;Umeda, Yukihiro;Honda, Takeshi;Watanabe, Satoshi;Ichikawa, Kosuke;Yanagisawa, Shin;Kasahara, Norimitsu;Higuchi, Tetsuya;Hashimoto, Kosuke;Miura, Yu;Shiono, Ayako;Mouri, Atsuto;Imai, Hisao;Iizuka, Kunihiko;Ishizuka, Tamotsu;Minato, Koichi;Suda, Satoshi;Kagamu, Hiroshi;Mori, Keita;Seki, Nobuhiko;Kuji, Ichiei, 2023年, CANCER IMAGING, CANCER IMAGING, 23, 1

  DOI
• Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia, Ishizawa, Kunihiko;Fujita, Yukio;Nagashima, Kazuaki;Nakamura, Takumi;Shibata, Makoto;Kasahara, Hiroo;Makioka, Kouki;Taketomi-Takahashi, Ayako;Hirasawa, Hiromi;Higuchi, Tetsuya;Tsushima, Yoshito;Ikeda, Yoshio, 2023年, JOURNAL OF THE NEUROLOGICAL SCIENCES, JOURNAL OF THE NEUROLOGICAL SCIENCES, 451

  DOI
• ＦＤＧ‐ＰＥＴによる頭頚部腫よう診断, 織内 昇;宮久保 満之;樋口 徹也;二宮 洋;近松 一朗;鎌田 英男;遠藤 啓吾, 2004年, 頭頸部癌, Toukeibu Gan, 30, 3, 439, 444

  DOI
• A 2-Year Prospective Study on the Differences in Prognostic Factors for Major Adverse Cardiovascular, Cerebrovascular and Renal Events Between Patients with Mild and Severe Chronic Kidney Disease, Toyama Takuji;Kasama Shu;Sato Makito;Sano Hirokazu;Ueda Tetsuya;Sasaki Toyoshi;Nakahara Takehiro;Higuchi Tetsuya;Tsushima Yoshito;Kurabayashi Masahiko, 2021年08月, Annals of Nuclear Cardiology, Annals of Nuclear Cardiology, 7, 1, 17, 26

  DOI
• 患者に優しい核医学治療の線量評価法としてのRAP法の基礎検討, 坂下 哲哉;渡辺 茂樹;花岡 宏史;大島 康宏;生駒 洋子;右近 直之;佐々木 一郎;東 達也;樋口 徹也;対馬 義人;石岡 典子, 2021年, アイソトープ・放射線研究発表会, The Annual Meeting on Radioisitopes and Radiation Researches, 1, 0, 66

  DOI
• FDG-PETで高度集積を認めた膵黄色肉芽腫の１例, 田中 寛;播本 憲史;新木 健一郎;久保 憲生;渡辺 亮;樋口 徹也;星 恒輝;下田 雄輝;調 憲, 2021年, 日本外科系連合学会誌, Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons), 46, 1, 90, 96

  DOI
• 本邦における外来放射性ヨウ素30mCi(1.1GBq)内用療法の現状と今後の展望, 朝永 博康;樋口 徹也, 2020年11月, 日本内分泌外科学会雑誌, 37, Suppl.2, S234
• 18F-FDG PET/CTにおけるmetabolic parameterと肝内胆管癌切除症例の予後との関連, 播本 憲史;萩原 慶;山中 崇弘;石井 範洋;五十嵐 隆通;渡辺 亮;久保 憲生;新木 健一郎;調 憲;朝永 博康;樋口 徹也;対馬 義人, 2018年11月, 日本消化器外科学会雑誌, 51, Suppl.2, 243
• FDG-PETで高度集積を認めた膵黄色肉芽腫の1例, 田中 寛;播本 憲史;新木 健一郎;久保 憲生;渡辺 亮;樋口 徹也;星 恒輝;下田 雄輝;調 憲, 2021年02月, 日本外科系連合学会誌, 46, 1, 90
• 膵神経内分泌腫瘍における拡散強調画像の意義, 播本 憲史;星野 弘毅;村主 遼;萩原 慶;石井 範洋;塚越 真梨子;五十嵐 隆通;渡辺 亮;久保 憲生;新木 健一郎;調 憲;対馬 義人;樋口 徹也, 2021年04月, 日本外科学会定期学術集会抄録集, 121回, SF
• 【甲状腺疾患　甲状腺診療の最新知見】知っておきたい甲状腺腫瘍の最近の話題　甲状腺癌の131I内用療法, 朝永 博康;樋口 徹也, 2022年01月, Medical Practice, 39, 1, 103
• セツキシマブ投与患者におけるPETテクスチャ解析を用いた治療効果予測に関する検討, 金 舞;Wenchao Gu;中島 崇仁;樋口 徹也;対馬 義人;横尾 聡, 2021年10月, 核医学, 58, Suppl., S227
• 骨シンチにおける画像解析ソフトでの結果と読影結果の比較検討, 嶋田 博孝;新井 啓祐;勘崎 貴雄;須藤 高行;樋口 徹也;徳江 梓;朝永 博康;川村 義文;大川 健一, 2022年08月, 核医学技術, 42, 予稿集, 336
• 進行再発大腸がんに対する効果的な外科治療介入を考える　大腸がん肝転移切除症例に対する早期再発とoverall survivalに基づいた切除戦略, 渡辺 亮;播本 憲史;新木 健一郎;塚越 真梨子;石井 範洋;萩原 慶;星野 弘毅;村主 遼;関 貴臣;吉住 朋晴;山下 洋市;馬場 秀夫;樋口 徹也;調 憲, 2022年10月, 日本癌治療学会学術集会抄録集, 60回, OWS28
• 小児腎ファントムを用いた99mTc-DMSAシンチグラフィの最適撮像時間の検討, 勘崎 貴雄;黒澤 裕司;清水 正挙;星野 洋満;茂木 彰子;市川 肇;嶋田 博孝;須藤 高行;樋口 徹也, 2023年10月, 核医学技術, 43, 予稿集, 308
• Absorbed dose simulation of meta-211At-astato-benzylguanidine using pharmacokinetics of 131I-MIBG and a novel dose conversion method, RAP., Sakashita Tetsuya;Watanabe Shigeki;Hanaoka Hirofumi;Ohshima Yasuhiro;Ikoma Yoko;Ukon Naoyuki;Sasaki Ichiro;Higashi Tatsuya;Higuchi Tetsuya;Tsushima Yoshito;Ishioka Noriko S, 2020年11月, Annals of nuclear medicine, Annals of nuclear medicine, 35, 1

  DOI
• Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study., Mukada Naoto;Tosaka Masahiko;Matsumura Nozomi;Yamaguchi Rei;Aihara Masanori;Isoda Koji;Higuchi Tetsuya;Tsushima Yoshito;Yokoo Hideaki;Yoshimoto Yuhei, 2021年01月, Scientific reports, Scientific reports, 11, 1

  DOI
• Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease., Ikeda Masaki;Kodaira Sayaka;Kasahara Hiroo;Takai Eriko;Nagashima Kazuaki;Fujita Yukio;Makioka Kouki;Hirayanagi Kimitoshi;Furuta Natsumi;Furuta Minori;Sanada Etsuko;Kobayashi Ayumi;Harigaya Yasuo;Nagamine Shun;Hattori Noriaki;Tashiro Yuichi;Kishi Kazuhiro;Shimada Hirotaka;Suto Takayuki;Tanaka Hisashi;Sakai Yasujiro;Yamazaki Tsuneo;Tanaka Yukiko;Aihara Yuko;Amari Masakuni;Yamaguchi Haruyasu;Okamoto Koichi;Takatama Masamitsu;Ishii Kenji;Higuchi Tetsuya;Tsushima Yoshito;Ikeda Yoshio, 2021年04月, Frontiers in neurology, Frontiers in neurology, 12

  DOI
• Rapid-Onset Dystonia-Parkinsonism Phenotype Consistency for a Novel Variant of ATP1A3 in Patients Across 3 Global Populations., Hoshino Kyoko;Sweadner Kathleen J;Kawarai Toshitaka;Saute Jonas Alex;Freitas Joel;Damásio Joana;Donis Karina C;Kimura Kazue;Fukuda Hideki;Hayashi Masaharu;Higuchi Tetsuya;Ikeda Yoshio;Ozelius Laurie J;Kaji Ryuji, 2021年03月, Neurology. Genetics, Neurology. Genetics, 7, 2

  DOI
• FDG-PET for preoperative evaluation of tumor invasion in ampullary cancer: A retrospective analysis., Watanabe Akira;Harimoto Norifumi;Araki Kenichiro;Kubo Norio;Igarashi Takamichi;Tsukagoshi Mariko;Ishii Norihiro;Hirai Keitaro;Tanaka Hiroshi;Mochida Yasushi;Kogure Norimichi;Higuchi Tetsuya;Shirabe Ken, 2021年05月, Journal of surgical oncology, Journal of surgical oncology, 124, 3

  DOI
• Texture analysis of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinoma treated with cetuximab., Kim Mai;Gu Wenchao;Nakajima Takahito;Higuchi Tetsuya;Ogawa Masaru;Shimizu Takahiro;Yamaguchi Takahiro;Takahashi Ayako;Tsushima Yoshito;Yokoo Satoshi, 2021年05月, Annals of nuclear medicine, Annals of nuclear medicine, 35, 8

  DOI
• Recurrent Lobar Hemorrhages and Multiple Cortical Superficial Siderosis in a Patient of Alzheimer's Disease With Homozygous APOE ε2 Allele Presenting Hypobetalipoproteinemia and Pathological Findings of 18F-THK5351 Positron Emission Tomography: A Case Report., Ikeda Masaki;Okamoto Koichi;Suzuki Keiji;Takai Eriko;Kasahara Hiroo;Furuta Natsumi;Furuta Minori;Tashiro Yuichi;Shimizu Chisato;Takatama Shin;Naito Isao;Sato Mie;Sakai Yasujiro;Takahashi Manabu;Amari Masakuni;Takatama Masamitsu;Higuchi Tetsuya;Tsushima Yoshito;Yokoo Hideaki;Kurabayashi Masahiko;Ishibashi Shun;Ishii Kenji;Ikeda Yoshio, 2021年07月, Frontiers in neurology, Frontiers in neurology, 12

  DOI
• An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma., Inaki Anri;Shiga Tohru;Tsushima Yoshito;Jinguji Megumi;Wakabayashi Hiroshi;Kayano Daiki;Akatani Norihito;Yamase Takafumi;Kunita Yuji;Watanabe Satoru;Hiromasa Tomo;Mori Hiroshi;Hirata Kenji;Watanabe Shiro;Higuchi Tetsuya;Tomonaga Hiroyasu;Kinuya Seigo, 2021年12月, Annals of nuclear medicine, Annals of nuclear medicine, 36, 3

  DOI
• Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid., Kanai Ayaka;Hanaoka Hirofumi;Yamaguchi Aiko;Mahendra Isa;Palangka Citra;Ohshima Yasuhiro;Higuchi Tetsuya;Tsushima Yoshito, 2021年12月, Nuclear medicine and biology, Nuclear medicine and biology, 104-105

  DOI
• Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy., Sakashita Tetsuya;Matsumoto Shojiro;Watanabe Shigeki;Hanaoka Hirofumi;Ohshima Yasuhiro;Ikoma Yoko;Ukon Naoyuki;Sasaki Ichiro;Higashi Tatsuya;Higuchi Tetsuya;Tsushima Yoshito;Ishioka Noriko S, 2021年12月, EJNMMI physics, EJNMMI physics, 8, 1

  DOI
• Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma., Wakabayashi Hiroshi;Inaki Anri;Yoshimura Kenichi;Murayama Toshinori;Imai Yasuhito;Higuchi Tetsuya;Jinguji Megumi;Shiga Tohru;Kinuya Seigo, 2022年01月, Scientific reports, Scientific reports, 12, 1

  DOI
• Usefulness of dual isotope 123I-IMP and 201Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma., Osawa Sho;Tosaka Masahiko;Horiguchi Keishi;Tokue Azusa;Higuchi Tetsuya;Tsushima Yoshito;Yoshimoto Yuhei, 2022年05月, International journal of clinical oncology, International journal of clinical oncology, 27, 8

  DOI
• Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer., Yamaguchi Ou;Kaira Kyoichi;Naruse Ichiro;Umeda Yukihiro;Honda Takeshi;Watanabe Satoshi;Ichikawa Kosuke;Tateishi Kazunari;Kasahara Norimitsu;Higuchi Tetsuya;Hashimoto Kosuke;Shinomiya Shun;Miura Yu;Shiono Ayako;Mouri Atsuto;Imai Hisao;Iizuka Kunihiko;Ishizuka Tamotsu;Minato Koichi;Suda Satoshi;Kagamu Hiroshi;Mori Keita;Kuji Ichiei;Seki Nobuhiko, 2022年07月, Scientific reports, Scientific reports, 12, 1

  DOI
• Usefulness of simulation in optimizing imaging settings for pediatric technetium-99m-dimercaptosuccinic acid single-photon emission computed tomography., Kurosawa Yuji;Kanzaki Takao;Higuchi Tetsuya;Suto Takayuki;Tsushima Yoshito, 2022年06月, Nuclear medicine communications, Nuclear medicine communications, 43, 9

  DOI
• Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer., Kaira Kyoichi;Yamaguchi Ou;Naruse Ichiro;Umeda Yukihiro;Honda Takeshi;Watanabe Satoshi;Ichikawa Kosuke;Yanagisawa Shin;Kasahara Norimitsu;Higuchi Tetsuya;Hashimoto Kosuke;Miura Yu;Shiono Ayako;Mouri Atsuto;Imai Hisao;Iizuka Kunihiko;Ishizuka Tamotsu;Minato Koichi;Suda Satoshi;Kagamu Hiroshi;Mori Keita;Seki Nobuhiko;Kuji Ichiei, 2023年03月, Cancer imaging : the official publication of the International Cancer Imaging Society, Cancer imaging : the official publication of the International Cancer Imaging Society, 23, 1

  DOI
• A 2-Year Prospective Study on the Differences in Prognostic Factors for Major Adverse Cardiovascular, Cerebrovascular and Renal Events Between Patients with Mild and Severe Chronic Kidney Disease., Toyama Takuji;Kasama Shu;Sato Makito;Sano Hirokazu;Ueda Tetsuya;Sasaki Toyoshi;Nakahara Takehiro;Higuchi Tetsuya;Tsushima Yoshito;Kurabayashi Masahiko, 2021年08月, Annals of nuclear cardiology, Annals of nuclear cardiology, 7, 1

  DOI
• Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia., Ishizawa Kunihiko;Fujita Yukio;Nagashima Kazuaki;Nakamura Takumi;Shibata Makoto;Kasahara Hiroo;Makioka Kouki;Taketomi-Takahashi Ayako;Hirasawa Hiromi;Higuchi Tetsuya;Tsushima Yoshito;Ikeda Yoshio, 2023年06月, Journal of the neurological sciences, Journal of the neurological sciences, 451

  DOI
• Total lesion glycolysis by 18 F-fluorodeoxyglucose positron emission tomography predicts tumor aggressiveness in patients with extrahepatic bile duct carcinoma., Fukushima Ryosuke;Harimoto Norifumi;Kawai Shunsuke;Ishii Norihiro;Tsukagoshi Mariko;Igarashi Takamichi;Araki Kenichiro;Tomonaga Hiroyasu;Higuchi Tetsuya;Shirabe Ken, 2024年03月, Journal of hepato-biliary-pancreatic sciences, Journal of hepato-biliary-pancreatic sciences

  DOI
• 特集 注意したいFDG-PET/CTでの見逃しと読み過ぎ 頭頸部領域, 徳江 梓;樋口 徹也;徳江 浩之;中嶌 崇仁;対馬 義人, 2019年08月, 臨床放射線, 64, 9, 1119, 1125

  DOI
• セツキシマブ投与患者におけるPETテクスチャ解析を用いた治療効果予測に関する検討, 金 舞;Wenchao Gu;中島 崇仁;樋口 徹也;対馬 義人;横尾 聡, 2021年, 核医学, 58, Suppl., S227
• 小児腎ファントムを用いた99mTc-DMSAシンチグラフィの最適撮像時間の検討, 勘崎 貴雄;黒澤 裕司;清水 正挙;星野 洋満;茂木 彰子;市川 肇;嶋田 博孝;須藤 高行;樋口 徹也, 2023年10月, 核医学技術, 43, 予稿集, 308
• 癌診断および癌スクリーニング検査としてのFDG-PETと拡散強調MRIの有用性, 遠藤 啓吾;織内 昇;樋口 徹也;堀越 浩幸;渡辺 祐司;落合 礼次;那須 克宏, 2008年05月, 核医学, 45, 2, 130, 131
• 当院におけるPRRTの初期経験と実際の運用について, 朝永 博康;山内 創聖;樋口 徹也;対馬 義人, 2024年, 核医学, 61, 1, 22
• 治療抵抗性口腔扁平上皮癌のFDG-PET/CTを用いたmLugano分類による病期診断と治療効果判定の検討, 金 舞;樋口 徹也;小川 将;対馬 義人;横尾 聡, 2023年07月, 日本口腔科学会雑誌, 72, 2, 153
• 治療抵抗性口腔扁平上皮癌のFDG-PET/CTを用いたmLugano分類による病期診断と治療効果判定の検討, 金 舞;樋口 徹也;小川 将;対馬 義人;横尾 聡, 2023年07月, 日本口腔科学会雑誌, 72, 2, 153

MISC

• l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Shigebumi Tanaka,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, 2008年12月, CANCER SCIENCE, 99, 12, 2380, 2386

  DOI
• l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Shigebumi Tanaka,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, 2008年12月, CANCER SCIENCE, 99, 12, 2380, 2386

  DOI
• Clinicopathological presentation of varying F-18-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma, Bishnuhari Paudyal,Noboru Oriuchi,Pramila Paudyal,Yoshito Tsushima,Tetsuya Higuchi,Mitsuyuki Miyakubo,Tomohiro Ishikita,Takashi Nakajima,Keigo Endo, 2008年01月, ANNALS OF NUCLEAR MEDICINE, 22, 1, 83, 86

  DOI
• Clinicopathological presentation of varying F-18-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma, Bishnuhari Paudyal,Noboru Oriuchi,Pramila Paudyal,Yoshito Tsushima,Tetsuya Higuchi,Mitsuyuki Miyakubo,Tomohiro Ishikita,Takashi Nakajima,Keigo Endo, 2008年01月, ANNALS OF NUCLEAR MEDICINE, 22, 1, 83, 86

  DOI
• Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with (18)F-FDG positron emission tomography and (123)I-MIBG scintigraphy, Akie Takano,Noboru Oriuchi,Yoshito Tsushima,Ayako Taketomi-Takahashi,Takahito Nakajima,Yukiko Arisaka,Tetsuya Higuchi,Makoto Amanuma,Keigo Endo, 2008年06月, ANNALS OF NUCLEAR MEDICINE, 22, 5, 395, 401

  DOI
• Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with (18)F-FDG positron emission tomography and (123)I-MIBG scintigraphy, Akie Takano,Noboru Oriuchi,Yoshito Tsushima,Ayako Taketomi-Takahashi,Takahito Nakajima,Yukiko Arisaka,Tetsuya Higuchi,Makoto Amanuma,Keigo Endo, 2008年06月, ANNALS OF NUCLEAR MEDICINE, 22, 5, 395, 401

  DOI
• Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [F-18]-2-fluro-2-deoxy-D-glucose positron emission tomography, Bishnuhari Paudyal,Noboru Oriuchi,Pramila Paudyal,Tetsuya Higuchi,Takashi Nakajima,Keigo Endo, 2008年02月, CANCER SCIENCE, 99, 2, 260, 266

  DOI
• Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [F-18]-2-fluro-2-deoxy-D-glucose positron emission tomography, Bishnuhari Paudyal,Noboru Oriuchi,Pramila Paudyal,Tetsuya Higuchi,Takashi Nakajima,Keigo Endo, 2008年02月, CANCER SCIENCE, 99, 2, 260, 266

  DOI
• Draft guidelines regarding appropriate use of I-131-MIBG radiotherapy for neuroendocrine tumors, Seigo Kinuya,Keiichiro Yoshinaga,Tetsuya Higuchi,Megumi Jinguji,Hiroaki Kurihara,Hiroshi Kawamoto, 2015年07月, ANNALS OF NUCLEAR MEDICINE, 29, 6, 543, 552

  DOI
• Draft guidelines regarding appropriate use of I-131-MIBG radiotherapy for neuroendocrine tumors, Seigo Kinuya,Keiichiro Yoshinaga,Tetsuya Higuchi,Megumi Jinguji,Hiroaki Kurihara,Hiroshi Kawamoto, 2015年07月, ANNALS OF NUCLEAR MEDICINE, 29, 6, 543, 552

  DOI
• Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma, Takashi Okamura,Yasuyo Nakajima,Tetsurou Satoh,Koshi Hashimoto,Santosh Sapkota,Eijiro Yamada,Shuichi Okada,Junya Fukuda,Tetsuya Higuchi,Yoshito Tsushima,Masanobu Yamada, 2015年06月, METABOLISM-CLINICAL AND EXPERIMENTAL, 64, 6, 706, 712

  DOI
• Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma, Takashi Okamura,Yasuyo Nakajima,Tetsurou Satoh,Koshi Hashimoto,Santosh Sapkota,Eijiro Yamada,Shuichi Okada,Junya Fukuda,Tetsuya Higuchi,Yoshito Tsushima,Masanobu Yamada, 2015年06月, METABOLISM-CLINICAL AND EXPERIMENTAL, 64, 6, 706, 712

  DOI
• Evaluation of bone scan index change over time on automated calculation in bone scintigraphy, Rini Shintawati,Arifudin Achmad,Tetsuya Higuchi,Hirotaka Shimada,Hiromi Hirasawa,Yukiko Arisaka,Ayako Takahashi,Takahito Nakajima,Yoshito Tsushima, 2015年12月, ANNALS OF NUCLEAR MEDICINE, 29, 10, 911, 920

  DOI
• Evaluation of bone scan index change over time on automated calculation in bone scintigraphy, Rini Shintawati,Arifudin Achmad,Tetsuya Higuchi,Hirotaka Shimada,Hiromi Hirasawa,Yukiko Arisaka,Ayako Takahashi,Takahito Nakajima,Yoshito Tsushima, 2015年12月, ANNALS OF NUCLEAR MEDICINE, 29, 10, 911, 920

  DOI
• Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands, Azusa Tokue,Tetsuya Higuchi,Yukiko Arisaka,Takahito Nakajima,Hiroyuki Tokue,Yoshito Tsushima, 2015年07月, ANNALS OF NUCLEAR MEDICINE, 29, 6, 499, 505

  DOI
• Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands, Azusa Tokue,Tetsuya Higuchi,Yukiko Arisaka,Takahito Nakajima,Hiroyuki Tokue,Yoshito Tsushima, 2015年07月, ANNALS OF NUCLEAR MEDICINE, 29, 6, 499, 505

  DOI
• Differentiation of malignant tumours from granulomas by using dynamic [F-18]-fluoro-L-alpha-methyltyrosine positron emission tomography, Aiko Yamaguchi,Hirofumi Hanaoka,Yutaka Fujisawa,Songji Zhao,Kazutomo Suzue,Akihiro Morita,Hideyuki Tominaga,Tetsuya Higuchi,Hajime Hisaeda,Yoshito Tsushima,Yuji Kuge,Yasuhiko Iida, 2015年04月, EJNMMI RESEARCH, 5, 29

  DOI
• Differentiation of malignant tumours from granulomas by using dynamic [F-18]-fluoro-L-alpha-methyltyrosine positron emission tomography, Aiko Yamaguchi,Hirofumi Hanaoka,Yutaka Fujisawa,Songji Zhao,Kazutomo Suzue,Akihiro Morita,Hideyuki Tominaga,Tetsuya Higuchi,Hajime Hisaeda,Yoshito Tsushima,Yuji Kuge,Yasuhiko Iida, 2015年04月, EJNMMI RESEARCH, 5, 29

  DOI
• Superficial Siderosis of the Central Nervous System Caused by Hemorrhagic Intraventricular Craniopharyngioma: Case Report and Literature Review, Masahiko Tosaka,Koji Sato,Makoto Amanuma,Tetsuya Higuchi,Motohiro Arai,Kaoru Aishima,Tatsuya Shimizu,Keishi Horiguchi,Kenichi Sugawara,Yuhei Yoshimoto, 2015年01月, NEUROLOGIA MEDICO-CHIRURGICA, 55, 1, 89, 94

  DOI
• Superficial Siderosis of the Central Nervous System Caused by Hemorrhagic Intraventricular Craniopharyngioma: Case Report and Literature Review, Masahiko Tosaka,Koji Sato,Makoto Amanuma,Tetsuya Higuchi,Motohiro Arai,Kaoru Aishima,Tatsuya Shimizu,Keishi Horiguchi,Kenichi Sugawara,Yuhei Yoshimoto, 2015年01月, NEUROLOGIA MEDICO-CHIRURGICA, 55, 1, 89, 94

  DOI
• Effects of Intratumoral Inflammatory Process on F-18-FDG Uptake: Pathologic and Comparative Study with F-18-Fluoro-alpha-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma, Mai Kim,Arifudin Achmad,Tetsuya Higuchi,Yukiko Arisaka,Hideaki Yokoo,Satoshi Yokoo,Yoshito Tsushima, 2015年01月, JOURNAL OF NUCLEAR MEDICINE, 56, 1, 16, 21

  DOI
• Effects of Intratumoral Inflammatory Process on F-18-FDG Uptake: Pathologic and Comparative Study with F-18-Fluoro-alpha-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma, Mai Kim,Arifudin Achmad,Tetsuya Higuchi,Yukiko Arisaka,Hideaki Yokoo,Satoshi Yokoo,Yoshito Tsushima, 2015年01月, JOURNAL OF NUCLEAR MEDICINE, 56, 1, 16, 21

  DOI
• Evaluation of thoracic tumors with F-18-FMT and F-18-FDG PET-CT: A clinicopathological study, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Tomohiro Ishikita,Tetsuya Higuchi,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, 2009年03月, INTERNATIONAL JOURNAL OF CANCER, 124, 5, 1152, 1160

  DOI
• Evaluation of thoracic tumors with F-18-FMT and F-18-FDG PET-CT: A clinicopathological study, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Tomohiro Ishikita,Tetsuya Higuchi,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, 2009年03月, INTERNATIONAL JOURNAL OF CANCER, 124, 5, 1152, 1160

  DOI
• Mesial Temporal Sclerosis Associated With Methotrexate-Induced Leukoencephalopathy, Kouhei Hamamoto,Noboru Oriuchi,Takashi Kanazawa,Tetsuya Higuchi,Keigo Endo, 2009年04月, PEDIATRIC NEUROLOGY, 40, 4, 306, 309

  DOI
• Mesial Temporal Sclerosis Associated With Methotrexate-Induced Leukoencephalopathy, Kouhei Hamamoto,Noboru Oriuchi,Takashi Kanazawa,Tetsuya Higuchi,Keigo Endo, 2009年04月, PEDIATRIC NEUROLOGY, 40, 4, 306, 309

  DOI
• Dual functional molecular imaging probe targeting CD20 with PET and optical imaging, Pramila Paudyal,Bishnuhari Paudyal,Yasuhiko Iida,Noboru Oriuchi,Hirofumi Hanaoka,Hideyuki Tominaga,Tomohiro Ishikita,Hiroki Yoshioka,Tetsuya Higuchi,Keigo Endo, 2009年07月, ONCOLOGY REPORTS, 22, 1, 115, 119

  DOI
• Dual functional molecular imaging probe targeting CD20 with PET and optical imaging, Pramila Paudyal,Bishnuhari Paudyal,Yasuhiko Iida,Noboru Oriuchi,Hirofumi Hanaoka,Hideyuki Tominaga,Tomohiro Ishikita,Hiroki Yoshioka,Tetsuya Higuchi,Keigo Endo, 2009年07月, ONCOLOGY REPORTS, 22, 1, 115, 119

  DOI
• Correlation of angiogenesis with F-18-FMT and F-18-FDG uptake in non-small cell lung cancer, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Tomohiro Ishikita,Tetsuya Higuchi,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, 2009年04月, CANCER SCIENCE, 100, 4, 753, 758

  DOI
• Correlation of angiogenesis with F-18-FMT and F-18-FDG uptake in non-small cell lung cancer, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Tomohiro Ishikita,Tetsuya Higuchi,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, 2009年04月, CANCER SCIENCE, 100, 4, 753, 758

  DOI
• Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity, Hirofumi Hanaoka,Toyomasa Katagiri,Chikako Fukukawa,Hiroki Yoshioka,Shinji Yamamoto,Yasuhiko Iida,Tetsuya Higuchi,Noboru Oriuchi,Bishnuhari Paudyal,Pramila Paudyal,Yusuke Nakamura,Keigo Endo, 2009年07月, ANNALS OF NUCLEAR MEDICINE, 23, 5, 479, 485

  DOI
• Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity, Hirofumi Hanaoka,Toyomasa Katagiri,Chikako Fukukawa,Hiroki Yoshioka,Shinji Yamamoto,Yasuhiko Iida,Tetsuya Higuchi,Noboru Oriuchi,Bishnuhari Paudyal,Pramila Paudyal,Yusuke Nakamura,Keigo Endo, 2009年07月, ANNALS OF NUCLEAR MEDICINE, 23, 5, 479, 485

  DOI
• Complementary roles of tumour specific PET tracer F-18-FAMT to F-18-FDG PET/CT for the assessment of bone metastasis, Motoho Morita,Tetsuya Higuchi,Arifudin Achmad,Azusa Tokue,Yukiko Arisaka,Yoshito Tsushima, 2013年10月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 40, 11, 1672, 1681

  DOI
• Complementary roles of tumour specific PET tracer F-18-FAMT to F-18-FDG PET/CT for the assessment of bone metastasis, Motoho Morita,Tetsuya Higuchi,Arifudin Achmad,Azusa Tokue,Yukiko Arisaka,Yoshito Tsushima, 2013年10月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 40, 11, 1672, 1681

  DOI
• Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy, Tomohiro Ishikita,Noboru Oriuchi,Tetsuya Higuchi,Go Miyashita,Yukiko Arisaka,Bishnuhari Paudyal,Pramila Paudyal,Hirofumi Hanaoka,Mitsuyuki Miyakubo,Yoshiki Nakasone,Akihide Negishi,Satoshi Yokoo,Keigo Endo, 2010年02月, ANNALS OF NUCLEAR MEDICINE, 24, 2, 77, 82

  DOI
• Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy, Tomohiro Ishikita,Noboru Oriuchi,Tetsuya Higuchi,Go Miyashita,Yukiko Arisaka,Bishnuhari Paudyal,Pramila Paudyal,Hirofumi Hanaoka,Mitsuyuki Miyakubo,Yoshiki Nakasone,Akihide Negishi,Satoshi Yokoo,Keigo Endo, 2010年02月, ANNALS OF NUCLEAR MEDICINE, 24, 2, 77, 82

  DOI
• F-18-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with F-18-FDG PET and immunohistochemistry, Go Miyashita,Tetsuya Higuchi,Noboru Oriuchi,Yukiko Arisaka,Hirofumi Hanaoka,Hideyuki Tominaga,Satoshi Morita,Mitsuyuki Miyakubo,Tomohiro Ishikita,Yoshiki Nakasone,Akihide Negishi,Satoshi Yokoo,Keigo Endo, 2010年10月, ANNALS OF NUCLEAR MEDICINE, 24, 8, 579, 584

  DOI
• F-18-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with F-18-FDG PET and immunohistochemistry, Go Miyashita,Tetsuya Higuchi,Noboru Oriuchi,Yukiko Arisaka,Hirofumi Hanaoka,Hideyuki Tominaga,Satoshi Morita,Mitsuyuki Miyakubo,Tomohiro Ishikita,Yoshiki Nakasone,Akihide Negishi,Satoshi Yokoo,Keigo Endo, 2010年10月, ANNALS OF NUCLEAR MEDICINE, 24, 8, 579, 584

  DOI
• Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment, H Kurosaki,N Oriuchi,A Okazaki,T Tamaki,A Uki,M Izuta,R Kojima,Y Kato,T Higuchi,H Maruno, 2006年04月, ANNALS OF NUCLEAR MEDICINE, 20, 3, 171, 174

  DOI
• Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment, H Kurosaki,N Oriuchi,A Okazaki,T Tamaki,A Uki,M Izuta,R Kojima,Y Kato,T Higuchi,H Maruno, 2006年04月, ANNALS OF NUCLEAR MEDICINE, 20, 3, 171, 174

  DOI
• Direct labeling of macroaggregated albumin with indium-111-chloride using acetate buffer, N Watanabe,Y Shirakami,K Tomiyoshi,N Oriuchi,T Hirano,T Higuchi,T Inoue,K Endo, 1997年10月, JOURNAL OF NUCLEAR MEDICINE, 38, 10, 1590, 1592
• Direct labeling of macroaggregated albumin with indium-111-chloride using acetate buffer, N Watanabe,Y Shirakami,K Tomiyoshi,N Oriuchi,T Hirano,T Higuchi,T Inoue,K Endo, 1997年10月, JOURNAL OF NUCLEAR MEDICINE, 38, 10, 1590, 1592
• Preparation of yttrium-90-labeled human macroaggregated albumin for regional radiotherapy, N Watanabe,N Oriuchi,H Igarashi,T Higuchi,M Yukihiro,Y Fukushima,K Tomiyoshi,T Hirano,T Inoue,K Endo, 1997年07月, NUCLEAR MEDICINE AND BIOLOGY, 24, 5, 465, 469

  DOI
• Preparation of yttrium-90-labeled human macroaggregated albumin for regional radiotherapy, N Watanabe,N Oriuchi,H Igarashi,T Higuchi,M Yukihiro,Y Fukushima,K Tomiyoshi,T Hirano,T Inoue,K Endo, 1997年07月, NUCLEAR MEDICINE AND BIOLOGY, 24, 5, 465, 469

  DOI
• Current status of cancer therapy with radiolabeled monoclonal antibody, N Oriuchi,T Higuchi,H Hanaoka,Y Iida,K Endo, 2005年07月, ANNALS OF NUCLEAR MEDICINE, 19, 5, 355, 365, 書評論文,書評,文献紹介等

  DOI
• Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer, N Khan,N Oriuchi,A Yoshizaki,T Kanuma,T Higuchi,K Endo, 2005年04月, ANNALS OF NUCLEAR MEDICINE, 19, 2, 137, 145

  DOI
• Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer, N Khan,N Oriuchi,A Yoshizaki,T Kanuma,T Higuchi,K Endo, 2005年04月, ANNALS OF NUCLEAR MEDICINE, 19, 2, 137, 145

  DOI
• Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer, N Khan,N Oriuchi,A Yoshizaki,T Kanuma,T Higuchi,K Endo, 2005年04月, ANNALS OF NUCLEAR MEDICINE, 19, 2, 137, 145

  DOI
• Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer, N Khan,N Oriuchi,A Yoshizaki,T Kanuma,T Higuchi,K Endo, 2005年04月, ANNALS OF NUCLEAR MEDICINE, 19, 2, 137, 145

  DOI
• Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging, M Tian,H Zhang,T Higuchi,N Oriuchi,Y Nakasone,K Takata,N Nakajima,K Mogi,K Endo, 2005年06月, ANNALS OF NUCLEAR MEDICINE, 19, 4, 335, 338

  DOI
• F-18-FAMT in patients with multiple myeloma: clinical utility compared to F-18-FDG, Atsushi Isoda,Tetsuya Higuchi,Sachiko Nakano,Yukiko Arisaka,Kyoichi Kaira,Tadashi Kamio,Momoko Mawatari,Morio Matsumoto,Morio Sawamura,Yoshito Tsushima, 2012年12月, ANNALS OF NUCLEAR MEDICINE, 26, 10, 811, 816

  DOI
• F-18-FAMT in patients with multiple myeloma: clinical utility compared to F-18-FDG, Atsushi Isoda,Tetsuya Higuchi,Sachiko Nakano,Yukiko Arisaka,Kyoichi Kaira,Tadashi Kamio,Momoko Mawatari,Morio Matsumoto,Morio Sawamura,Yoshito Tsushima, 2012年12月, ANNALS OF NUCLEAR MEDICINE, 26, 10, 811, 816

  DOI
• In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy, Hiroki Yoshioka,Shinji Yamamoto,Hirofumi Hanaoka,Yasuhiko Iida,Pramila Paudyal,Tetsuya Higuchi,Hideyuki Tominaga,Noboru Oriuchi,Hidewaki Nakagawa,Yasuhiro Shiba,Koji Yoshida,Ryuji Osawa,Toyomasa Katagiri,Takuya Tsunoda,Yusuke Nakamura,Keigo Endo, 2012年08月, CANCER IMMUNOLOGY IMMUNOTHERAPY, 61, 8, 1211, 1220

  DOI
• In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy, Hiroki Yoshioka,Shinji Yamamoto,Hirofumi Hanaoka,Yasuhiko Iida,Pramila Paudyal,Tetsuya Higuchi,Hideyuki Tominaga,Noboru Oriuchi,Hidewaki Nakagawa,Yasuhiro Shiba,Koji Yoshida,Ryuji Osawa,Toyomasa Katagiri,Takuya Tsunoda,Yusuke Nakamura,Keigo Endo, 2012年08月, CANCER IMMUNOLOGY IMMUNOTHERAPY, 61, 8, 1211, 1220

  DOI
• Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma, Sachiko Nakano,Yoshito Tsushima,Tetsuya Higuchi,Ayako Taketomi-Takahashi,Makoto Amanuma, 2012年05月, JAPANESE JOURNAL OF RADIOLOGY, 30, 4, 310, 316

  DOI
• Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma, Sachiko Nakano,Yoshito Tsushima,Tetsuya Higuchi,Ayako Taketomi-Takahashi,Makoto Amanuma, 2012年05月, JAPANESE JOURNAL OF RADIOLOGY, 30, 4, 310, 316

  DOI
• Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET, H Zhang,M Tian,N Oriuchi,T Higuchi,S Tanada,K Endo, 2002年05月, BRITISH JOURNAL OF RADIOLOGY, 75, 893, 409, 416
• Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET, H Zhang,M Tian,N Oriuchi,T Higuchi,S Tanada,K Endo, 2002年05月, BRITISH JOURNAL OF RADIOLOGY, 75, 893, 409, 416
• C-11-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET, H Zhang,M Tian,N Oriuchi,T Higuchi,H Watanabe,J Aoki,S Tanada,K Endo, 2003年03月, NUCLEAR MEDICINE COMMUNICATIONS, 24, 3, 273, 279

  DOI
• C-11-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET, H Zhang,M Tian,N Oriuchi,T Higuchi,H Watanabe,J Aoki,S Tanada,K Endo, 2003年03月, NUCLEAR MEDICINE COMMUNICATIONS, 24, 3, 273, 279

  DOI
• C-11-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET, H Zhang,M Tian,N Oriuchi,T Higuchi,H Watanabe,J Aoki,S Tanada,K Endo, 2003年03月, NUCLEAR MEDICINE COMMUNICATIONS, 24, 3, 273, 279

  DOI
• Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET, M Tian,K Koyama,H Zhang,N Oriuchi,T Higuchi,K Endo, 2003年04月, NUCLEAR MEDICINE COMMUNICATIONS, 24, 4, 367, 374

  DOI
• Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET, M Tian,K Koyama,H Zhang,N Oriuchi,T Higuchi,K Endo, 2003年04月, NUCLEAR MEDICINE COMMUNICATIONS, 24, 4, 367, 374

  DOI
• A comparative study of C-11-choline PET and [F-18]fluorodeoxyglucose PET in the evaluation of lung cancer, N Khan,N Oriuchi,H Zhang,T Higuchi,M Tian,T Inoue,N Sato,K Endo, 2003年04月, NUCLEAR MEDICINE COMMUNICATIONS, 24, 4, 359, 366

  DOI
• A comparative study of C-11-choline PET and [F-18]fluorodeoxyglucose PET in the evaluation of lung cancer, N Khan,N Oriuchi,H Zhang,T Higuchi,M Tian,T Inoue,N Sato,K Endo, 2003年04月, NUCLEAR MEDICINE COMMUNICATIONS, 24, 4, 359, 366

  DOI
• Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor, S Takasu,T Takahashi,S Okamoto,N Oriuchi,N Nakayashiki,K Okamoto,H Muramatsu,T Hayashi,N Nakahara,M Mizuno,T Wakabayashi,T Higuchi,K Endo,K Kozaki,O Miyaishi,S Saga,R Ueda,J Yoshida,K Yoshikawa, 2003年07月, JOURNAL OF NEURO-ONCOLOGY, 63, 3, 247, 256

  DOI
• Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor, S Takasu,T Takahashi,S Okamoto,N Oriuchi,N Nakayashiki,K Okamoto,H Muramatsu,T Hayashi,N Nakahara,M Mizuno,T Wakabayashi,T Higuchi,K Endo,K Kozaki,O Miyaishi,S Saga,R Ueda,J Yoshida,K Yoshikawa, 2003年07月, JOURNAL OF NEURO-ONCOLOGY, 63, 3, 247, 256

  DOI
• PET in the follow-up of differentiated thyroid cancer, N Khan,N Oriuchi,T Higuchi,H Zhang,K Endo, 2003年10月, BRITISH JOURNAL OF RADIOLOGY, 76, 910, 690, 695, 書評論文,書評,文献紹介等

  DOI
• PET in the follow-up of differentiated thyroid cancer, N Khan,N Oriuchi,T Higuchi,H Zhang,K Endo, 2003年10月, BRITISH JOURNAL OF RADIOLOGY, 76, 910, 690, 695, 書評論文,書評,文献紹介等

  DOI
• Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice, M Tian,H Zhang,T Higuchi,N Oriuchi,T Inoue,K Endo, 2004年10月, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 19, 5, 601, 605

  DOI
• Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice, M Tian,H Zhang,T Higuchi,N Oriuchi,T Inoue,K Endo, 2004年10月, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 19, 5, 601, 605

  DOI
• Oncological diagnosis using C-11-choline-positron emission tomography in comparison with 2-deoxy 2-[F-18]fluoro-D-glucose-positron emission tomography, M Tian,H Zhang,T Higuchi,N Oriuchi,K Endo, 2004年05月, MOLECULAR IMAGING AND BIOLOGY, 6, 3, 172, 179

  DOI
• Oncological diagnosis using C-11-choline-positron emission tomography in comparison with 2-deoxy 2-[F-18]fluoro-D-glucose-positron emission tomography, M Tian,H Zhang,T Higuchi,N Oriuchi,K Endo, 2004年05月, MOLECULAR IMAGING AND BIOLOGY, 6, 3, 172, 179

  DOI
• Positron emission tomographic imaging with C-11-choline in differential diagnosis of head and neck tumors: comparison with F-18-FDG PET, N Khan,N Oriuchi,H Ninomiya,T Higuchi,H Kamada,K Endo, 2004年07月, ANNALS OF NUCLEAR MEDICINE, 18, 5, 409, 417
• Positron emission tomographic imaging with C-11-choline in differential diagnosis of head and neck tumors: comparison with F-18-FDG PET, N Khan,N Oriuchi,H Ninomiya,T Higuchi,H Kamada,K Endo, 2004年07月, ANNALS OF NUCLEAR MEDICINE, 18, 5, 409, 417
• Noninvasive measurement of renal function with (TC)-T-99m-MAG(3) gamma-camera renography based on the one-compartment model, N Oriuchi,Y Onishi,H Kitamura,T Inoue,Y Tomaru,T Higuchi,T Inoue,K Endo, 1998年11月, CLINICAL NEPHROLOGY, 50, 5, 289, 294
• Noninvasive measurement of renal function with (TC)-T-99m-MAG(3) gamma-camera renography based on the one-compartment model, N Oriuchi,Y Onishi,H Kitamura,T Inoue,Y Tomaru,T Higuchi,T Inoue,K Endo, 1998年11月, CLINICAL NEPHROLOGY, 50, 5, 289, 294
• In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens, N Watanabe,N Oriuchi,T Higuchi,M Yukihiro,Y Fukushima,K Tomiyoshi,T Hirano,T Inoue,K Endo, 1998年01月, NUCLEAR MEDICINE COMMUNICATIONS, 19, 1, 63, 70
• In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens, N Watanabe,N Oriuchi,T Higuchi,M Yukihiro,Y Fukushima,K Tomiyoshi,T Hirano,T Inoue,K Endo, 1998年01月, NUCLEAR MEDICINE COMMUNICATIONS, 19, 1, 63, 70
• A new approach for simple radioisotope cisternography examination in cerebrospinal fluid leakage detection, Hiromitsu Hoshino,Tetsuya Higuchi,Arifudin Achmad,Ayako Taketomi-Takahashi,Hiroya Fujimaki,Yoshito Tsushima, 2016年01月, ANNALS OF NUCLEAR MEDICINE, 30, 1, 40, 48

  DOI
• A new approach for simple radioisotope cisternography examination in cerebrospinal fluid leakage detection, Hiromitsu Hoshino,Tetsuya Higuchi,Arifudin Achmad,Ayako Taketomi-Takahashi,Hiroya Fujimaki,Yoshito Tsushima, 2016年01月, ANNALS OF NUCLEAR MEDICINE, 30, 1, 40, 48

  DOI
• Advantages of L-3-[F-18] fluoro-alpha-methyl tyrosine over 2-[F-18]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan, Sayaka Kodaira,Takahito Nakajima,Yukiko Arisaka,Azusa Tokue,Tetsuya Higuchi,Yoshito Tsushima, 2016年05月, SPRINGERPLUS, 5, 618

  DOI
• Advantages of L-3-[F-18] fluoro-alpha-methyl tyrosine over 2-[F-18]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan, Sayaka Kodaira,Takahito Nakajima,Yukiko Arisaka,Azusa Tokue,Tetsuya Higuchi,Yoshito Tsushima, 2016年05月, SPRINGERPLUS, 5, 618

  DOI
• Usefulness of F-18-alpha-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer, Kyoichi Kaira,Tetsuya Higuchi,Noriaki Sunaga,Yukiko Arisaka,Takeshi Hisada,Hideyuki Tominaga,Noboru Oriuchi,Takayuki Asao,Yoshihito Tsushima,Masanobu Yamada, 2016年12月, ANTICANCER RESEARCH, 36, 12, 6481, 6490

  DOI
• Usefulness of F-18-alpha-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer, Kyoichi Kaira,Tetsuya Higuchi,Noriaki Sunaga,Yukiko Arisaka,Takeshi Hisada,Hideyuki Tominaga,Noboru Oriuchi,Takayuki Asao,Yoshihito Tsushima,Masanobu Yamada, 2016年12月, ANTICANCER RESEARCH, 36, 12, 6481, 6490

  DOI
• Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study, Shu Kasama,Takuji Toyama,Makito Sato,Hirokazu Sano,Tetsuya Ueda,Toyoshi Sasaki,Takehiro Nakahara,Tetsuya Higuchi,Yoshito Tsushima,Masahiko Kurabayashi, 2016年02月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 43, 2, 302, 311

  DOI
• Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicen・・・, Kasama\, Shu,Toyama\, Takuji,Sato\, Makito,Sano\, Hirokazu,Ueda\, Tetsuya,Sasaki\, Toyoshi,Nakahara\, Takehiro,Higuchi\, Tetsuya,Tsushima\, Yoshito,Kurabayashi\, Masahiko, 2016年02月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 43, 2, 302, 311

  DOI
• Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma, Sachiko Nakano,Yoshito Tsushima,Ayako Taketomi-Takahashi,Tetsuya Higuchi,Makoto Amanuma,Noboru Oriuchi,Keigo Endo, 2011年07月, JAPANESE JOURNAL OF RADIOLOGY, 29, 6, 449, 451

  DOI
• Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma, Sachiko Nakano,Yoshito Tsushima,Ayako Taketomi-Takahashi,Tetsuya Higuchi,Makoto Amanuma,Noboru Oriuchi,Keigo Endo, 2011年07月, JAPANESE JOURNAL OF RADIOLOGY, 29, 6, 449, 451

  DOI
• Pulmonary artery intimal sarcoma: the role of F-18-fluorodeoxyglucose positron emission tomography in monitoring response to treatment, Enrique Leonardo P. Ote,Noboru Oriuchi,Go Miyashita,Bishnuhari Paudyal,Tomohiro Ishikita,Yukiko Arisaka,Tetsuya Higuchi,Junko Hirato,Keigo Endo, 2011年05月, JAPANESE JOURNAL OF RADIOLOGY, 29, 4, 279, 282

  DOI
• Pulmonary artery intimal sarcoma: the role of F-18-fluorodeoxyglucose positron emission tomography in monitoring response to treatment, Enrique Leonardo P. Ote,Noboru Oriuchi,Go Miyashita,Bishnuhari Paudyal,Tomohiro Ishikita,Yukiko Arisaka,Tetsuya Higuchi,Junko Hirato,Keigo Endo, 2011年05月, JAPANESE JOURNAL OF RADIOLOGY, 29, 4, 279, 282

  DOI
• Clinical significance of 2-[F-18]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of I-131-metaiodobenzylguanidine therapy in malignant phaeochromocytoma, Azusa Nakazawa,Tetsuya Higuchi,Noboru Oriuchi,Yukiko Arisaka,Keigo Endo, 2011年10月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 38, 10, 1869, 1875

  DOI
• Clinical significance of 2-[F-18]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of I-131-metaiodobenzylguanidine therapy in malignant phaeochromocytoma, Azusa Nakazawa,Tetsuya Higuchi,Noboru Oriuchi,Yukiko Arisaka,Keigo Endo, 2011年10月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 38, 10, 1869, 1875

  DOI
• Different biodistribution of Tc-99m-labelled chimeric mouse-human monoclonal antibody between athymic mite model and human, N Oriuchi,N Watanabe,S Sugiyama,T Higuchi,K Imai,H Yamanaka,M Hashmoto,H Kanda,K Endo, 1996年06月, BRITISH JOURNAL OF CANCER, 73, 12, 1466, 1472
• Different biodistribution of Tc-99m-labelled chimeric mouse-human monoclonal antibody between athymic mite model and human, N Oriuchi,N Watanabe,S Sugiyama,T Higuchi,K Imai,H Yamanaka,M Hashmoto,H Kanda,K Endo, 1996年06月, BRITISH JOURNAL OF CANCER, 73, 12, 1466, 1472
• Metabolic activity by F-18-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC, Kyoichi Kaira,Tetsuya Higuchi,Ichiro Naruse,Yukiko Arisaka,Azusa Tokue,Bolag Altan,Satoshi Suda,Akira Mogi,Kimihiro Shimizu,Noriaki Sunaga,Takeshi Hisada,Shigehisa Kitano,Hideru Obinata,Takehiko Yokobori,Keita Mori,Masahiko Nishiyama,Yoshihito Tsushima,Takayuki Asao, 2018年01月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, 1, 56, 66

  DOI
• Metabolic activity by F-18-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC, Kyoichi Kaira,Tetsuya Higuchi,Ichiro Naruse,Yukiko Arisaka,Azusa Tokue,Bolag Altan,Satoshi Suda,Akira Mogi,Kimihiro Shimizu,Noriaki Sunaga,Takeshi Hisada,Shigehisa Kitano,Hideru Obinata,Takehiko Yokobori,Keita Mori,Masahiko Nishiyama,Yoshihito Tsushima,Takayuki Asao, 2018年01月, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, 1, 56, 66

  DOI
• L[3-F-18]-alpha-Methyltyrosine Accumulation as a Definitive Chemoradiotherapy Response Predictor in Patients with Esophageal Cancer, Makoto Sohda,Hiroaki Honjyo,Keigo Hara,Daigo Ozawa,Shigemasa Suzuki,Naritaka Tanaka,Akihiko Sano,Makoto Sakai,Takehiko Yokobori,Takanori Inose,Tatsuya Miyazaki,Hitoshi Ojima,Tetsuya Higuchi,Yoshito Tsushima,Hiroyuki Kuwano, 2014年02月, ANTICANCER RESEARCH, 34, 2, 909, 913
• L[3-F-18]-alpha-Methyltyrosine Accumulation as a Definitive Chemoradiotherapy Response Predictor in Patients with Esophageal Cancer, Makoto Sohda,Hiroaki Honjyo,Keigo Hara,Daigo Ozawa,Shigemasa Suzuki,Naritaka Tanaka,Akihiko Sano,Makoto Sakai,Takehiko Yokobori,Takanori Inose,Tatsuya Miyazaki,Hitoshi Ojima,Tetsuya Higuchi,Yoshito Tsushima,Hiroyuki Kuwano, 2014年02月, ANTICANCER RESEARCH, 34, 2, 909, 913
• Biological significance of fluorine-18-alpha-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer, S. Suzuki,K. Kaira,Y. Ohshima,N. S. Ishioka,M. Sohda,T. Yokobori,T. Miyazaki,N. Oriuchi,H. Tominaga,Y. Kanai,N. Tsukamoto,T. Asao,Y. Tsushima,T. Higuchi,T. Oyama,H. Kuwano, 2014年04月, BRITISH JOURNAL OF CANCER, 110, 8, 1985, 1991

  DOI
• Biological significance of fluorine-18-alpha-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer, S. Suzuki,K. Kaira,Y. Ohshima,N. S. Ishioka,M. Sohda,T. Yokobori,T. Miyazaki,N. Oriuchi,H. Tominaga,Y. Kanai,N. Tsukamoto,T. Asao,Y. Tsushima,T. Higuchi,T. Oyama,H. Kuwano, 2014年04月, BRITISH JOURNAL OF CANCER, 110, 8, 1985, 1991

  DOI
• CSF levels of A beta 1-38/A beta 1-40/A beta 1-42 and C-11 PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease, Masaki Ikeda,Yuichi Tashiro,Eriko Takai,Sachiko Kurose,Naoko Fugami,Kazuhisa Tsuda,Yukiko Arisaka,Sayaka Kodaira,Yukio Fujita,Kouki Makioka,Yuji Mizuno,Hirotaka Shimada,Yasuo Harigaya,Masamitsu Takatama,Masakuni Amari,Tsuneo Yamazaki,Haruyasu Yamaguchi,Tetsuya Higuchi,Koichi Okamoto,Yoshito Tsushima,Yoshio Ikeda, 2014年12月, AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 21, 4, 238, 245

  DOI
• CSF levels of A beta 1-38/A beta 1-40/A beta 1-42 and C-11 PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease, Masaki Ikeda,Yuichi Tashiro,Eriko Takai,Sachiko Kurose,Naoko Fugami,Kazuhisa Tsuda,Yukiko Arisaka,Sayaka Kodaira,Yukio Fujita,Kouki Makioka,Yuji Mizuno,Hirotaka Shimada,Yasuo Harigaya,Masamitsu Takatama,Masakuni Amari,Tsuneo Yamazaki,Haruyasu Yamaguchi,Tetsuya Higuchi,Koichi Okamoto,Yoshito Tsushima,Yoshio Ikeda, 2014年12月, AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 21, 4, 238, 245

  DOI
• A case of multiple hepatic angiomyolipomas with high F-18-fluorodeoxyglucose uptake, Soma Kumasaka,Yukiko Arisaka,Azusa Tokue,Tetsuya Higuchi,Takahito Nakajima,Yoshito Tsushima, 2014年05月, BMC MEDICAL IMAGING, 14, 17

  DOI
• A case of multiple hepatic angiomyolipomas with high F-18-fluorodeoxyglucose uptake, Soma Kumasaka,Yukiko Arisaka,Azusa Tokue,Tetsuya Higuchi,Takahito Nakajima,Yoshito Tsushima, 2014年05月, BMC MEDICAL IMAGING, 14, 17

  DOI
• Effectiveness of FDG-PET in Screening of Synchronous Cancer of Other Organs in Patients with Esophageal Cancer, Tatsuya Miyazaki,Makoto Sohda,Tetsuya Higuchi,Naritaka Tanaka,Shigemasa Suzuki,Makoto Sakai,Takehiko Yokobori,Masanobu Nakajima,Minoru Fukuchi,Yoshito Tsushima,Hiroyuki Kato,Hiroyuki Kuwano, 2014年01月, ANTICANCER RESEARCH, 34, 1A, 283, 287
• Effectiveness of FDG-PET in Screening of Synchronous Cancer of Other Organs in Patients with Esophageal Cancer, Tatsuya Miyazaki,Makoto Sohda,Tetsuya Higuchi,Naritaka Tanaka,Shigemasa Suzuki,Makoto Sakai,Takehiko Yokobori,Masanobu Nakajima,Minoru Fukuchi,Yoshito Tsushima,Hiroyuki Kato,Hiroyuki Kuwano, 2014年01月, ANTICANCER RESEARCH, 34, 1A, 283, 287
• Fractionated Radioimmunotherapy with Y-90-Labeled Fully Human Anti-CEA Antibody, Hirofumi Hanaoka,Masahide Kuroki,Aiko Yamaguchi,Arifudin Achmad,Yasuhiko Iida,Tetsuya Higuchi,Noboru Oriuchi,Yoshito Tsushima,Keigo Endo, 2014年03月, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 29, 2, 70, 76

  DOI
• Fractionated Radioimmunotherapy with Y-90-Labeled Fully Human Anti-CEA Antibody, Hirofumi Hanaoka,Masahide Kuroki,Aiko Yamaguchi,Arifudin Achmad,Yasuhiko Iida,Tetsuya Higuchi,Noboru Oriuchi,Yoshito Tsushima,Keigo Endo, 2014年03月, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 29, 2, 70, 76

  DOI
• L-[3-F-18]-alpha-Methyltyrosine Uptake by Lymph Node Metastasis Is a Predictor of Complete Response to CRT in Esophageal Cancer, Makoto Sohda,Tatsuya Miyazaki,Hiroaki Honjyo,Keigo Hara,Daigo Ozawa,Shigemasa Suzuki,Naritaka Tanaka,Akihiko Sano,Makoto Sakai,Takehiko Yokobori,Masanobu Nakajima,Minoru Fukuchi,Hiroyuki Kato,Tetsuya Higuchi,Yoshito Tsushima,Hiroyuki Kuwano, 2014年12月, ANTICANCER RESEARCH, 34, 12, 7473, 7477
• L-[3-F-18]-alpha-Methyltyrosine Uptake by Lymph Node Metastasis Is a Predictor of Complete Response to CRT in Esophageal Cancer, Makoto Sohda,Tatsuya Miyazaki,Hiroaki Honjyo,Keigo Hara,Daigo Ozawa,Shigemasa Suzuki,Naritaka Tanaka,Akihiko Sano,Makoto Sakai,Takehiko Yokobori,Masanobu Nakajima,Minoru Fukuchi,Hiroyuki Kato,Tetsuya Higuchi,Yoshito Tsushima,Hiroyuki Kuwano, 2014年12月, ANTICANCER RESEARCH, 34, 12, 7473, 7477
• Use of Pre-treatment F-18-FAMT PET to Predict Patient Survival in Squamous Cell Carcinoma of the Esophagus Treated by Curative Surgery, Makoto Sohda,Makoto Sakai,Hiroaki Honjyo,Keigo Hara,Daigo Ozawa,Shigemasa Suzuki,Naritaka Tanaka,Takehiko Yokobori,Tatsuya Miyazaki,Minoru Fukuchi,Tetsuya Higuchi,Yoshito Tsushima,Hiroyuki Kuwano, 2014年07月, ANTICANCER RESEARCH, 34, 7, 3623, 3628
• Use of Pre-treatment F-18-FAMT PET to Predict Patient Survival in Squamous Cell Carcinoma of the Esophagus Treated by Curative Surgery, Makoto Sohda,Makoto Sakai,Hiroaki Honjyo,Keigo Hara,Daigo Ozawa,Shigemasa Suzuki,Naritaka Tanaka,Takehiko Yokobori,Tatsuya Miyazaki,Minoru Fukuchi,Tetsuya Higuchi,Yoshito Tsushima,Hiroyuki Kuwano, 2014年07月, ANTICANCER RESEARCH, 34, 7, 3623, 3628
• Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT, Koichi Okamura,Yukio Yonemoto,Chisa Okura,Tetsuya Higuchi,Yoshito Tsushima,Kenji Takagishi, 2014年11月, BMC MUSCULOSKELETAL DISORDERS, 15, 393

  DOI
• Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT, Koichi Okamura,Yukio Yonemoto,Chisa Okura,Tetsuya Higuchi,Yoshito Tsushima,Kenji Takagishi, 2014年11月, BMC MUSCULOSKELETAL DISORDERS, 15, 393

  DOI
• Case of radioactive iodine exposure during pregnancy, Hisanobu Sadakata,Hiromitsu Shinozaki,Tetsuya Higuchi,Takashi Minegishi, 2014年12月, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 40, 12, 2201, 2203

  DOI
• Case of radioactive iodine exposure during pregnancy, Hisanobu Sadakata,Hiromitsu Shinozaki,Tetsuya Higuchi,Takashi Minegishi, 2014年12月, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 40, 12, 2201, 2203

  DOI
• Iodine concentration calculated by dual-energy computed tomography (DECT) as a functional parameter to evaluate thyroid metabolism in patients with hyperthyroidism, Duong Duc Binh,Takahito Nakajima,Hidenori Otake,Tetsuya Higuchi,Yoshito Tsushima, 2017年07月, BMC MEDICAL IMAGING, 17, 43

  DOI
• The diagnostic performance of F-18-FAMT PET and F-18-FDG PET for malignancy detection: a meta-analysis, Arifudin Achmad,Anu Bhattarai,Ryan Yudistiro,Yusri Dwi Heryanto,Tetsuya Higuchi,Yoshito Tsushima, 2017年12月, BMC MEDICAL IMAGING, 17, 66

  DOI
• The diagnostic performance of F-18-FAMT PET and F-18-FDG PET for malignancy detection: a meta-analysis, Arifudin Achmad,Anu Bhattarai,Ryan Yudistiro,Yusri Dwi Heryanto,Tetsuya Higuchi,Yoshito Tsushima, 2017年12月, BMC MEDICAL IMAGING, 17, 66

  DOI
• Clinical value of fluorine-18a-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET, Keishi Horiguchi,Masahiko Tosaka,Tetsuya Higuchi,Yukiko Arisaka,Kenichi Sugawara,Junko Hirato,Hideaki Yokoo,Yoshito Tsushima,Yuhei Yoshimoto, 2017年05月, EJNMMI RESEARCH, 7, 1, 50

  DOI
• Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas., KHAN NASIM MOHAMMAD,ORIUCHI NOBORU,HIGUCHI TETSUYA,ENDO KEIGO, 2005年, Cancer Control, 12, 4, 254, 260
• Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging., Mei Tian,Zhang Hong,HIGUCHI TETSUYA,ORIUCHI NOBORU,NAKASONE YOSHIKI,TAKATA KUNIAKI,Nakajima N,MOGI KENJI,ENDO KEIGO, 2005年, Ann Nucl Med, 19, 335, 338

  DOI
• Usefulness of FDG-PET in the evaluation of diffuse pulmonary involvement of malignant lymphoma., HIGUCHI TETSUYA,ORIUCHI NOBORU,MIYAKUBO MITSUYUKI,OOTAKE,HIDENORI,MATSUBARA KUNIO,KHAN NASIM,MOHAMMAD,田 梅,ENDO KEIGO, 2004年, International Congress Series, 1264, 233, 238
• Current status of cancer therapy with radiolabeled monoclonal antibody., ORIUCHI NOBORU,HIGUCHI TETSUYA,HANAOKA HIROFUMI,IIDA YASUHIKO,ENDO KEIGO, 2005年, Ann Nucl Med, 19, 5, 355, 365

  DOI
• Pulmonary thromboembolism -Evaluating the indication and effect of a vena caval filter with indium-111-platelet scintigraphy-., YAGI AKIKO,ORIUCHI NOBORU,SATO NORIKO,AOKI JUN,HIGUCHI TETSUYA,ENDO KEIGO, 2004年, Circ J, 68, 6, 599, 601

  DOI
• 11C-choline PET for the detection of bone and soft tissue tumorurs in comparison with FDG PET, WATANABE HIDEOMI,ORIUCHI NOBORU,HIGUCHI TETSUYA,ENDO KEIGO,Aoki Jun, 2003年, Nucl. Med. Commun., 24 (273-279)

  DOI
• Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors., Mei Tian,Hong Zhang,ORIUCHI NOBORU,HIGUCHI TETSUYA,ENDO KEIGO, 2004年, Eur J Nucl Med Mol Imaging, 31, 8, 1064, 1072
• Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: Comparative study with 2-[18F]fluoro-2-dexy-D-glucose (FDG) PET, NINOMIYA HIROSHI,ORIUCHI NOBORU,Nasim Kahn,HIGUCHI TETSUYA,ENDO KEIGO,TAKAHASHI KATSUMASA,CHIKAMATSU,KAZUAKI,KAMADA HIDEO,FURUYA,NOBUHIKO, 2004年, Ann Nucl Med, 18, 1, 29, 34

  DOI
• Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET., Zhang Hong,Tian Mei,ORIUCHI NOBORU,HIGUCHI TETSUYA,Tanada Syuji,ENDO KEIGO, 2003年, EJR, 47, 199, 205

  DOI
• Biodistribution and scintigraphy of [111ln]DTPA-adriamycin in mammaary tumor-bearing rats., HIGUCHI TETSUYA,Yang DJ,IIgan S,Tansey LW,Zareneyrizi F,Inoue T,ENDO KEIGO,Kim EE,Podoloff DA, 1999年, Anticancer Drugs, 10, 89-95
• Biodistribution studies on L-3-[Fluorine-18]fluoro-a-methyl tyrosine : A potential tumor-detecting agent, Inoue T,Tomiyoshi K,HIGUCHI TETSUYA,Ahmed K,Sarwar M,koyama keiko,Amano S,Aflyafei S,Zhan H,ENDO KEIGO, 1998年, J Nucl Med, 39:663-667
• Grade II astrocytoma visualized by technetium-99m-ECD SPECT, Hirano T,Suzuki H,Higuchi T,Watnabe N,Oriuchi N,Shibazaki, 1996年, Clin Nudl Med, 21, 111, 114
• Fill-in after reinjection of Tc-99m MAA, Watanabe N,Oriuchi N,Higuchi T,Yukihiro M,Fukushima Y,Hirano T,Inoue T,Endo K, 1998年, Clin Nuc Med, 37, 104, 106

  DOI
• Technetium-99m-labeled chimeric human/mouse antigranulocyte antibody bone marrow scintigraphy: A Preliminary clinical study, Higuchi T,Inoue T,Sarwar M,Oriuchi N,Karasawa M,Naruse T,Yamanaka H,Watanabe T,Chung JK,Endo K, 1998年, Nucl Med Commun, 19, 463, 474
• Evaluation of In-111-paclitaxel scintigraphy to predict response on musine tumors to paclitaxel, Inoue T,Li C,Yang DJ,Higuchi T,Oriuchi N,Yu DF,Milas L,Hunter NR,Wallace S,Kim EE,Podoloff DA, 1999年, Ann Nucl Med, 13, 169, 174
• 99mTc-labeled chimeric antij-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging, Sarwar M,Higuchi T,Tomiyoshi K,Inoue T,Oriuchi N,Khalil A,Alyafei S,Sakahara H,Chung JK,Endo K, 1998年, Radiat Med, 16, 391, 397
• Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors., Hanaoka H,Tominaga H,Yamada K,Paudyal P,Iida Y,Watanabe S,Paudyal B,Higuchi T,Oriuchi N,Endo K, 2009年, Ann Nucl Med., 23, 6, 559, 67
• Clinical significance of F-18-alpha-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with F-18-FDG PET/CT and MRI, Kim\, Mai,Higuchi\, Tetsuya,Arisaka\, Yukiko,Achmad\, Arifudin,Tokue\, Azusa,Tominaga\, Hideyuki,Miyashita\, Go,Miyazaki\, Hidetaka,Negishi\, Akihide,Yokoo\, Satoshi,Tsushima\, Yoshito, 2013年, ANNALS OF NUCLEAR MEDICINE, 27, 5, 423, 430

  DOI
• Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors., Yamaguchi A,Hanaoka H,Higuchi T,Tsushima Y, 2018年, JOURNAL OF NUCLEAR MEDICINE, 59, 5, 815, 821

  DOI
• Quantitative Analysis of Iodine Image of Dual-energy Computed Tomography at Rest: Comparison With 99mTc-Tetrofosmin Stress-rest Single-photon Emission Computed Tomography Myocardial Perfusion Imaging as the Reference Standard, Nakahara T,Toyama T,Jinzaki M,Seki R,Saito Y,Higuchi T,Yamada M,Arai M,Tsushima Y,Kuribayashi S,Kurabayashi M, 2018年, JOURNAL OF THORACIC IMAGING, 33, 2, 97, 104

  DOI
• Computer-assisted Diagnosis of Metastases Based on Bone Scintigraphy:Lesion Detection Compared Using BONENAVI 1 and 2., Tomonaga H,Nakajima T,Arisaka Y,Azusa T,Higuchi T,Tsushima Y, 2017年, The Kitakanto Medical Journal, 67, 4, 299, 305

  DOI
• Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective., Higuchi T,Achmad A,Binh DD,Bhattarai A,Tsushima Y, 2018年, ENDOCRINE JOURNAL, 65, 3, 345, 357

  DOI
• Preoperative Evaluation of Sellar and Parasellar Macrolesions by [F-18] Fluorodeoxyglucose Positron Emission Tomography, Tosaka\, Masahiko,Higuchi\, Tetsuya,Horiguchi\, Keishi,Osawa\, Tadashi,Arisaka\, Yukiko,Fujita\, Haruyasu,Tsushima\, Yoshito,Yoshimoto\, Yuhei, 2017年, WORLD NEUROSURGERY, 103, 591, 599

  DOI
• Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma, Okano\, Yudai,Satoh\, Tetsurou,Horiguchi\, Kazuhiko,Toyoda\, Minoru,Osaki\, Aya,Matsumoto\, Shunichi,Tomaru\, Takuya,Nakajima\, Yasuyo,Ishii\, Sumiyasu,Ozawa\, Atsushi,Shibusawa\, Nobuyuki,Shimada\, Takehiro,Higuchi\, Tetsuya,Chikamatsu\, Kazuaki,Yamada\, Masanobu, 2014年, ENDOCRINE JOURNAL, 63, 10, 905, 912

  DOI
• Effects and safety of I-131-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results, from a multicenter observational registry, Yoshinaga\, Keiichiro,Oriuchi\, Noboru,Wakabayashi\, Hiroshi,Tomiyama\, Yuuki,Jinguji\, Megumi,Higuchi\, Tetsuya,Kayano\, Daiki,Fukuoka\, Makoto,Inaki\, Anri,Toratani\, Ayane,Okamoto\, Shozo,Shiga\, Tohru,Ito\, Yoichi M,Nakajo\, Masatoyo,Nakajo\, Masayuki,Kinuya\, Seigo, 2015年, ENDOCRINE JOURNAL, 61, 12, 1171, 1180

  DOI
• Diagnostic usefulness of F-18-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma, Nobusawa\, Aiko,Kim\, Mai,Kaira\, Kyoichi,Miyashita\, Go,Negishi\, Akihide,Oriuchi\, Noboru,Higuchi\, Tetsuya,Tsushima\, Yoshito,Kanai\, Yoshikatsu,Yokoo\, Satoshi,Oyama\, Tetsunari, 2017年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 40, 11, 1692, 1700

  DOI
• Evaluation of muscle activity just after straight leg raising exercise by using (18)FDG-PET, Shiozawa\, Hiroyuki,Ohsawa\, Takashi,Tsushima\, Yoshito,Higuchi\, Tetsuya,Takagishi\, Kenji,Chikuda\, Hirotaka, 2018年, JOURNAL OF ORTHOPAEDIC SCIENCE, 23, 2, 328, 333

  DOI
• 18F-FAMT PET Is Useful to Distinguish between Specific Uptake and Nonspecific Uptake Compared to 18F-Flourodeoxyglucose Position Emission Tomography in Esophageal Cancer Patients., Sohda M,Miyazaki T,Honjyo H,Hara K,Ozawa D,Sakai M,Yokobori T,Higuchi T,Tsushima Y,Kuwano H, 2017年, DIGESTIVE SURGERY, in press

  DOI
• A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma: a study protocol., Inaki A,Yoshimura K,Murayama T,Imai Y,Kuribayashi Y,Higuchi T,Jinguji M,Shiga T,Kinuya S, 2017年, The Journal of Medical Investigation, 64, 3-4., 205, 209

  DOI
• Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma, Kasahara\, Norimitsu,Kaira\, Kyoichi,Bao\, Pinjie,Higuchi\, Tetsuya,Arisaka\, Yukiko,Erichem-Ochir\, Bilguun,Sunaga\, Noriaki,Ohtaki\, Yoichi,Yajima\, Toshiki,Kosaka\, Takayuki,Oyama\, Tetsunari,Yokobori\, Takehiko,Asao\, Takayuki,Nishiyama\, Masahiko,Tsushima\, Yoshito,Kuwano\, Hiroyuki,Shimizu\, Kimihiro,Mogi\, Akira, 2018年, LUNG CANCER, 119, 71, 77

  DOI
• Normal database (NDB) of 123I-IMP brain perfusion SPECT examination is affected by statistical image analysis in the presence or absence of scatter correction and attenuation correction., Shimada H,Otake H,Higuchi T,Arisaka Y,Oriuchi N,Endo K, 2012年, Kaku Igaku., 49(4), 341, 9
• Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas., KHAN NASIM MOHAMMAD,ORIUCHI NOBORU,HIGUCHI TETSUYA,ENDO KEIGO, 2005年, Cancer Control, 12, 4, 254, 260
• カドミウム亜鉛テルライド半導体検出器を使用した小型ガンマカメラの性能評価., 大竹英則,樋口徹也,竹内康直,流王英樹,神保昌夫,松原國夫,小山一郎,織内 昇,井上登美夫,遠藤啓吾, 2002年, 核医学, 39, 549, 553
• 悪性リンパ腫患者の診療におけるPETの有用性., 樋口 徹也,井上登美夫, 2001年, 血液・腫瘍科, 43(4):272-278
• Usefulness of FDG-PET in the evaluation of diffuse pulmonary involvement of malignant lymphoma., HIGUCHI TETSUYA,ORIUCHI NOBORU,MIYAKUBO MITSUYUKI,OOTAKE,HIDENORI,MATSUBARA KUNIO,KHAN NASIM,MOHAMMAD,田 梅,ENDO KEIGO, 2004年, International Congress Series, 1264, 233, 238
• がんの分子画像診断の動向．, 樋口 徹也,織内 昇,宮久保 満之,新井 清和,遠藤 啓吾, 2004年, がん分子標的治療, 2, 2, 170, 173
• FDG-PET検査のがん診療への臨床応用（悪性リンパ腫）, 樋口 徹也, 2002年, 日本医学放射線学会雑誌, 62, 6, 278, 283
• FDG-PETによる頭頚部腫瘍診断．, 織内 昇,宮久保 満之,樋口 徹也,二宮 洋,近松 一朗,鎌田 英男,遠藤 啓吾, 2004年, 頭頚部癌, 30, 3, 439, 444

  DOI
• PETの放射線治療への応用, 樋口 徹也,織内 昇,遠藤 啓吾, 2002年, 映像情報Medical, 34, 1316, 1320
• Pulmonary thromboembolism -Evaluating the indication and effect of a vena caval filter with indium-111-platelet scintigraphy-., YAGI AKIKO,ORIUCHI NOBORU,SATO NORIKO,AOKI JUN,HIGUCHI TETSUYA,ENDO KEIGO, 2004年, Circ J, 68, 6, 599, 601

  DOI
• Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors., Mei Tian,Hong Zhang,ORIUCHI NOBORU,HIGUCHI TETSUYA,ENDO KEIGO, 2004年, Eur J Nucl Med Mol Imaging, 31, 8, 1064, 1072
• FDG-PETが診断の契機となったPancoast腫瘍の1例．, 2002., 濱口真吾,織内 昇,樋口 徹也,市川聡裕,小山 恵子,青木 純,井上登美夫,福里利夫,遠藤 啓吾, 2002年, 画像診断, 22, 58, 62
• ポジトロンCTが特徴的な所見を示した全身サルコイドーシスの2例., 濱口真吾,織内 昇,樋口 徹也,市川聡裕,小山 恵子,冨吉勝美,青木 純,井上登美夫,遠藤 啓吾, 2001年, 画像診断, 21(11):1232-1237
• Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: Comparative study with 2-[18F]fluoro-2-dexy-D-glucose (FDG) PET, NINOMIYA HIROSHI,ORIUCHI NOBORU,Nasim Kahn,HIGUCHI TETSUYA,ENDO KEIGO,TAKAHASHI KATSUMASA,CHIKAMATSU,KAZUAKI,KAMADA HIDEO,FURUYA,NOBUHIKO, 2004年, Ann Nucl Med, 18, 1, 29, 34

  DOI
• Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET., Zhang Hong,Tian Mei,ORIUCHI NOBORU,HIGUCHI TETSUYA,Tanada Syuji,ENDO KEIGO, 2003年, EJR, 47, 199, 205

  DOI
• Biodistribution and scintigraphy of [111ln]DTPA-adriamycin in mammaary tumor-bearing rats., HIGUCHI TETSUYA,Yang DJ,IIgan S,Tansey LW,Zareneyrizi F,Inoue T,ENDO KEIGO,Kim EE,Podoloff DA, 1999年, Anticancer Drugs, 10, 89-95
• Biodistribution studies on L-3-[Fluorine-18]fluoro-a-methyl tyrosine : A potential tumor-detecting agent, Inoue T,Tomiyoshi K,HIGUCHI TETSUYA,Ahmed K,Sarwar M,koyama keiko,Amano S,Aflyafei S,Zhan H,ENDO KEIGO, 1998年, J Nucl Med, 39:663-667
• Grade II astrocytoma visualized by technetium-99m-ECD SPECT, Hirano T,Suzuki H,Higuchi T,Watnabe N,Oriuchi N,Shibazaki, 1996年, Clin Nudl Med, 21, 111, 114
• Fill-in after reinjection of Tc-99m MAA, Watanabe N,Oriuchi N,Higuchi T,Yukihiro M,Fukushima Y,Hirano T,Inoue T,Endo K, 1998年, Clin Nuc Med, 37, 104, 106

  DOI
• Technetium-99m-labeled chimeric human/mouse antigranulocyte antibody bone marrow scintigraphy: A Preliminary clinical study, Higuchi T,Inoue T,Sarwar M,Oriuchi N,Karasawa M,Naruse T,Yamanaka H,Watanabe T,Chung JK,Endo K, 1998年, Nucl Med Commun, 19, 463, 474
• 癌診断および癌スクリーニング検査としてのFDG-PETと拡散強調MRIの有用性, 遠藤啓吾,織内昇,樋口徹也,堀越浩幸,渡辺祐司,落合礼次,那須克宏, 2008年, 核医学, 45, 2, 130, 131
• Evaluation of In-111-paclitaxel scintigraphy to predict response on musine tumors to paclitaxel, Inoue T,Li C,Yang DJ,Higuchi T,Oriuchi N,Yu DF,Milas L,Hunter NR,Wallace S,Kim EE,Podoloff DA, 1999年, Ann Nucl Med, 13, 169, 174
• 99mTc-labeled chimeric antij-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging, Sarwar M,Higuchi T,Tomiyoshi K,Inoue T,Oriuchi N,Khalil A,Alyafei S,Sakahara H,Chung JK,Endo K, 1998年, Radiat Med, 16, 391, 397
• Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors., Hanaoka H,Tominaga H,Yamada K,Paudyal P,Iida Y,Watanabe S,Paudyal B,Higuchi T,Oriuchi N,Endo K, 2009年, Ann Nucl Med., 23, 6, 559, 67
• 透析医療におけるアイソトープ診断と治療, 樋口徹也,織内 昇,有坂有紀子,宮下 剛,石北朋宏,対馬義人,遠藤啓吾, 2008年, 日本透析医学会雑誌, 23, 3, 415, 419
• 特集 最近の核医学検査・PETと核医学治療 核医学治療（アイソトープ治療）., 樋口徹也,岡内研三,織内 昇,遠藤啓吾, 2010年, 画像診断, 30, 1198, 1206
• 肺癌のPET診断, 樋口徹也,有坂有紀子,中澤梓,対馬義人,織内昇,遠藤啓吾, 2012年, 肺癌, 52, 161, 167

  DOI
• 核医学におけるチームワーク医療の試み－骨シンチ診断支援ソフトBONENAVIの積極的活用－, 樋口徹也, 2012年, みちのく核医学の会会誌, 19, 43, 47
• 甲状腺分化癌のRI内照射療法, 樋口徹也,織内 昇, 2009年, 臨床画像, 25, 585, 591
• PET/CT診断特集肺癌-診断・治療の実際, 樋口徹也,織内 昇,宮下 剛,有坂有紀子,遠藤啓吾, 2010年, 臨床画像, 26, 2, 162, 169
• Iodine concentration calculated by dual-energy computed tomography (DECT) as a functional parameter to evaluate thyroid metabolism in patients with hyperthyroidism, Duong Duc Binh,Nakajima\, Takahito,Otake\, Hidenori,Higuchi\, Tetsuya,Tsushima\, Yoshito, 2017年, BMC MEDICAL IMAGING, 17, 43

  DOI
• Clinical significance of F-18-alpha-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with F-18-FDG PET/CT and MRI, Kim\, Mai,Higuchi\, Tetsuya,Arisaka\, Yukiko,Achmad\, Arifudin,Tokue\, Azusa,Tominaga\, Hideyuki,Miyashita\, Go,Miyazaki\, Hidetaka,Negishi\, Akihide,Yokoo\, Satoshi,Tsushima\, Yoshito, 2013年, ANNALS OF NUCLEAR MEDICINE, 27, 5, 423, 430

  DOI
• Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors., Yamaguchi A,Hanaoka H,Higuchi T,Tsushima Y, 2018年, JOURNAL OF NUCLEAR MEDICINE, 59, 5, 815, 821

  DOI
• Quantitative Analysis of Iodine Image of Dual-energy Computed Tomography at Rest: Comparison With 99mTc-Tetrofosmin Stress-rest Single-photon Emission Computed Tomography Myocardial Perfusion Imaging as the Reference Standard, Nakahara T,Toyama T,Jinzaki M,Seki R,Saito Y,Higuchi T,Yamada M,Arai M,Tsushima Y,Kuribayashi S,Kurabayashi M, 2018年, JOURNAL OF THORACIC IMAGING, 33, 2, 97, 104

  DOI
• Computer-assisted Diagnosis of Metastases Based on Bone Scintigraphy:Lesion Detection Compared Using BONENAVI 1 and 2., Tomonaga H,Nakajima T,Arisaka Y,Azusa T,Higuchi T,Tsushima Y, 2017年, The Kitakanto Medical Journal, 67, 4, 299, 305

  DOI
• Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective., Higuchi T,Achmad A,Binh DD,Bhattarai A,Tsushima Y, 2018年, ENDOCRINE JOURNAL, 65, 3, 345, 357

  DOI
• シンチグラフィ, 2011年, 内分泌画像検査・診断マニュアル 診断と治療社
• 123I-IMP脳血流SPECTノーマルデータベース（NDB）作成時の散乱および減弱補正が統計学的画像解析結果に与える影響., 2012年, 日本核医学会機関誌, 49, 341, 349
• 核医学におけるチームワーク医療の試み－骨シンチ診断支援ソフトBONENAVIの積極的活用－., 2012年, みちのく核医学の会会誌, 19, 43, 47
• Preoperative Evaluation of Sellar and Parasellar Macrolesions by [F-18] Fluorodeoxyglucose Positron Emission Tomography, Tosaka\, Masahiko,Higuchi\, Tetsuya,Horiguchi\, Keishi,Osawa\, Tadashi,Arisaka\, Yukiko,Fujita\, Haruyasu,Tsushima\, Yoshito,Yoshimoto\, Yuhei, 2017年, WORLD NEUROSURGERY, 103, 591, 599

  DOI
• Clinical value of fluorine-18a-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET, Horiguchi\, Keishi,Tosaka\, Masahiko,Higuchi\, Tetsuya,Arisaka\, Yukiko,Sugawara\, Kenichi,Hirato\, Junko,Yokoo\, Hideaki,Tsushima\, Yoshito,Yoshimoto\, Yuhei, 2017年, EJNMMI RESEARCH, 7, 1, 50

  DOI
• Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma, Okano\, Yudai,Satoh\, Tetsurou,Horiguchi\, Kazuhiko,Toyoda\, Minoru,Osaki\, Aya,Matsumoto\, Shunichi,Tomaru\, Takuya,Nakajima\, Yasuyo,Ishii\, Sumiyasu,Ozawa\, Atsushi,Shibusawa\, Nobuyuki,Shimada\, Takehiro,Higuchi\, Tetsuya,Chikamatsu\, Kazuaki,Yamada\, Masanobu, 2014年, ENDOCRINE JOURNAL, 63, 10, 905, 912

  DOI
• Effects and safety of I-131-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results, from a multicenter observational registry, Yoshinaga\, Keiichiro,Oriuchi\, Noboru,Wakabayashi\, Hiroshi,Tomiyama\, Yuuki,Jinguji\, Megumi,Higuchi\, Tetsuya,Kayano\, Daiki,Fukuoka\, Makoto,Inaki\, Anri,Toratani\, Ayane,Okamoto\, Shozo,Shiga\, Tohru,Ito\, Yoichi M,Nakajo\, Masatoyo,Nakajo\, Masayuki,Kinuya\, Seigo, 2015年, ENDOCRINE JOURNAL, 61, 12, 1171, 1180

  DOI
• Diagnostic usefulness of F-18-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma, Nobusawa\, Aiko,Kim\, Mai,Kaira\, Kyoichi,Miyashita\, Go,Negishi\, Akihide,Oriuchi\, Noboru,Higuchi\, Tetsuya,Tsushima\, Yoshito,Kanai\, Yoshikatsu,Yokoo\, Satoshi,Oyama\, Tetsunari, 2017年, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 40, 11, 1692, 1700

  DOI
• Evaluation of muscle activity just after straight leg raising exercise by using (18)FDG-PET, Shiozawa\, Hiroyuki,Ohsawa\, Takashi,Tsushima\, Yoshito,Higuchi\, Tetsuya,Takagishi\, Kenji,Chikuda\, Hirotaka, 2018年, JOURNAL OF ORTHOPAEDIC SCIENCE, 23, 2, 328, 333

  DOI
• 18F-FAMT PET Is Useful to Distinguish between Specific Uptake and Nonspecific Uptake Compared to 18F-Flourodeoxyglucose Position Emission Tomography in Esophageal Cancer Patients., Sohda M,Miyazaki T,Honjyo H,Hara K,Ozawa D,Sakai M,Yokobori T,Higuchi T,Tsushima Y,Kuwano H, 2017年, DIGESTIVE SURGERY, in press

  DOI
• A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma: a study protocol., Inaki A,Yoshimura K,Murayama T,Imai Y,Kuribayashi Y,Higuchi T,Jinguji M,Shiga T,Kinuya S, 2017年, The Journal of Medical Investigation, 64, 3-4., 205, 209

  DOI
• 最近の核医学診療その進歩とこれから., 樋口徹也, 2017年, 臨床画像, 33, 4, 391
• 「IgG4関連疾患の画像所見を整理する」核医学所見‐特にFDG-PETの有用性‐, 徳江 梓,樋口 徹也,有坂 有紀子,徳江 浩之,対馬 義人, 2014年, 臨床画像, 30, 1
• Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma, Kasahara\, Norimitsu,Kaira\, Kyoichi,Bao\, Pinjie,Higuchi\, Tetsuya,Arisaka\, Yukiko,Erichem-Ochir\, Bilguun,Sunaga\, Noriaki,Ohtaki\, Yoichi,Yajima\, Toshiki,Kosaka\, Takayuki,Oyama\, Tetsunari,Yokobori\, Takehiko,Asao\, Takayuki,Nishiyama\, Masahiko,Tsushima\, Yoshito,Kuwano\, Hiroyuki,Shimizu\, Kimihiro,Mogi\, Akira, 2018年, LUNG CANCER, 119, 71, 77

  DOI
• Normal database (NDB) of 123I-IMP brain perfusion SPECT examination is affected by statistical image analysis in the presence or absence of scatter correction and attenuation correction., Shimada H,Otake H,Higuchi T,Arisaka Y,Oriuchi N,Endo K, 2012年, Kaku Igaku., 49(4), 341, 9

書籍等出版物

• B細胞非ホジキンリンパ腫治療のストラテジー, B細胞非ホジキンリンパ腫治療のストラテジー, 2003年
• 臨床核医学・PET検査技術学 遠藤啓吾、大竹英則、高橋康幸 編集, 文光堂, 2009年
• 臨床核医学・PET検査技術学 遠藤啓吾、大竹英則、高橋康幸 編集, 文光堂, 2009年
• 内分泌画像検査・診断マニュアル, 診断と治療社, 2011年

講演・口頭発表等

• Cellular proliferation and amino-acid transporter expression of maxillofacial tumor evaluated with L-3[18F]fluoro-alpha-methyltyrosine and 18F-FDG PET., The First International Symposium on Biomedical Research Using Accelerator Technology, 2005年
• Difference of FDG uptake in MALT lymphoma arising from different primary sites., Annual congress of the European association of Nuclear Medicine, 2002年
• Clinical study using L-3-[18F] fluoro-methyltyrosine (FAMT) and 18F-FDG PET for maxillofacial tumor: Comparative immunohistopathological analysis with cellular proliferation (Ki-67) and amino-acid transporter expression (LAT-1)., 53th Annual Meeting of the Society of Nuclear Medicine, 2006年
• Clinical study using L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) and 18F-FDG PET for maxillofacial tumor with analysis on cellular proliferation (Ki-67) and amino-acid transporter expression (LAT-1)., The Second International Symposium on Biomedical Research Using Accelerator Technology, 2005年
• Relation between FDG uptake and immunohistochemistry of gastrointestinal stromal tumor., 51th Annual Meeting of the Society of Nuclear Medicine, 2004年
• Cellular proliferation and amino-acid transporter expression of maxillofacial tumor evaluated with L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) and 18F-FDG PET., Australian and New Zealand Society of Nuclear Medicine 35th Annual Scientific Meeting 2005, 2005年
• Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody, NuB2, for cancer therapy., 52th Annual Meeting of the Society of Nuclear Medicine, 2005年
• A preliminary of the usefulness of L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) PET in the evaluation of malignancy of maxillofacial tumor; Comparative study with 18F-FDG PET and immunohistochemical analysis of cellular proliferation (Ki-67) and amino-a・・・, EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine, 2005年
• Preclinical Evaluation of Radiolabeled Anti-CD20 Monoclonal Antibody, NuB2, for Cancer Therapy., EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine, 2005年
• Use of FDG-PET in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation., Australian and New Zealand Society of Nuclear Medicine 35th Annual Scientific Meeting 2005, 2005年
• Preclinical evaluation of 67Cu-labeled monoclonal antibody for cancer therapy., 53th Annual Meeting of the Society of Nuclear Medicine, 2006年
• FDG-PET and immunohistochemical staining to differentiate hepatocellular carcinoma and cholangiocellular carcinoma: Representative case presentation., 9th Congress of the World Federation of Nuclear Medicine & Biology, 2006年
• Diagnosis of primary tumor in patients with cancer of unknown primary using F-18-FDG PET, 9th Congress of the World Federation of Nuclear Medicine & Biology, 2006年
• Preliminary evaluation of fluorine-18 alpha-methyl tyrosine PET in the differential diagnosis of pancreatic tumor; comparative study with FDG-PET, Annual Congress of the Europian Association of Nuclear Medicine, 2006年
• Glucose transporters expression in hepatocellular carcinoma compared with FDG-PET, Annual Congress of the Europian Association of Nuclear Medicine, 2006年
• Current status and problems of radioimmunotherapy (RIT) in Japan, The 22nd Nagoya International Cancer Treatment Symposium., 2007年
• Preliminary evaluation of fluorine-18 alpha-methyl tyrosine PET in the differential diagnosis of mass-forming pancreatitis with pancreatic malignancy, 9th Congress of the World Federation of Nuclera Medicine & Biology, 2006年
• Preliminary evaluation of the usefulness of collimator opne caliber correction in myocardial SPECT, Annual Congress of the Europian Association of Nuclear Medicine, 2006年
• 滑膜肉腫の治療を目的としたFZD10を標的分子とする90Y標識抗体開発, 第４６回 日本核医学会学術総会, 2006年
• 悪性褐色細胞腫症例の治療前後18F-FDG心臓集積の検討, 第４６回 日本核医学会学術総会, 2006年
• Diagnosis of cercinoma of unknown primary with F-18-FDG PET, 9th Congress of the World Federation of Nuclear Medicine & Biology, 2006年
• Application of PET Imaging with [Cu-64] for quantitative evaluation of radioimmunotherapy, 9th Congress of the World Federation of Nuclear Medicine & Biology, 2006年
• Usefulness of FDG-PET for the evaluation of maxillofacial tumors: Comparison to conventional studies with CT/MRI., snm annual meeting, 2006年
• 悪性褐色細胞腫のI-131 MIBG治療中にFDG-PETで見られる褐色脂肪組織への集積とノルアドレナリン刺激との関係．, 第64回日本医学放射線学会総会, 2005年
• L-[F-18]-alpha-methyl tyrosine PET as a metabolic marker for the diagnosis of pulmonary adenocarcinoma., World Cancer Congress 2008., 2008年
• Potential utility of 64Cu labeled monoclonal antibody for imaging with PET., Annual congress of the European Association of Nuclear Medicine,, 2008年
• 放射性ストロンチウム（89Sr）による転移性骨腫瘍の疼痛緩和療法．, 第58回日本癌学会総会, 1999年
• 3DSRT処理ソフトを用いた脳循環予備能の評価, 第44回日本核医学会, 2004年
• Antigen-antibody dependent difference in the biodistribution and pharmacokinetics of Tc-99m-labeled monoclonal antibodies between animal models and patients with tumors., 12nd Annual Congress of the European Association of Nuclear Medicine, 1999年
• Radioimmunotherapy of SCID mice bearing human B-cell lymphoma using I-131 labeled anti-CD20 monoclonal antibody., 12nd Annual Congress of the European Association of Nuclear Medicine, 1999年
• Clinical significance of L-[3-18F]-a-methyl tyrosine PET studies in intracranial and intrathoracic tumor: A comparative study with 18F-FDG PET., 47th Annual Meeting of the Society of Nuclear Medicine, 2000年
• 消化器癌関連抗原A33に対するI-131標識ヒト型モノクローナル抗体（huA33）による進行再発胃癌を対象としたPhaseⅠ臨床試験．, 第61回日本癌学会総会, 2002年
• Gastrointestinal stromal tumorに対するFDG-PETの有用性の検討．, 第43回日本核医学会総会, 2003年
• Prognostic implication of LAT1 expression determined by [F-18]-α-methyl tyrosine PET in non-small cell lung cancer, 67th Annual Meeting of the Japan Cancer Association 第67回 日本癌学会総会, 2008年
• 悪性リンパ腫の早期の治療効果と予後予測における18F-FDG-PETの有用性．, 第48回日本核医学会学術総会, 2008年
• 非小細胞肺癌における[F-18]-α-methyl tyrosine PETと予後．, 第48回日本核医学会学術総会, 2008年
• 放射線ヨード（131I）標識抗体CD20抗体を用いるB細胞性悪性リンパ腫移植SCIDマウスの放射免疫治療, 癌学会, 1999年
• Diagnosis of primary tumor in patients with cancer of unknown primary using F-18-FDG PET., European Association of Nuclear Medicine Congress., 2006年
• Biodistribution, Safety, and Pharmacokinetics of Humanized Monoclonal Antibody huA33 in Patients with Gastric Carcinoma Determined by 131I-labeled huA33., 第20回欧州核医学会年次総会, 2007年
• Comparison of gated myocardial perfusion single-photon emission tomography with contrast enhanced MRI for detection of myocardial damage in dilated cardiomyopathy., Annual congress of the European Association of Nuclear Medicine,, 2008年
• Clinical usefulness of FDG-PET/CT in the evaluation of Langerhans cell histiocytosis occurred in pelvic bone., Annual congress of the European Association of Nuclear Medicine, 2008年
• Radio-activated compound produced associated with the operation of small medical cyclotron., Annual congress of the European Association of Nuclear Medicine,, 2008年
• Expression of L-type amino acid transporter 1 determined by [18F] fluoro alpha-methyl tyrosine (18F-FMT) PET correlates with the prognosis of patients with resectable stage I-III non-small cell lung cancer ．, 56th SNM Annual Meeting 第56回米国核医学会, 2009年
• 骨シンチグラフィとの比較による血中ICTPの骨転移診断における臨床的有用性の検討．, 第47回日本核医学会学術総会, 2007年
• Assessment of therapeutic response and prognosis in malignant pleural mesotheliona with 18F-FDG-PET., 22th Annual Congress of the EANM, 2009年
• 造影MRI検査と心筋血流シンチグラフィを施行した拡張型心筋症の所見．, 第47回日本核医学会学術総会, 2007年
• Multimodality molecular imaging of CD20 expressing lymphoma with combined nuclear and optical modalities., 2008 world molecular imaging congress (世界分子イメジング学会）, 2008年
• Correlation between PET and spectral fluorescence for imaging lymphoma using dual labeled probe., Japanese society for molecular imaging(日本分子イメジング学会）, 2008年
• 64Cu labeled antibody for tumor imaging with PET., 12th Annual meeting of society of fundamental cancer immunology（日本免疫学会総会）, 2008年
• Can whole body bone SPECT (MIP) with shorter waiting time (90 minutes) replace conventional whole body bone scan without losing lesion detectability?, 22th Annual Congress of the EANM, 2009年
• Evaluation of dispersion of SUV obtained by different PET system; preliminary cylinder phantom study., EANM 2007, 2007年
• Synthesis and evaluation of 76BrDG for tumor diagnosis using microPET in mice., 22th Annual Congress of the EANM, 2009年
• Can serum catecholamine at 1 week after I-131 MIBG therapy predict response in malignant pheochromocytoma?, 22th Annual Congress of the EANM, 2009年
• Advantage of LMEGP collimator in the brain SPECT image acquisition with I-123 labeled radiophamaceutical;Preliminary evaluation of the image quality using one day rest and rest method., 22th Annual Congress of the EANM, 2009年
• Comparative study of FDG-PET and I-123 MIBG scan in the evaluation of therapeutic effect of malignant pheochromocytoma treated bya I-131 MIBG therapy., EANM 2007, 2007年
• PET/CT装置における三次元逐次近似画像再構成方法の臨床的有用性の評価（Evaluation of the usefulness of new 3D iterative image reconstruction method in the diagnostic reading of clinical PET/CT image, 第48回日本核医学会総会, 2008年
• Differential Diagnosis of Mass-forming Pancreatic Diseases with [F-18] Alpha-methyl Tyrosine PET., RSNA2008, 2008年
• Initial evaluation of [F-18] alfa-methyl tyrosine PET for differential diaguosis of pancreatic lesions, ＳＮＭ2009, 2009年
• Preliminary evaluation of L-[F-18]-alpha-methyl tyrosine PET/CT in the differential diagnosis of maxillofacial tumor., 56th SNM Annual Meeting, 2009年
• Differential Diagnosis and Assessment of Prognosis in Malignant Pleural Mesothelioma with 18F-FDG PET., RSNA 2009, 2009年
• Clinical significance of [18F]-α-methyl tyrosine PET as a potential surrogate marker of LAT1 expression for predicting prognosis of non-small cell lung cancer., ASCO2010, 2010年
• Clinical implication of F-18-FDG-PET and MRI for assessing therapeutic effect of anti TNF?antibody in patient with rheumatoid arthritis., SNM2010, 2010年
• FDG-PETにおける集積が結核の活動性を反映していたと推察される1剖検例, 第435回日本医学放射線学会関東地方会, 2009年
• Contrast and non-contrast US findings of hepatic metastasis from malignant pheochromocytoma., European Congress of Radiology (ECR) 2010, 2010年
• Clinicopathological study with F-18-FDG PET for assessing metabolic activity of arthritis in patients with rheumatoid arthritis., RSNA2008, 2008年
• 滑膜肉腫の治療を目的としたFZD10を標的分子とする90Y標識抗体開発, 第41回 腫瘍・免疫核医学研究会, 2007年
• イットリウム-90標識ヒト抗CEA抗体によるがん治療の基礎的検討, 第11回 基盤的癌免疫研究会総会, 2007年
• Targeting FZD10, a cell-surface protein, for radioimmunotherapy of synovial sarcoma., 55th SNM annual meeting, 2007年
• 90Y標識ヒト抗CEA抗体によるがん治療の基礎的検討, 第7回放射性医薬品・画像診断研究会, 2007年
• Development of a radiolabeled peptide derivative targeting matrix metalloproteinase-2, for imaging tumors., 第67回癌学会総会, 2008年
• 新規放射性核種『ルテチウム-177』標識抗体によるがん治療の基礎的検討, 第13回日本がん免疫学会総会, 2009年
• 64Cu-DOTA-オクトレオタイドの有用性の検討, 第49回日本核医学会総会, 2009年
• 新規放射性核種『ルテチウム-177』標識抗体によるがん治療の基礎的検討, 第4回高崎量子応用研究シンポジウム, 2009年
• がんのPETイメージング薬剤としての76Br標識アミノ酸の有用性, 第5回日本分子イメージング学会総会, 2010年
• 新規放射性核種『ルテチウム-177』標識抗体によるがん治療, 第14回日本がん免疫学会総会, 2010年
• Bevacizumab based nearinfrared fluorescence imaging of VEGF in colon cancer., 4th Annual meeting of Japanese Society of Molecular imaging (日本分子イメジング学会）, 2009年
• Imaging and localization of 64Cu labeled trastuzumab in Her2/neu overexpressing non-small lung cancer xenografts., The Fourth International Symposium on Biomedical Research Using Accelerator Technology, 2008年
• PET imaging and biodistribution of 64Cu labeled monoclonal antibody., The Third Takasaki Advanced Radiation Research Symposium, 2008年
• 内照射療法が奏効した悪性褐色細胞腫の１例, 第７１回日本核医学会関東甲信越地方会, 2009年
• 原発性骨病変の診断にFDG-PETが有用であった成人発症ランゲルハンス細胞組織球症の2例, 第７１回日本核医学会関東甲信越地方会, 2009年
• Clinicopathological features of metastasis of liver from rectalcarcinoid determined by F-18-FDG uptake and expression of glucose transporter I and hexokinase Ⅱ, EANM 2009, 2009年
• Expression of Glucose Transporter in hepatocellular carcinoma compared with FDG-PET, 65th annual meeting of Japanese Radiological Society,, 2006年
• 放射性同位元素標識抗体のがん治療への臨床応用, 第63回日本癌学会総会 「がん抗体療法の新展開」, 2004年
• Correlation between FDG-PET and alpha fetoprotein in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation, 45th Annual meeting of Japanese society of Nuclear medicine (JSNM ), 2005年
• Preliminary evaluation of the usefulness of originally established normal database of Brain perfusion SPECT for the statistical analysis using 3D-SSP software., Annual Congress of the Europian Association of Nuclear Medicine 2010, 2010年
• Comparative utility of F-18-FDG-PET and MRI for the assessment of the therapeutic effect in patients with rheumatoid arthritis treated by anti tumor necrosis factor alpha antibody., Annual Congress of the Society of Nuclear Medicine 2010, 2010年
• F-18 FAMT uptake correlates tumor proliferative activity in oral squamous cell carcinoma; Comparative study with F-18 FDG PET and immunohistochemistry., Annaul Congress of Europian Association of Nuclear Medicine, 2010年
• Comparative study of the usefulness of 18F-FDG PET/CT and serum catecholamine in the evaluation of 131I -MIBG Therapy for malignant Pheochromocytoma., Annual Congress of the Radiological Society of North America 2010, 2010年
• Clinical significance of 18F-FDG PET/CT for the assessment of 131I-MIBG therapy in Malignant Pheochromocytoma., Annual Congress of the Radiological Society of North America 2010, 2010年
• 松果体腫瘍と副腎腫瘍を合併した神経線維腫症１症例., 第49回群馬県核医学研究会, 2010年
• 松果体腫瘍を合併した神経線維腫症(NF1)の2症例., 第73回日本核医学会関東甲信越地方会, 2010年
• 悪性褐色細胞腫I-131MIBG治療の効果判定:FDG-PET/CTと血中カテコールアミンの有用性の比較., 第50回日本核医学会学術総会, 2010年
• シンポジウムS3-4 肺癌のPET診断., 第51回日本肺癌学会, 2010年
• Preliminary comparison of 18F-FDG PET and 123I-MIBG scan for the assessment of 131I-MIBG therapeutic effect in malignant pheochromocytoma., Europian Congress of Radiology 2011, 2011年
• Assessment of disease activity with F-18-FDG-PET for evaluating response to anti TNFαantibody in rheumatoid arthritis., Annual Congress of Europian Association of Nuclear Medicine, 2011年
• Additioal value of 18F-FAMT PET/CT in the assessment of preoperative oral tumor patient with suspected cervical lymph node metastasis;Comparative study with 18F-FDG PET/CT., Annual Congress of the Europian Association of Nuclear Medicine 2011, 2011年
• Serial alterations of myocardial fatty acid metabolism in patients with acute myocardial infarction., Annual Congress of the Europian Association of Nuclear Medicine 2011, 2011年
• Comparison of FDG and I-123 IMP-SPECT analyzed by statistical software(3D-SSP and SEE）for the initial evaluation of Alzheimer's disease;Is there significant difference？., Annual Congress of the Europian Association of Nuclear Medicine 2011, 2011年
• Additional value of FAMT PET/CT for the assessment of multiple myeloma-computed study with FDG PET/CT., Annual Congress of the Europian Association of Nuclear Medicine 2011, 2011年
• 骨転移との鑑別にFAMT-PET/CTが有用であったPaget病の１例., 第51回群馬県核医学研究会, 2011年
• コンピューター支援診断(CAD)による骨シンチグラフィの診断能向上に関する研究 臨床的検討., 第51回日本核医学会総会, 2011年
• 123I-IMP脳血流検査の統計学的画像解析結果において自施設NDBと同機種., 第51回日本核医学会総会, 2011年
• 心筋血流SPECTによる心筋虚血の評価；CT補正と従来法の比較., 第51回日本核医学会総会, 2011年
• 18F-FDG PET/SPECTによる関節リウマチの治療効果判定の検討., 第51回日本核医学会総会, 2011年
• 同時係数機能を搭載したSPECT装置による心筋糖代謝と心筋血流評価の経験., 第51回日本核医学会総会, 2011年
• FDG-PETによる口腔悪性腫瘍の術前頸部リンパ節転移診断:FAMT-PETの追加による診断特異性改善の可能性., 第51回日本核医学会総会, 2011年
• FAMT-PET/CTの多発性骨髄腫に対する有用性について:FDG-PET/CTとの比較・検討., 第51回日本核医学会総会, 2011年
• Incremental value of I-123 MIBG SPECT/CT over FDG-PET in the evaluation of malignant pheochromocytoma., Progress in Radiology, 2012年
• Preliminary technical assessment of 11C-Pittsburgh Compound-B PET(PIB PET) imaging in different image display conditions., Progress in Radiology, 2012年
• A Preliminary Report on EGFR-targeted PEGylated PLGA Immunonanobubbles as an Intratumor-specific targeted Ultrasound Contrast Agent., Progress in Radiology, 2012年
• A preliminary report on HER1-targeted PEG-PLGA nanobubbles as an intratumor-specific targeted ultrasound contrast agent., 第71回日本癌学会学術集会, 2012年
• Effect of scatter correctiono the accuracy of I cresed cerebral perfusion rate in 123I-IMP brain SPECT;Multicenter study., Annual Congress of the Europian Association of Muclear Medicine, 2012年
• 転移性骨腫瘍とBisphosphonate製剤による顎骨壊死との鑑別に有用であったFAMT-PETの2例., 第441回日本医学放射線学会関東地方会定期大会, 2012年
• 診断困難な副甲状腺線種の局所診断に99mTc-MIBI SPECT/CTが有用であった3症例., 第441回日本医学放射線学会関東地方会定期大会, 2012年
• FDG-PET/CTにてFDG高集積を認めた副腎褐色細胞腫と副腎癌を合併した一例., 第441回日本医学放射線学会関東地方会定期大会, 2012年
• 18F-FDG PET/CTにて経過を追いえたIgG4関連疾患の2例., 第441回日本医学放射線学会関東地方会定期大会, 2012年
• FAMT‐PET が診断に有用であった口腔腺様嚢胞癌の一例, 第52回日本核医学会学術総会, 2012年
• FDG集積と細胞増殖能との関連について検討を行った副腎褐色細胞腫と副腎癌の2例., 第52回日本核医学会学術総会, 2012年
• 口腔扁平上皮癌患者の顎骨浸潤検出におけるFAMT‐PETの臨床的意義; FDG ‐PETとMRIの比較., 第52回日本核医学会学術総会, 2012年
• 冠動脈疾患スクリーニングに施工された負荷心筋血流シンチグラフィと冠動脈CT所見の対比., 第52回日本核医学会学術総会, 2012年
• 進行性失語症と考えられる症例の認知機能,脳脊髄液および神経放射線学的検討., 第31回日本認知症学会学術集会, 2012年
• 悪性褐色細胞腫の131I-MIBG治療評価における18F-FDG PET/CTの臨床的有用性., 第76回日本核医学会関東甲信越地方会, 2012年
• 骨転移腫瘍におけるFDG ‐PET/CTと併用でのFAMT-PET/CTの診断的価値., 第52回日本核医学会学術総会, 2012年
• FDG-PETで高集積を認めた心嚢内神経鞘腫の一例., 第52回日本核医学会学術総会, 2012年
• Incremental value of L-3- [18F]-fluoro-alpha-methyl tyrosine (FAMT) PET for the accurate evaluation of bone marrow invasion in patients with oral squamous cell carcinoma;Comparison with FDG-PET and MRI., Progress in Radiology, 2012年
• 悪性褐色細胞腫診断におけるI‐123MIBG SPECT/CT の有用性 ;FDG‐PET/CTとの比較., 第52回日本核医学会学術総会, 2012年
• 心電図同期心筋SPECTと心臓超音波での左室機能評価指標の比較., 第82回日本心臓血管放射線研究会, 2016年
• Non-invasive quantitative evaluation of cerebral blood flow (CBF) using technetium labeled ethyl cysteinate dimer (99mTc-ECD): performance of aorta’s region of interest (ROI)., Progress in Radiology 2016 11th symposium of the Japanese Scandinavian Radiological Society, 2016年
• Retrospective evaluation of the utility of thyroglobulin doubling time in the diagnosis of radioactive-io-dine-refractory differentiated thyroid cancer; initial experience from 6 patients treated with Lenvatinib., Progress in Radiology 2016 11th symposium of the Japanese Scandinavian Radiological Society, 2016年
• 放射性ヨード抵抗性分化型甲状腺癌におけるTKI治療適応判断でのサイログロブリン倍加時間の有用性の検討., 第56回日本核医学会学術総会, 2016年
• 心筋SPECTと心臓MRIの心機能解析結果の比較(SPECT解析ソフトおよびMRI解析方法の影響）., 第62回群馬県核医学研究会, 2016年
• 頭蓋咽頭腫とFDG-PET, 第62回群馬県核医学研究会, 2016年
• Marine-Lenhart症候群に対し、放射性ヨード内用療法が有効であった1例., 第86回日本核医学会関東甲信越地方会, 2017年
• The Effect of Shape of Ragion of Interest(ROI) in Aortic Arch for Cerebral Blood Flow Quantification Using 99mTc-ECD., JRS, 2017年
• Influence of Attenuation and Scatter Corrections on Quantitative Analysis of [123I]FP-CIT SPECT Brain Imaging., JRS, 2017年
• A Novel Parameter to Evaluate Thyroid Function with Dual Energy Computed Tomography in Patients with Hyperthyroidism., JRS, 2017年
• ノルエピネフリントランスポーター標的放射性薬剤の有用性評価: 芳香族フッ素化が与える影響., 第15回次世代を担う若手のためのフィジカル・ファーマフォーラム, 2017年
• Can18F FDG PET Predict 131I Radioiodine Therapeutic Response in Metastatic Differentiated Thyroid Carcinome?, 第64回北関東医学会総会, 2017年
• Prognastic Value of Tumor Volume of Pretreatment 18F-FAMT PET in Non-Small Cell Lung Cancer., RSNA2017, 2017年
• 副甲状腺腫の局在診断におけるSPECT－CTの有用性., 第55回群馬県核医学研究会, 2013年
• Objective methods for the diagnosis of myocardial ischemia using computed tomographic iodine images: comparison with 99mTc-stress perfusion SPECT., European Society of cardiology (ESC) Congress 2013, 2013年
• 18F-FDG-PET/CTにて高集積を呈した多発肝血管筋脂肪腫の一例., 第53回日本核医学会学術総会, 2013年
• 下顎歯肉扁平上皮癌の顎骨浸潤検出におけるFAMT-PET/CTの臨床的意義: FDG‐PET/CTとMRIとの比較., 第53回日本核医学会学術総会, 2013年
• Clinical utility of Fluorine-18-α-Methyltyrosine dynamic PET study in the differentioal diagnosis of glioma., 10th Symposium of the Scandinavian Japanese Radiological Society & 13th Nordic Japan PACS Symposium, 2014年
• 疼痛を有する褐色細胞腫骨転移に対し経皮的凍結療法を施行した1例., 第9回日本IVR学会関東地方会, 2014年
• Computer-aided diagnosis system for bone scans BONENAVI needs the second reading of the radiologist?（Besoin de personne)., 第72回日本医学放射線学会総会, 2013年
• 舌癌術後転移の検出にFAMT-PET/CTが有用であった一例., 第78回日本核医学会 関東甲信地方会, 2013年
• 口腔腫瘍のPET/CT診断., 第78回日本核医学会 関東甲信地方会, 2013年
• 心サルコイドーシス(FDG)～PET検査を有効に活用するために～., 第38回New Town Conference, 2013年
• 18F-FAMT-PETにて悪性転化が診断可能であったエナメル上皮腫の一例., 第50回腫瘍・免疫核医学研究会, 2013年
• Clinical significance of 18F-alpha-methyl tyrosine (FAMT）PET for evaluation of resection area in patients with oral squamous cell carcinoma., 第72回日本医学放射線学会総会, 2013年
• 上下顎歯肉扁平上皮癌の顎骨浸潤検出におけるFAMT-PET/CTの臨床的意義；FDG-PET/CTとMRIとの比較., 第67回NPO法人日本口腔科学会学術集会, 2013年
• 肺病変におけるFANTダイナミック撮影による良悪性診断の可能性., 第55回群馬県核医学研究会, 2013年
• 下垂体, トルコ鞍近傍病変のFDG－PET., . 第55回群馬県核医学研究会, 2013年
• BSIは乳癌骨転移治療効果判定の新たな画像バイオマーカーとなり得るか？, 第21回日本乳癌学会学術総会, 2016年
• 絶食プロトコールと低糖食プロトコールの18F-FDG PET 検査を実施した心サルコイドーシス症例., 第77回日本心臓血管放射線研究会, 2016年
• 口腔腫瘍におけるFAMT-PET/CTの早期画像の有用性について., PETサマーセミナー2013in加賀百万石, 2013年
• 褐色細胞腫におけるFDGの集積とMIBG-1indexによる増殖能との関連について., PETサマーセミナー2013in加賀百万石, 2013年
• FAMT-PETによる悪性褐色細胞腫骨転移の評価：FDG-PETとの比較., 第1回日本神経内分泌腫瘍研究会学術集会, 2013年
• Cardiac CTにおけるiodine imageの定量による心筋虚血の評価: Tc負荷心筋シンチとの比較., 第61回日本心臓病学会学術集会, 2013年
• 副腎褐色細胞腫および副腎癌におけるFDG集積と細胞増殖能との関連について., 第1回日本神経内分泌腫瘍研究会学術集会, 2013年
• Differentiation of malignant tumors from granulomas with dynamic [18F］-Fluoro-L-α-methyltyrosine PET imaging., EANM, 2013年
• PET volume computer-assisted reading (PET VCAR) software for accurate measurement of tumor volume using 18F-FAMT PET/CT in oral cancer., EANM, 2013年
• 神経膠腫の診断に於けるFAMT-PETの有用性～FDG-PETとの比較～., 第56回群馬県核医学研究会, 2013年
• 肺癌での18F-FAMT-PETの予後予測における意義., 第56回群馬県核医学研究会, 2013年
• 褐色細胞腫における18F-fluorodeoxyglucoseの集積とMIB-1indexによる増殖能との関連について., 第53回日本核医学会学術総会, 2013年
• 腫瘍と肉芽腫の鑑別診断におけるDynamic[18F]-Fluoro-L-α-methyltyrosine(18F-FAMT)-PETの有用性., 第53回日本核医学会学術総会, 2013年
• レビー小体型認知症(レビー症）,パーキンソン病(P病)における心臓交感神経活性の役割と限界., 第53回日本核医学会学術総会, 2013年
• 心サルコイドーシス症例の最長6年間の18F-FDG PET所見の経過., 第53回日本核医学会学術総会, 2013年
• Iodine imageの定量評価による心筋perfusion－心筋シンチとの比較－., 第53回日本核医学会学術総会, 2013年
• Duai Energy CTを用いたiodine imaging の定量評価による心筋虚血の評価: Tc負荷心筋シンチとの比較., 第16回心世代核医学研究会, 2013年
• 口腔腫瘍におけるFAMT-PET/CT Dynamic撮影の初期検討., 第80回日本核医学会関東甲信越地方会, 2014年
• 口腔扁平上皮癌における18F-FAMT-PET/CTの臨床的意義: 骨髄浸潤や腫瘍進展範囲, 病理組織学的検討., 第68回日本口腔科学会学術集会, 2014年
• FAMT-PETにて集積を認めた脊髄腫瘍の一例., 第57回群馬県核医学研究会, 2014年
• 進行肺癌における18F－FAMT PETの治療効果における有用性., 第57回群馬県核医学研究会, 2014年
• Current topics of PET/CT in the diagnosis of oral cancer., 16th National congress of the Vietnamese society of radiology and nuclear medicine, 2014年
• PET/CT metabolic tumor volume and total lesion glycolysis/retention predict outcome in oral squamous carcinoma: comparison study of 18F-FDG and 18F-FAMT., EANM, 2014年
• Cellular proliferation and amino-acid transporter expression of maxillofacial tumor evaluated with L-3[18F]fluoro-alpha-methyltyrosine and 18F-FDG PET., The First International Symposium on Biomedical Research Using Accelerator Technology, 2005年
• Difference of FDG uptake in MALT lymphoma arising from different primary sites., Annual congress of the European association of Nuclear Medicine, 2002年
• Clinical study using L-3-[18F] fluoro-methyltyrosine (FAMT) and 18F-FDG PET for maxillofacial tumor: Comparative immunohistopathological analysis with cellular proliferation (Ki-67) and amino-acid transporter expression (LAT-1)., 53th Annual Meeting of the Society of Nuclear Medicine, 2006年
• Clinical study using L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) and 18F-FDG PET for maxillofacial tumor with analysis on cellular proliferation (Ki-67) and amino-acid transporter expression (LAT-1)., The Second International Symposium on Biomedical Research Using Accelerator Technology, 2005年
• Relation between FDG uptake and immunohistochemistry of gastrointestinal stromal tumor., 51th Annual Meeting of the Society of Nuclear Medicine, 2004年
• Cellular proliferation and amino-acid transporter expression of maxillofacial tumor evaluated with L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) and 18F-FDG PET., Australian and New Zealand Society of Nuclear Medicine 35th Annual Scientific Meeting 2005, 2005年
• Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody, NuB2, for cancer therapy., 52th Annual Meeting of the Society of Nuclear Medicine, 2005年
• A preliminary of the usefulness of L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) PET in the evaluation of malignancy of maxillofacial tumor; Comparative study with 18F-FDG PET and immunohistochemical analysis of cellular proliferation (Ki-67) and amino-a・・・, EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine, 2005年
• Preclinical Evaluation of Radiolabeled Anti-CD20 Monoclonal Antibody, NuB2, for Cancer Therapy., EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine, 2005年
• Use of FDG-PET in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation., Australian and New Zealand Society of Nuclear Medicine 35th Annual Scientific Meeting 2005, 2005年
• Preclinical evaluation of 67Cu-labeled monoclonal antibody for cancer therapy., 53th Annual Meeting of the Society of Nuclear Medicine, 2006年
• FDG-PET and immunohistochemical staining to differentiate hepatocellular carcinoma and cholangiocellular carcinoma: Representative case presentation., 9th Congress of the World Federation of Nuclear Medicine & Biology, 2006年
• Diagnosis of primary tumor in patients with cancer of unknown primary using F-18-FDG PET, 9th Congress of the World Federation of Nuclear Medicine & Biology, 2006年
• Preliminary evaluation of fluorine-18 alpha-methyl tyrosine PET in the differential diagnosis of pancreatic tumor; comparative study with FDG-PET, Annual Congress of the Europian Association of Nuclear Medicine, 2006年
• Glucose transporters expression in hepatocellular carcinoma compared with FDG-PET, Annual Congress of the Europian Association of Nuclear Medicine, 2006年
• Current status and problems of radioimmunotherapy (RIT) in Japan, The 22nd Nagoya International Cancer Treatment Symposium., 2007年
• Preliminary evaluation of fluorine-18 alpha-methyl tyrosine PET in the differential diagnosis of mass-forming pancreatitis with pancreatic malignancy, 9th Congress of the World Federation of Nuclera Medicine & Biology, 2006年
• Preliminary evaluation of the usefulness of collimator opne caliber correction in myocardial SPECT, Annual Congress of the Europian Association of Nuclear Medicine, 2006年
• Diagnosis of cercinoma of unknown primary with F-18-FDG PET, 9th Congress of the World Federation of Nuclear Medicine & Biology, 2006年
• Application of PET Imaging with [Cu-64] for quantitative evaluation of radioimmunotherapy, 9th Congress of the World Federation of Nuclear Medicine & Biology, 2006年
• Usefulness of FDG-PET for the evaluation of maxillofacial tumors: Comparison to conventional studies with CT/MRI., snm annual meeting, 2006年
• L-[F-18]-alpha-methyl tyrosine PET as a metabolic marker for the diagnosis of pulmonary adenocarcinoma., World Cancer Congress 2008., 2008年
• Potential utility of 64Cu labeled monoclonal antibody for imaging with PET., Annual congress of the European Association of Nuclear Medicine,, 2008年
• Antigen-antibody dependent difference in the biodistribution and pharmacokinetics of Tc-99m-labeled monoclonal antibodies between animal models and patients with tumors., 12nd Annual Congress of the European Association of Nuclear Medicine, 1999年
• Radioimmunotherapy of SCID mice bearing human B-cell lymphoma using I-131 labeled anti-CD20 monoclonal antibody., 12nd Annual Congress of the European Association of Nuclear Medicine, 1999年
• Clinical significance of L-[3-18F]-a-methyl tyrosine PET studies in intracranial and intrathoracic tumor: A comparative study with 18F-FDG PET., 47th Annual Meeting of the Society of Nuclear Medicine, 2000年
• Prognostic implication of LAT1 expression determined by [F-18]-α-methyl tyrosine PET in non-small cell lung cancer, 67th Annual Meeting of the Japan Cancer Association 第67回 日本癌学会総会, 2008年
• Diagnosis of primary tumor in patients with cancer of unknown primary using F-18-FDG PET., European Association of Nuclear Medicine Congress., 2006年
• Biodistribution, Safety, and Pharmacokinetics of Humanized Monoclonal Antibody huA33 in Patients with Gastric Carcinoma Determined by 131I-labeled huA33., 第20回欧州核医学会年次総会, 2007年
• Comparison of gated myocardial perfusion single-photon emission tomography with contrast enhanced MRI for detection of myocardial damage in dilated cardiomyopathy., Annual congress of the European Association of Nuclear Medicine,, 2008年
• Clinical usefulness of FDG-PET/CT in the evaluation of Langerhans cell histiocytosis occurred in pelvic bone., Annual congress of the European Association of Nuclear Medicine, 2008年
• Radio-activated compound produced associated with the operation of small medical cyclotron., Annual congress of the European Association of Nuclear Medicine,, 2008年
• Expression of L-type amino acid transporter 1 determined by [18F] fluoro alpha-methyl tyrosine (18F-FMT) PET correlates with the prognosis of patients with resectable stage I-III non-small cell lung cancer ．, 56th SNM Annual Meeting 第56回米国核医学会, 2009年
• Assessment of therapeutic response and prognosis in malignant pleural mesotheliona with 18F-FDG-PET., 22th Annual Congress of the EANM, 2009年
• Multimodality molecular imaging of CD20 expressing lymphoma with combined nuclear and optical modalities., 2008 world molecular imaging congress (世界分子イメジング学会）, 2008年
• 64Cu labeled antibody for tumor imaging with PET., 12th Annual meeting of society of fundamental cancer immunology（日本免疫学会総会）, 2008年
• Correlation between PET and spectral fluorescence for imaging lymphoma using dual labeled probe., Japanese society for molecular imaging(日本分子イメジング学会）, 2008年
• Synthesis and evaluation of 76BrDG for tumor diagnosis using microPET in mice., 22th Annual Congress of the EANM, 2009年
• Can whole body bone SPECT (MIP) with shorter waiting time (90 minutes) replace conventional whole body bone scan without losing lesion detectability?, 22th Annual Congress of the EANM, 2009年
• Advantage of LMEGP collimator in the brain SPECT image acquisition with I-123 labeled radiophamaceutical;Preliminary evaluation of the image quality using one day rest and rest method., 22th Annual Congress of the EANM, 2009年
• Can serum catecholamine at 1 week after I-131 MIBG therapy predict response in malignant pheochromocytoma?, 22th Annual Congress of the EANM, 2009年
• Comparative study of FDG-PET and I-123 MIBG scan in the evaluation of therapeutic effect of malignant pheochromocytoma treated bya I-131 MIBG therapy., EANM 2007, 2007年
• Evaluation of dispersion of SUV obtained by different PET system; preliminary cylinder phantom study., EANM 2007, 2007年
• Clinicopathological study with F-18-FDG PET for assessing metabolic activity of arthritis in patients with rheumatoid arthritis., RSNA2008, 2008年
• Differential Diagnosis of Mass-forming Pancreatic Diseases with [F-18] Alpha-methyl Tyrosine PET., RSNA2008, 2008年
• Initial evaluation of [F-18] alfa-methyl tyrosine PET for differential diaguosis of pancreatic lesions, ＳＮＭ2009, 2009年
• Preliminary evaluation of L-[F-18]-alpha-methyl tyrosine PET/CT in the differential diagnosis of maxillofacial tumor., 56th SNM Annual Meeting, 2009年
• Differential Diagnosis and Assessment of Prognosis in Malignant Pleural Mesothelioma with 18F-FDG PET., RSNA 2009, 2009年
• Clinical significance of [18F]-α-methyl tyrosine PET as a potential surrogate marker of LAT1 expression for predicting prognosis of non-small cell lung cancer., ASCO2010, 2010年
• Clinical implication of F-18-FDG-PET and MRI for assessing therapeutic effect of anti TNF?antibody in patient with rheumatoid arthritis., SNM2010, 2010年
• Contrast and non-contrast US findings of hepatic metastasis from malignant pheochromocytoma., European Congress of Radiology (ECR) 2010, 2010年
• Targeting FZD10, a cell-surface protein, for radioimmunotherapy of synovial sarcoma., 55th SNM annual meeting, 2007年
• Development of a radiolabeled peptide derivative targeting matrix metalloproteinase-2, for imaging tumors., 第67回癌学会総会, 2008年
• Bevacizumab based nearinfrared fluorescence imaging of VEGF in colon cancer., 4th Annual meeting of Japanese Society of Molecular imaging (日本分子イメジング学会）, 2009年
• Imaging and localization of 64Cu labeled trastuzumab in Her2/neu overexpressing non-small lung cancer xenografts., The Fourth International Symposium on Biomedical Research Using Accelerator Technology, 2008年
• PET imaging and biodistribution of 64Cu labeled monoclonal antibody., The Third Takasaki Advanced Radiation Research Symposium, 2008年
• Clinicopathological features of metastasis of liver from rectalcarcinoid determined by F-18-FDG uptake and expression of glucose transporter I and hexokinase Ⅱ, EANM 2009, 2009年
• Expression of Glucose Transporter in hepatocellular carcinoma compared with FDG-PET, 65th annual meeting of Japanese Radiological Society,, 2006年
• Correlation between FDG-PET and alpha fetoprotein in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation, 45th Annual meeting of Japanese society of Nuclear medicine (JSNM ), 2005年
• Preliminary evaluation of the usefulness of originally established normal database of Brain perfusion SPECT for the statistical analysis using 3D-SSP software., Annual Congress of the Europian Association of Nuclear Medicine 2010, 2010年
• Comparative utility of F-18-FDG-PET and MRI for the assessment of the therapeutic effect in patients with rheumatoid arthritis treated by anti tumor necrosis factor alpha antibody., Annual Congress of the Society of Nuclear Medicine 2010, 2010年
• F-18 FAMT uptake correlates tumor proliferative activity in oral squamous cell carcinoma; Comparative study with F-18 FDG PET and immunohistochemistry., Annaul Congress of Europian Association of Nuclear Medicine, 2010年
• Comparative study of the usefulness of 18F-FDG PET/CT and serum catecholamine in the evaluation of 131I -MIBG Therapy for malignant Pheochromocytoma., Annual Congress of the Radiological Society of North America 2010, 2010年
• Clinical significance of 18F-FDG PET/CT for the assessment of 131I-MIBG therapy in Malignant Pheochromocytoma., Annual Congress of the Radiological Society of North America 2010, 2010年
• Preliminary comparison of 18F-FDG PET and 123I-MIBG scan for the assessment of 131I-MIBG therapeutic effect in malignant pheochromocytoma., Europian Congress of Radiology 2011, 2011年
• Assessment of disease activity with F-18-FDG-PET for evaluating response to anti TNFαantibody in rheumatoid arthritis., Annual Congress of Europian Association of Nuclear Medicine, 2011年
• Serial alterations of myocardial fatty acid metabolism in patients with acute myocardial infarction., Annual Congress of the Europian Association of Nuclear Medicine 2011, 2011年
• Comparison of FDG and I-123 IMP-SPECT analyzed by statistical software(3D-SSP and SEE）for the initial evaluation of Alzheimer's disease;Is there significant difference？., Annual Congress of the Europian Association of Nuclear Medicine 2011, 2011年
• Additional value of FAMT PET/CT for the assessment of multiple myeloma-computed study with FDG PET/CT., Annual Congress of the Europian Association of Nuclear Medicine 2011, 2011年
• Additioal value of 18F-FAMT PET/CT in the assessment of preoperative oral tumor patient with suspected cervical lymph node metastasis;Comparative study with 18F-FDG PET/CT., Annual Congress of the Europian Association of Nuclear Medicine 2011, 2011年
• Incremental value of I-123 MIBG SPECT/CT over FDG-PET in the evaluation of malignant pheochromocytoma., Progress in Radiology, 2012年
• Preliminary technical assessment of 11C-Pittsburgh Compound-B PET(PIB PET) imaging in different image display conditions., Progress in Radiology, 2012年
• A Preliminary Report on EGFR-targeted PEGylated PLGA Immunonanobubbles as an Intratumor-specific targeted Ultrasound Contrast Agent., Progress in Radiology, 2012年
• Effect of scatter correctiono the accuracy of I cresed cerebral perfusion rate in 123I-IMP brain SPECT;Multicenter study., Annual Congress of the Europian Association of Muclear Medicine, 2012年
• Incremental value of L-3- [18F]-fluoro-alpha-methyl tyrosine (FAMT) PET for the accurate evaluation of bone marrow invasion in patients with oral squamous cell carcinoma;Comparison with FDG-PET and MRI., Progress in Radiology, 2012年
• Non-invasive quantitative evaluation of cerebral blood flow (CBF) using technetium labeled ethyl cysteinate dimer (99mTc-ECD): performance of aorta’s region of interest (ROI)., Progress in Radiology 2016 11th symposium of the Japanese Scandinavian Radiological Society, 2016年
• Retrospective evaluation of the utility of thyroglobulin doubling time in the diagnosis of radioactive-io-dine-refractory differentiated thyroid cancer; initial experience from 6 patients treated with Lenvatinib., Progress in Radiology 2016 11th symposium of the Japanese Scandinavian Radiological Society, 2016年
• The Effect of Shape of Ragion of Interest(ROI) in Aortic Arch for Cerebral Blood Flow Quantification Using 99mTc-ECD., JRS, 2017年
• Influence of Attenuation and Scatter Corrections on Quantitative Analysis of [123I]FP-CIT SPECT Brain Imaging., JRS, 2017年
• A Novel Parameter to Evaluate Thyroid Function with Dual Energy Computed Tomography in Patients with Hyperthyroidism., JRS, 2017年
• Can18F FDG PET Predict 131I Radioiodine Therapeutic Response in Metastatic Differentiated Thyroid Carcinome?, 第64回北関東医学会総会, 2017年
• Prognastic Value of Tumor Volume of Pretreatment 18F-FAMT PET in Non-Small Cell Lung Cancer., RSNA2017, 2017年
• Objective methods for the diagnosis of myocardial ischemia using computed tomographic iodine images: comparison with 99mTc-stress perfusion SPECT., European Society of cardiology (ESC) Congress 2013, 2013年
• Clinical utility of Fluorine-18-α-Methyltyrosine dynamic PET study in the differentioal diagnosis of glioma., 10th Symposium of the Scandinavian Japanese Radiological Society & 13th Nordic Japan PACS Symposium, 2014年
• Differentiation of malignant tumors from granulomas with dynamic [18F］-Fluoro-L-α-methyltyrosine PET imaging., EANM, 2013年
• PET volume computer-assisted reading (PET VCAR) software for accurate measurement of tumor volume using 18F-FAMT PET/CT in oral cancer., EANM, 2013年
• Current topics of PET/CT in the diagnosis of oral cancer., 16th National congress of the Vietnamese society of radiology and nuclear medicine, 2014年
• PET/CT metabolic tumor volume and total lesion glycolysis/retention predict outcome in oral squamous carcinoma: comparison study of 18F-FDG and 18F-FAMT., EANM, 2014年

共同研究・競争的資金等の研究課題

• RIを用いた腫瘍の診断と治療, 科学研究費補助金, 2001年, 2002年, 競争的資金
• Nuclear oncolor, Grant-in-Aid for Scientific Research, 2001年, 2002年, 競争的資金